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ABSTRACT 
Courtney Colleen Roberts: New Classes of Transition Metal N-Heterocyclic Carbon(0) 
Catalysts for C–C and C–N Bond Forming Reactions 
(Under the direction of Simon J. Meek) 
 
I. Development of Carbodicarbene-Rh Complexes 
 The development and synthesis of new carbodicarbene-Rh(I) pincer complexes is 
reported. These complexes incorporate electron-rich carbon(0) ligands and represent the first 
carbodicarbene pincer complexes ever reported. 
II. Carbodicarbene-Rh Catalyzed Hydroamination of Dienes 
 The first example of carbodicarbene ligands used in catalysis is reported. The 
hydroamination of 1,3-dienes is catalyzed by 1-5 mol% of readily available carbodicarbene-
Rh catalysts to generate a variety of allylic amines in up to 97% yield.  
III. Lewis Acid Activation of Carbodicarbene-Rh Catalysts for Hydroarylation of 
Dienes 
 
 The use of Lewis acid cocatalysts to activate carbodicarbene-Rh complexes for the 
hydroarylation of 1,3-dienes is reported. Substituted indoles and pyrroles are competent 
reaction partners with both terminal and internal 1,3-dienes. NMR spectroscopy is used to 
study the effect of the Lewis acid on the carbodicarbene-Rh complexes. 
IV. Development of Chiral Carbodicarbene and Cyclic Bent Allene Catalysts for 
Enantioselective Hydrofunctionalization 
 
 The development and synthesis of chiral carbodicarbene and cyclic bent allene Rh(I) 
complexes is reported. Using these catalysts, enantioselective hydroarylation, 
	 iv	
hydroamination, hydroalkylation, and hydroallylation is enabled in yields of up to 80% and 
enantioselectivities of up to 85%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 v	
 
For the all the FIRST mentors and volunteers, especially from FRC 330 from 2003 – 2007. 
The work that you do changes lives. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 vi	
 
 
ACKNOWLEDGMENTS 
 I need to thank the mentors that I have had along the way. To the mentors of FRC 
330, especially Matt Driggs, you were the first people who showed me that science was fun 
and that math had a purpose. I will always be grateful for your mentorship. To Dr. Joe 
Fritsch, thank you for introducing me to research. I’ve come quite a long way from the 
freshman who dropped pipettes into columns while loading them. Without your 
encouragement and support, I would have never even considered going to graduate school. 
To Simon Meek, thank you for taking a chance on an inorganic chemist. You taught me to 
never talk myself out of a reaction and because of this, I was able to discover so many 
different facets of my project. My favorite part about working for you is that your door is 
always open and you are always willing to offer advice about what to try next when things 
don’t work as planned. A special thank you to my orals (Profs. Brookhart, Miller, Waters, 
and Templeton) and thesis committees (Profs. Dempsey, Miller, Waters and Alexanian) for 
supporting me throughout my career with advice, guidance, and letters of recommendation.  
 I also have to thank my family for supporting me throughout my time in graduate 
school. Thank you for allowing me to have the opportunity to go to Pepperdine, believing in 
me when I switched my major to chemistry 8 years ago, and supporting me throughout my 
whole graduate career and life. I wouldn’t be where I am today without you. A special thanks 
to my mom who dedicated her life to teaching her children. 
 To all my labmates, past and present, thank you so much for making each day so 
much fun. Even when you forced me to listen to Bruno Mars, I still enjoyed (at least part of) 
	 vii	
every single day. Steph, I will always remember that crazy shot that Marcus Paige made to 
beat Louisville that kicked off our tradition of watching UNC basketball games together. 
Thanks for always being there to talk about anything and to decorate cookies! To Jake, “I 
invented the piano key necktie, what have you done!?” “It’s a miracle” that we found a way 
to bond over “wwwwhiskey” and “beets, bears, Battle Star Galactica.” When I’m gone, be 
sure to take care of our pump! Thanks to Jess for being an amazing undergrad and to Charles 
for keeping us all entertained. I need to give a special thank you to Matt Joannou. Matt, I’ve 
told you a million times, but without your friendship and advice (both chemistry and non-
chemistry) I wouldn’t have survived graduate school (and would have far fewer crystal 
structures!) Just remember, everyone is crazy except you and me…and I’m not so sure about 
you.  
  Finally, I would never have made it through graduate school without the incredible 
support of my friends, both inside and outside the chemistry department. A special shout out 
to my Durham “family”.  Samantha (aka old man Sammy), I will always remember your 
ability to humanely get rid of spiders, made up words, and TV shows we watched together. 
Alex and Caitlin deserve an acknowledgement for all the games of shoe and family dinners 
we had together. I will miss Sunday nights and Tri Restaurant Week with the fam. I have to 
thank Kyle, my first real friend in Chapel Hill, for putting up with me at our weekly lunches 
throughout these 5 years. Some of my best memories (Washington DC, Fearrington, making 
you do things you didn’t want to, then gloating after when you enjoyed them) in graduate 
school are with you. Korrina, whether we were dancing, swimming at the quarry, or 
practicing for story slams, your positive attitude always made me feel like everything was 
going to be all right in the end. To Andrea, my fellow “mom,” I’m so grateful to have had a 
	 viii	
planning buddy who is ready, at a moment’s notice, to salsa dance on the most decorated 
battleship of WWII. Gizem, your adventurous spirit and willingness to talk for hours over 
fancy cocktails or hookah provided me a much-needed escape for the craziness of grad 
school. Allison, your thoughtfulness and willingness to try new things (contact improv 
anyone?) combine to make you an absolutely incredible friend. To Sara, my feminist kindred 
spirit, your positivity and support through my last year of graduate school is so appreciated. 
A special thank you to the members of WISE including Jazz, Tien, Abby, Val, Michelle, and 
so many others who set an incredible example for me as women in science. There are so 
many people (Piotr, Katie, Kristin, Shweta, Effie, Cari, Aly, Chelsea, and Zeal) who have 
made my life incredible during graduate school. Finally, to my best friend Taylor, when I 
was forced to meet you for brunch on Sunday three years ago I had no idea that I would find 
my best friend. Without our adventures (you forcing me to go camping, road tripping to DC, 
hiding from people while eating comfort cones, staying out all night at salsa clubs, sharing 
margaritas (but not straws or tents), and making up nicknames for people), I would have 
never survived graduate school.  
 
 
 
 
 
 
	 ix	
 
TABLE OF CONTENTS 
 
List of Tables..……………………………………….………………………………………xii 
List of Charts………………………………………………………………………………..xiii 
List of Figures……………………………....………………......…..………………….……xiv 
List of Schemes………………………………………………….………......……………….xv 
List of Abbreviations…………………………………………………………....………..…xvi 
Chapter 1 Development of Carbodicarbene-Rh Complexes….........…...…………….. 1 
1.1 Introduction ................................................................................................................. 1 
1.2 Background .................................................................................................................. 2 
1.2.1 Definition of carbodicarbenes .............................................................................. 2 
1.2.2 Theoretical studies on carbodicarbenes ................................................................ 3 
1.2.3 Synthesis of carbodicarbenes ................................................................................ 1 
1.2.4 Carbodicarbenes in transition metal catalysis ...................................................... 3 
1.2.5 Carbodicarbenes in organocatalysis ..................................................................... 6 
1.3 Results and discussion ................................................................................................. 7 
1.3.1 Design of CDC pincer ligands .............................................................................. 7 
1.3.2 Synthesis of CDC pincer ligand salts ................................................................... 8 
1.3.3 Demonstration of a second proton affinity ........................................................... 9 
1.3.4 Rh-carbodicarbene chloride complexes .............................................................. 10 
1.3.5 Rh-carbodicarbene acetonitrile complexes ......................................................... 11 
	 x	
1.3.6 Rh-carbodicarbene carbonyl complexes ............................................................. 14 
1.3.7 Rh-methylene complex formation ...................................................................... 15 
1.4 Conclusion ................................................................................................................. 16 
1.5 Experimental .............................................................................................................. 16 
References……………………………………………………………………………………80 
Chapter 2 Carbodicarbene-Rh Catalyzed Hydroamination of Dienes ................................ 81 	
2.1 Introduction ............................................................................................................... 81 
2.2 Background ................................................................................................................ 82 
2.2.1 Mechanisms of late transition metal-catalyzed hydroamination ........................ 82 
2.2.2 Group 10-catalyzed hydroamination .................................................................. 84 
2.3 Carbodicarbene Rh-catalyzed hydroamination .......................................................... 86 
2.3.1 Development of hydroamination catalysts ......................................................... 86 
2.3.2 Optimization of CDC Rh-catalyzed hydroamination of phenylbuta-1,3-diene .. 87 
2.3.3 Substrate scope ................................................................................................... 88 
2.3.4 Mechanistic insights ........................................................................................... 92 
2.4 Conclusion ................................................................................................................. 92 
References…………………………………………………………………………………..172 
Chapter 3 Lewis Acid Activation of Carbodicarbene-Rh Catalysts for  
Hydroarylation of Dienes ………………………….……………………………………….173 	
3.1 Introduction ............................................................................................................. 173 
3.2 Background .............................................................................................................. 174 
3.2.1 Metal-catalyzed hydroarylation ........................................................................ 174 
3.2.2 Bimetallic C(0) complexes ............................................................................... 175 
3.3 Results and Discussion ............................................................................................ 176 
	 xi	
3.3.1 Initial observation of hydroarylation ................................................................ 176 
3.3.2 Synthesis of a CDC-Rh styrene complex ......................................................... 177 
3.3.3 Optimization of Lewis acid additive ................................................................ 179 
3.3.4 Substrate scope ................................................................................................. 180 
3.3.5 Studies of the effect of Lewis acid additives Scheme 3-4 Studies  
on the effect of Lewis acid additive .............................................................................. 184 	
3.4 Conclusion ............................................................................................................... 186 
3.5 Experimental ............................................................................................................ 186 
References…………………………………………………………………………………..280 
Chapter 4 Development of Chiral CDC and CBA Catalysts for Enantioselective 
Hydrofunctionalization ......................................................................................................... 281 	
4.1 Introduction ............................................................................................................. 281 
4.2 Background .............................................................................................................. 281 
4.2.1 Transition metal-catalyzed enantioselective hydroarylation ............................ 281 
4.2.2 Transition metal-catalyzed enantioselective hydroamination .......................... 282 
4.3 Results and Discussion ............................................................................................ 283 
4.3.1 Catalyst design .................................................................................................. 283 
4.3.2 Chiral carbodicarbene catalyst synthesis .......................................................... 285 
4.3.3 Catalysis with chiral carbodicarbene Rh complexes ........................................ 287 
4.3.4 Cyclic bent allene catalyst synthesis ................................................................ 288 
4.3.5 Catalysis with CBA complex 4.2 ..................................................................... 290 
4.3.6 Expanding the scope of nucleophiles ............................................................... 293 
4.4 Conclusion ............................................................................................................... 294	
References…………………………………………………………………………………..329 
	 xii	
LIST OF TABLES 
Table 2-1 Hydroamination of dienes with Rh-carbodicarbene catalysts 2.7 and 2.8 ............. 87 
 
Table 3-1 Optimization of Lewis acid additives .................................................................. 179 
 
Table 4-1 Enantioselective hydroarylation of 1,3-dienes using chiral CBA catalyst 4.2 .... 290 
 
Table 4-2 Optimization of the hydroarylation of dienes ...................................................... 292 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 xiii	
LIST OF CHARTS 
 
Chart 2-1 Aryl and alkyl amine substrate scope .................................................................... 89 
 
Chart 2-2 Diene substrate scope ............................................................................................ 91 
 
Chart 3-1 Hydroarylation of terminal dienes with functionalized indoles and pyrroles ..... 182 
 
Chart 3-2 Hydroarylation of internal dienes with indole and pyrrole ................................. 183 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 xiv	
LIST OF FIGURES 
Figure 1-1 General representations of carbodiphosphoranes (CDPs), tetraaminoallenes 
(TAAs), and carbodicarbenes (CDCs) .............................................................................. 2 	
Figure 1-2 Models for bonding in CDCs……………………………………………………..3 
Figure 1-3 Carbodicarbene ligands and complexes………………………………………......3 
Figure 1-4 The first examples of cyclic bent allenes and their adducts ................................... 2 	
Figure 1-5 Dihydridoboron complex………………………………………………………....9 
Figure 1-6 Design of new CDC ligands ................................................................................... 7 	
Figure 1-7 ORTEP drawing of 1.17........................................................................................15 
Figure 1-8 ORTEP drawing of 1.18........................................................................................16 
Figure 1-9 ORTEP drawing of 1.21........................................................................................18 
Figure 2-1 Hydroamination of an olefin.................................................................................84 
Figure 2-2 Rh-carbodicarbene complexes..............................................................................89 
Figure 3-1 CDC-Rh pincer complexes for hydroamination of dienes ................................. 174 
 
Figure 3-2 Bimetallic C(0) complexes ................................................................................. 175 
 
Figure 3-3 ORTEP drawing of 3.8 ....................................................................................... 178 
 
Figure 4-1 Chiral CDC and CBA catalyst design ................................................................ 284 
 
Figure 4-2 Synthesis of chiral CDC Rh pincer complex 4.1 ............................................... 285 
 
 
 
 
 
 
	 xv	
LIST OF SCHEMES 
Scheme 1-2 Hydrogenation of alkenes catalyzed by a CDC ruthenium complex ................... 5 
 
Scheme 1-3 Synthesis of diazapinium salts .............................................................................. 8 
 
Scheme 1-4 Protonation of diazapinium salt 1.12 .................................................................... 9 
 
Scheme 1-5 Synthesis of Rh carbodicarbene pincer complexes ............................................ 10 
 
Scheme 1-6 Synthesis of CDC Rh-acetonitrile complexes .................................................... 11 
 
Scheme 1-7 Synthesis of Rh-carbonyl complexes ................................................................. 14 
 
Scheme 1-8 Rh-methylene complex formed during recrystallization .................................... 15 
 
Scheme 2-1 Late transition metal-catalyzed mechanisms for hydroamination ...................... 83 
 
Scheme 2-2 PNP-Pd-catalyzed intramolecular hydroamination of alkenes ........................... 84 
 
Scheme 2-3 Rh-catalyzed intra- and intermolecular hydroamination of alkenes ................... 85 
 
Scheme 2-4 Reaction of 2.9 and aniline ................................................................................. 92 	
Scheme 3-1 Transition metal-catalyzed hydroarylation of olefins through an electrophilic 
activation mechanism .................................................................................................... 174 
 
Scheme 3-2 Hydroarylation of phenylbuta-1,3-diene with 3.1 ............................................ 176 
 
Scheme 3-3 Synthesis of a soluble CDC-Rh styrene complex 3.8 ....................................... 177 
 
Scheme 3-4 Studies on the effect of Lewis acid additive ..................................................... 184 
 
Scheme 3-5 Effect of acid on CO stretching frequencies ..................................................... 185 
 
Scheme 3-6 Deuterium labeling studies ............................................................................... 186 
 
Scheme 4-1 Previous examples of enantioselective hydroamination of 1,3-dienes ............. 282 
 
Scheme 4-2 Enantioselective hydrofunctionalization with CDC-Rh complex 4.1 .............. 287 
 
Scheme 4-3 Synthesis of CBA-Rh complex 4.2 .................................................................. 288 
 
Scheme 4-4 N- and C-based nucleophiles tolerated for hydrofunctionalization of phenylbuta-
1,3-diene with CBA-Rh catalyst 4.2 ............................................................................. 293 
 
	 xvi	
LIST OF ABBREVIATIONS 
BA – Bent allene 
9-BBN – 9-Borabicyclo[3.3.1]nonane BIPHEP	–	(biphenyl-2,2′-diyl)bis(diphenylphosphine)	
	Bn	–	Benzyl		
Boc – Tert-butyloxycarbonyl 
Bu – Butyl 
CAAC – Cyclic(alkyl)(amino)carbene 
CBA – Cyclic bent allene 
Cbz - Carboxybenzyl 
CDC – Carbodicarbene 
CDP – Carbodiphosphorane 
COD – Cylcoocta-1,4-diene 
DCE – 1,2-Dichloroethane 
Et – Ethyl 
GC – Gas chromatography 
HMDS – Hexamethyldisilazane 
HOMO – Highest occupied molecular orbital 
HPLC – High performance liquid chromatography 
iPr – isopropyl 
LA – Lewis acid 
LUMO – Lowest unoccupied molecular orbital 
Me – Methyl 
	 xvii	
MeCN – Acetonitrile 
MIDA – Methyliminodiacetate 
Mbs – 4-Methoxybenzenesulfonyl 
NHC – N-heterocyclic carbene  
NMR – Nuclear magnetic resonance 
OTf – Triflate or trifluoromethanesulfonate 
PA – Proton affinity 
Ph – Phenyl 
Segphos – (R/S)-(+/-)-5,5′-Bis(diphenylphosphino)-4,4′-bi-1,3-benzodioxole, [4(R/S)-(4,4′-
bi-1,3-benzodioxole)-5,5′-diyl]bis[diphenylphosphine] 
 
SIMes - 1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene 
TAA – Tetraaminoallene 
tBu – Tertiary butyl or 1,1-dimethylethyl 
TFA – Trifluoroacetic acid 
thf – Tetrahydrofuran 
TIPS – Triisopropylsilyl 
 		
 
	 1	
 
Chapter 1 Development of Carbodicarbene-Rh Complexes1 
1.1 Introduction 
 Development of new ligands and catalysts is necessary to access novel organic 
compounds.1,2 Over the past three decades, carbon-based ligands, such as N-heterocyclic 
carbenes (NHCs), cyclic(alkyl)(amino)carbenes (CAACs), and carbodiphosphoranes (CDPs), 
have enabled catalytic transformations such as alkene metathesis, hydroamination, and 
conjugate addition.3,4 Carbon donors are attractive ligands because they are strong σ-donors 
to transition metals and provide a different steric environment compared to phosphine 
ligands.5,6 
 Carbodicarbenes (CDCs) are a class of divalent carbon(0) compounds. They can be 
described as a C(0) atom that is being donated into by two neutral carbon donors.7 This 
generates an electron-rich central carbon that possesses two lone pair orbitals (one s and one 
p) that could potentially bind to a metal center. Because of their potential to be good ligands 
for transition-metal catalysis, our group wanted to explore their utility. Herein is reported the   
																																																								
1 A portion of this chapter appeared as a communication in the Journal of the American 
Chemical Society The original citation is as follows: *Goldfogel, M. J.; *Roberts, C. C.; 
Meek, S. J. J. Am. Chem. Soc. 2014, 136, 6227-6230. (*Authors contributed equally.) Author 
contributions: CCR and SJM designed and synthesized the ligands and catalysts. CCR (with 
special focus on amine scope) and MJG (with special focus on diene scope and initial 
optimization) ran catalytic reactions. Crystals were obtained by CCR and structures were 
solved by M. V. Joannou. 
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development of carbodicarbene-Rh(I) pincer complexes. These complexes represent the first 
examples of carbodicarbene complexes being utilized in catalysis. 
1.2 Background 
1.2.1 Definition of carbodicarbenes 
  
Figure 1-1 General representations of carbodiphosphoranes (CDPs), tetraaminoallenes 
(TAAs), and carbodicarbenes (CDCs) 
 In 2007, carbodicarbenes with the general formula of C(NHC)2 were first investigated 
theoretically by Frenking and Tonner.8 The generic structure that is described involves a 
carbon(0) atom that is bound to two NHCs. Since 2008, a number of different carbon(0) 
compounds (also known as carbones) have been synthesized that are considered 
carbodicarbenes but do not have NHC donors.9,10 They instead contain CR2 (where R = OR1 
or NR12) donors and are called bent allenes. The definition of a carbodicarbene was expanded 
to include these carbon(0) compounds.7 One property of carbodicarbenes is that the central 
carbon possesses two proton affinities (which is a measure of the gas phase basicity of a 
molecule).   
 CDCs are related to carbodiphosphoranes, which also involve a carbon(0) atom 
bound to two donor ligands, in this case phosphines (Figure 1-1).11 Tetraaminoallenes 
(TAAs) adopt a linear configuration and are best described as carbon(IV) compounds in the 
ground state, but behave in a similar way to carbon(0) compounds because the central carbon 
possesses two proton affinities (R = tBu has been isolated at the dication).7 Previous to our 
RN
N
RC
NR
N
R
C PR3R3P C
R2N
R2N NR2
NR2
CDP CDCTAA
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report, CDCs had never been used in catalysis and there exists only a limited number of 
reports of carbodiphosphorane complexes being used in catalysis.12,13  
1.2.2 Theoretical studies on carbodicarbenes 
 In order to understand the unique properties of these previously unstudied carbon(0) 
compounds, the structures and optimal geometries of the CDCs (R = H, Me) in Figure 1-1 
were examined computationally.8 When R = H, the most stable conformation of the CDC has 
an acute CNHC-C(0)-CNHC angle of 125.88° and a torsion angle between the NHCs of 81.68°. 
There was little difference in energy between the ground state configuration and that of the 
NHCs being orthogonal to each other (2.3 kcal/mol higher) and the NHCs being planar (3.3 
kcal/mol higher). The linear structure CNHC=C=CNHC that mimics a tetraaminoallene was 
found to be only 3.7 kcal/mol higher in energy. For the case of R = Me, the ground state 
structure has a wider CNHC-C(0)-CNHC angle of 131.8° due to the sterics of the methyl groups. 
The planar structure is much higher in energy (12.6 kcal/mol) whereas the TAA analogue is 
only higher in energy by 3.0 kcal/mol. 
 The molecular orbitals of the C(0) were also studied. The highest occupied molecular 
orbital (HOMO) is a π-type orbital with the largest coefficient on the central carbon and 
because it is in conjugation with the NHC donors, the HOMO is more delocalized than the 
HOMO-1 which is an σ-type orbital. The first and second proton affinities (PAs) were 
calculated and the C(0) was found to be strongly basic with PAs equal to 294.3 and 168.4 
kcal/mol when R = Me.  
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 A number of different models have been proposed to describe the bonding in 
carbodicarbenes (Figure 1-2).7,14–17 The Lewis dot model which is the standard that will be 
used throughout (Figure 1-2a) illustrates the zwitterionic character of CDCs, with two 
positive charges delocalized on the NHC moieties and two lone pairs of electrons on the 
central carbon. The captodative model (Figure 1-2b) describes the carbodicarbene as a 
having a C(0) ligated by two NHCs. Some groups have described CDCs as “bent allenes” 
which are formally carbon(IV) compounds (Figure 1-2c).7,18 
1.2.3 Synthesis of carbodicarbenes 	
Me
Me
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Me Me
C
Me
Me
NN
NN
Me Me
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Me Me
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Figure 1-2 Models for bonding in CDCs a) Lewis dot model, b) 
captodative model, c) bent allene 
Figure 1-3 Carbodicarbene ligands and complexes synthesized by Bertrand (1.1 and 1.2) 
and Fürstner (1.3 and 1.4) 
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 In 2008, the groups of Bertrand and Fürstner independently synthesized the first 
carbodicarbenes (Figure 1-3).9,19 As predicted by Frenking and Tonner, the CDC structure 
1.1 is “bent” with a C-C-C bond angle of 134.8°.8 Also, in agreement with calculations, the 
planes that contain the two different NHCs are twisted by 69°. Although these compounds 
are referred to as “bent allenes,” Bertrand and coworkers point out that the central carbon is 
not sp hybridized like a typical allene but can be described as a sp2 carbon with two lone 
pairs of electrons with σ and π donor capabilities. Carbodicarbene 1.1 also does not bind in 
an η2 fashion like a traditional allene does.20 Instead 1.1 binds η1 to Rh(I) to yield carbonyl 
complex 1.2, which has an average CO stretching frequency of 2014 cm-1. A number of 
different derivatives of 1.1 have been synthesized by Ong and coworkers.21 
 Fürstner and coworkers examined teraaminoallene 1.3, which in the ground  
state adopts a more traditional linear allene structure but has latent contributions from the 
carbodicarbene-type structure represented in Figure 1-3.8,19 Additionally, two proton 
affinities have been calculated for compound 1.3, giving it carbodicarbene like properties. 
These CDC-like properties are also manifested when 1.3 is bound to a transition metal. 
Cationic gold(I) complex 1.4 was synthesized and characterized crystallographically. The 
CNHC-C(0)-CNHC bonds have an angle of 118.5° and the torsion angle between the diamine 
donors is 62°. 
 
Figure 1-4 The first examples of cyclic bent allenes and their adducts 
N N
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Me Me
Me
N N
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Me Me
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  Later in 2008, Bertrand and coworkers synthesized cyclic carbodicarbenes 1.5 and 
1.6, which are also known as cyclic bent allenes (CBAs) (Figure 1-4).10 The free pyrrolidine 
substituted carbodicarbene 1.5 could not be isolated. It was instead isolated as the lithium 
adduct. By switching to less basic substituents, aryloxy substituted CBA 1.6 was able to be 
isolated as the free CBA. The crystal structure of 1.6 was obtained and has a CNHC-C(0)-CNHC 
angle of 97.5°. Rhodium-carbonyl complex 1.7 was synthesized by exposing 1.6 to 0.5 
equivalents of [Rh(CO)2Cl]2 and has an average CO stretching frequency of 2018 cm-1. 
Stephan and coworkers synthesized a three-coordinate Fe(II) complex using 1.6 as a ligand.22 
 Computational studies on these compounds conclude that there is stabilization from 
conjugation between the π-donating, exocyclic substituents at the 3- and 5- positions and the 
ring.18 This causes the compounds to have reduced aromaticity or be non-aromatic, 
depending on the extent of donation from the exocyclic donor. This is confirmed by the 
pyramidalization of the nitrogens in the pyrazole ring that is seen in the crystal structures of 
1.5 and 1.6. Additionally, a derivative of 1.5, where the pyrrolidines are replaced with 
dimethylamine groups, was treated with tetrafluoroboric acid and the C-4 position was 
protonated, instead of any of the four nitrogens, which would have preserved aromaticity.  
1.2.4 Carbodicarbenes in transition metal catalysis 
	 4	
 Shortly after our report on the first use of carbodicarbenes in catalysis, Ong and 
coworkers reported the use of tridentate CDC-Pd(II) pincer complex 1.7 to catalyze a Suzuki 
cross coupling (Scheme 1-1) as well as a Heck reaction.23,24 Pd-complex 1.7 was synthesized 
by heating the dicationic salt of the ligand with PdCl2 and K2CO3 to 100 °C in acetonitrile. 
Both the free CDC ligand as well as complex 1.7 were isolated and characterized 
crystallographically. The geometry around palladium in 1.7 is square planar as expected; the 
tridentate CDC pincer ligand is distorted so that the methyl substituents on the NHC moieties 
do not have unfavorable steric interactions. The Pd-Cl bond is lengthened to 2.4090(0) Å 
indicating the strong trans influence of the CDC ligand. It is noteworthy that the Heck 
reactions were performed in aqueous media with a tetrabutylammonium salt present at 120 
°C indicating that complex 1.7 is stable to water.  
 
 
 
 
 
 
N
NN
N
Me
Me
NPdN
Cl
I
B(OH)2
O
Me
Br
+
O
Me
0.5 mol%
K3PO4, 3-chloropyridine
PhMe, 120 °C, 3 h
1.7
Scheme 1-1 Suzuki cross-coupling using CDC Pd complex 1.7 
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Scheme 1-2 Hydrogenation of alkenes catalyzed by a CDC ruthenium complex 
 
 
 In 2015, Stephan and coworkers published a CDC-Ru catalyzed hydrogenation of 
alkenes.22 Ruthenium complex 1.8 and other analogs were synthesized using aryloxy CDC 
ligand 1.6 and RuHCl(CO)(PPh3)3.10 After screening a variety of catalysts with different L- 
(SIMes, PPh3) and X-type (OTf, Cl) ancillary ligands, complex 1.8 was found to be the 
optimal catalyst for alkene hydrogenation. A variety of simple alkenes, such as 1-hexene, 
styrene, and cyclohexene, and 1,1 or 1,2–disubstituted alkenes were hydrogenated using low 
catalyst loadings. Catalyst 1.8 was directly compared to other known hydrogenation catalysts 
such as Crabtree’s and Wilkinson’s catalysts and found to have comparable or superior 
performance. Nitro groups, esters, free alcohols, ethers, and enones were all tolerated under 
the reaction conditions.  
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1.2.5 Carbodicarbenes in organocatalysis 		
 
 
 
  
 
 
  
 Ong and coworkers have used CDC ligands to stabilize boron compounds (Figure 1-
5).25,26 Due to the strong donor properties of CDCs, the first ever three-coordinate, dicationic 
hydrido boron complex was synthesized (Figure 1-5). This was used as precedent for a step 
in the catalytic methylation of amines using CO2 and 9-BBN. 
N
N
NN
Me
iPr
Me
iPrMe
iPr
iPr MeNN
N
N
B
H
2 BH4
1.9
Figure 1-5 Dihydridoboron 
complex 
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1.3 Results and discussion 
1.3.1 Design of CDC pincer ligands
 
Figure 1-6 Design of new CDC ligands 
 Our group wanted to design a class of tridentate ligands that incorporated three 
neutral donors (a carbodicarbene donor and two phosphines (Figure 1-6)). We wanted to 
utilize these CDC pincer ligands for use in late transition metal-catalyzed 
hydrofunctionalization reactions (Chapters 2 and 3). This tridentate structure facilitates 
metallation through binding of a phosphine to a metal center which assists in guiding the 
metal center to associate with the carbodicarbene.27–31 When bound to group 9 and 10 metals 
such as Rh(I), Pd(II), and their congeners, pincer ligands have been shown to prevent β-
hydride elimination.32–34 The tethered backbone renders the ligands cyclic and quite planar, 
which favors a more carbodicarbene structure over a bent allene.10 The N-heterocyclic 
carbene moieties provide modularity. They can be saturated (as shown) or unsaturated (as in 
Tethered backbone:
l Provides rigidity
l Maintains orbital alignment
NHC component:
l Provides modularity
l Can incorporate chirality
Phosphine substituents: 
l Provides steric and
l electronic tunability
Tridentate structure:
l Prevents β-hydride elimination
l Facilitates metallation
l Incorporates 3 neutral donors
N N
NN
P P RR
R R
G G
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imidazole or benzimidazole). The saturated NHC moieties can be made chiral through amino 
acids or other members of the chiral pool.35 Finally, we envisioned that the addition of 
neutral phosphine donors would allow for both steric and electronic tunability.  
1.3.2 Synthesis of CDC pincer ligand salts 
Scheme 1-3 Synthesis of diazapinium salts 
 
 Achiral diazapinium CDC precursor salts 1.12 and 1.13 were targeted (Scheme 1-3). 
I wanted to test both alkyl and aryl substituents on the phosphines due to their differing 
electronic and steric properties. Achiral diazapinium CDC precursor salts 1.12 and 1.13 were 
synthesized through common diazapinium salt intermediate 1.11. To achieve this, 
unsubstituted diazapinium salt 1.11 was synthesized according to a modified literature 
procedure.36 The cyclization was performed using technical grade triethylene tetraamine and 
malononitrile in the presence of ammonium tetrafluoroborate. The reaction was heated at 180 
°C for 1 hour to produce 1.11 in 80% yield after purification using silica gel 
chromoatography. The original procedure calls for making the chloride salt, but that is not 
stable to silica gel chromatography so NH4Cl was substituted for NH4BF4.  
 Unsubstituted diazapinium 1.11 was converted to the phosphine carbodicarbene 
precursor salts 1.12 and 1.13 using either phenyl or isopropyl substituted chlorophosphines in 
the presence of triethylamine at room temperature for 18 hours. A large excess of 
triethylamine is necessary because with a stoichiometric amount, the product is formed in 
N N
NN
P P RR
R R
NH HN
H2NNH2
N N
N
H
N
H
CNNC
NH4BF4
2-(2-methoxyethoxy)-
ethanol,
180 oC, 1 h
R2P-Cl, Et3N
CH2Cl2, 
22 oC, 18 h
1.12 R = Ph
1.13 R = i-Pr
BF4BF4
80% yield
1.10 1.11
1.12, 85% yield
1.13, 71% yield
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much lower yield and monosubstituted products are formed. A variety of other bases such as 
NaHMDS, NaOtBu, NaOMe, and n-butyl lithium were tried but yielded low amounts of 
product. Salts 1.12 and 1.13 were synthesized via the triethylamine route in 85% and 71% 
yields respectively. It should be noted that these compounds are stable to silica gel 
chromatography and can be stored on the bench top indefinitely. A variety of bases (NaH, n-
BuLi, NaHMDS, NaOtBu, and NaOMe) at cryogenic or room temperatures were used in an 
attempt to deprotonate the methine proton to form the free carbodicarbene, but all conditions 
that I tried were unsuccessful.   
1.3.3 Demonstration of a second proton affinity 
Scheme 1-4 Protonation of diazapinium salt 1.12 
  
 In order to demonstrate that 1.12 has significant electron density and a second proton 
affinity at the central carbon, I subjected 1.12 to one equivalent of tetrafluoroboric acid 
diethyletherate (Scheme 1-4). After 10 minutes, dication 1.14 was observed in greater than 
90% conversion. This result is in agreement with both previous experimental and 
computational data.7,18,37  
 
 
 
N N
NN
Ph2P PPh2
BF4
NN
N N
PPh2
BF42
HBF4 • Et2O 
CD2Cl2, 22 oC,
10 min
2
H HPh2P
>90% conversion
1.12 1.14
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1.3.4 Rh-carbodicarbene chloride complexes 	
Scheme 1-5 Synthesis of Rh carbodicarbene pincer complexes 
		
 I synthesized the desired carbodicarbene complexes 1.15 and 1.16 as shown in 
Scheme 1-5. [RhCODCl]2 and 1.12 or 1.13 are reacted in tetrahydrofuran at 22 °C for 2 
hours. Wilkinson’s catalyst can also be used as a rhodium source, but excess phosphine in the 
reaction proved problematic during subsequent steps. Using [RhCODCl]2, a bright yellow 
(with diazapinium salt 1.12) or red (with diazapinium salt 1.13) heterogeneous reaction is 
produced after 2 hours. This hydride intermediate is the product of the oxidative insertion of 
the Rh into the methine proton-carbon bond. A variety of bases such as NaOtBu and 
NaHMDS were attempted to cleanly deprotonate the hydride but gave mixtures of products. 
When I used NaOMe, chloride complexes 1.15 and 1.16 were formed cleanly in excellent 
yields as bright orange or yellow powders, respectively. I attempted to crystalize complexes 
1.15 and 1.16 using tetrahydrofuran and hexanes but all attempts yielded crystals that formed 
as thin plates. When the recrystallization of 1.15 was attempted using MeCN, the salt 
metathesis of 1.15 and sodium tetrafluoroborate (which is a byproduct formed during the 
metallation that is mostly filtered off) occurred which produced 1.17 (vide infra). The same 
salt metathesis was observed to occur with 1.16 to form 1.18. To confirm the product, 1.17 
was independently synthesized. 
N
N
N
N P
P
R
R R
R
BF4
1. [RhCODCl]2
thf, 22 °C, 2 h
2. NaOMe
 thf, 22 °C, 2h
N
N
N
N P
P
R
R R
R
Rh Cl
R = Ph 1.15 >98% yield
R = iPr 1.16 >98% yield
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1.3.5 Rh-carbodicarbene acetonitrile complexes 
Scheme 1-6 Synthesis of CDC Rh-acetonitrile complexes 
  	
 Because neutral complexes 1.15 and 1.16 did not produce crystals that were suitable 
for obtaining a crystal structure, I independently synthesized cationic acetonitrile complex 
1.17. The reaction using only 1 equivalent of silver tetrafluoroborate did not go to 
completion. Using 1.5 equivalents of silver tetrafluoroborate and acetonitrile as the solvent, 
the cationic Rh acetonitrile complex was produced in good yield (86%) after 2 hours. A small 
amount of an acetonitrile ligated silver complex was produced as a byproduct. Since the 
NMR spectrum of complex 1.17 is taken in CD3CN, the amount couldn’t be quantified. X-
ray structures of 1.17 and 1.18 were obtained (Figures 1-7 and 1-8). Both complexes are 
square planar and are monoclinic. Rhodium complex 1.17 is in the P21/c space group, and its 
isopropyl-substituted congener 1.18 is in the P21/n space group.  Due to the rigid pincer 
structure of the ligand, the carbodicarbene carbon (C1) and Rh bond distances in each 
complex are nearly identical at 2.043 and 2.045 Å for 1.17 and 1.18 respectively. The 
distances for the Rh-N1 bonds for 2.027 Å for 1.17 and slightly elongated for 1.18 at 2.041 Å.  			
 
N
N
N
N P
P
R
R R
R
Rh Cl
AgBF4 or NaBF4
MeCN, 22 °C, 2-24 h N
N
N
N P
P
R
R R
R
Rh N
BF4
R = Ph 1.17 86% yield
R = iPr 1.18
C Me
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N1 
Figure 1-7 ORTEP drawing of 1.17 (BF4 and solvent omitted for clarity) 
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C1 
 
 
 
 
 
 
Rh 
 
 
 
N1 
Figure 1-8 OPRTEP drawing of 1.18 (BF4 and solvent omitted for clarity) 
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1.3.6 Rh-carbodicarbene carbonyl complexes 
Scheme 1-7 Synthesis of Rh-carbonyl complexes 
 To gain insight into the electronic properties of these new carbodicarbene pincer 
complexes, I developed the synthesis of carbonyl complexes (Scheme 1.7). Initially, I tried 
to substitute the chloride ligand in CDC Rh-Cl complex 1.15 by adding AgBF4 in MeCN 
under 1 atm of CO. Only 10% of the desired product formed and this route was abandoned. 
Using [Rh(CO)2Cl]2 as the rhodium source followed by deprotonation using NaOMe, 
carbonyl complex 1.19 was formed cleanly in 80% yield (Scheme 1-7). Complex 1.20 was 
synthesized by M. J. Goldfogel in an 85% yield using the procedure I developed. The CO 
stretching frequency of these complexes was evaluated using IR spectroscopy. Ph substituted 
phosphine complex 1.19 exhibited a stretching frequency of 1986 cm-1 and iPr-substituted 
phosphine complex 1.20 exhibited a stretching frequency of 1970 cm-1. These frequencies 
indicate the carbodicarbene complexes are very electron rich. These have stretching 
frequencies that are higher than analogous complexes with NHC, phosphine, and other 
carbodicarbene ligands.4,9,38,39  
a. [Rh(CO)2Cl]2,
THF, 22 oC, 18 h
b. NaOMe, 
THF, 22 oC, 6h
R = Ph 1.19 80% yield
R = iPr 1.20 83% yield
1.19 vRh(CO) 1986 cm-1
1.20 vRh(CO) 1970 cm-1N
N
N
N P
P
R
R R
R
BF4
N
N
N
N P
P
R
R R
R
Rh CO
BF4
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1.3.7 Rh-methylene complex formation 
Scheme 1-8 Rh-methylene complex formed during recrystallization 
  
 While trying to recrystallize complex 1.16, I used dichloromethane to dissolve the 
complex. Suitable crystals were produced and an x-ray crystal structure was obtained 
(Figure 1-9). Instead of the expected carbodicarbene chloride complex, methylene complex 
1.21 was formed (Scheme 1-8). This complex is reminiscent of methylene complexes 
synthesized by Milstein and coworkers,40–42 as well as by Iluc and coworkers.43 
 				
N
N N
N PiPr2
PiPr2
Rh Cl
N
N
N
N PiPr2
PiPr2
Rh Cl
CH2Cl2
22 °C, 24 h
2 Cl
1.16 1.21
during recrystallization
C1 C2 
Rh 
Cl 
C1 
C2 
Rh 
Cl 
Figure 1-9 ORTEP drawing of 1.21 (2 chlorides and dichloromethane omitted for clarity) 
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1.4 Conclusion 
 I have developed and synthesized a number of carbodicarbene-Rh pincer complexes. 
The CDC pincer ligands are electron-rich and the carbonyl stretching frequencies for the 
CDC-Rh-CO complexes demonstrate their ability to be electron-rich donors. These 
complexes were designed to be used as catalysts for the hydrofunctionalization of olefins 
(Chapters 2–3).  
1.5 Experimental  
General: All reactions were carried out in flame or oven (140 oC) dried glassware that had 
been cooled under vacuum.  Unless otherwise stated, all reactions were carried out under an 
inert N2 atmosphere. All reagents were purged or sparged with N2 for 20 min prior to 
distillation or use.  All solid reagents were dried by azeotropic distillation with benzene three 
times prior to use.  Infrared (IR) spectra were obtained using a Jasco 460 Plus Fourier 
transform infrared spectrometer or a ASI ReactIR 1000, Model: 001-1002 for air sensitive 
rhodium carbonyl complexes.  Mass spectra were obtained using a Micromass Quattro-II 
triple quadrupole mass spectrometer in combination with an Advion NanoMate chip-based 
electrospray sample introduction system and nozzle for low-res or Waters Q-ToF Ultima 
Tandem Quadrupole/Time-of-Flight Instrument UE521 at University of Illinois at Urbana 
Champaign for high-res or Waters Q-ToF Xevo Tandem Quadrupole/Time-of-Flight 
Instrument.  The Q-Tof Ultima mass spectrometer was purchased in part with a grant from 
the National Science Foundation, Division of Biological Infrastructure (DBI-0100085).  All 
samples were prepared in MeOH or MeCN for metal complexes.  Proton and carbon 
magnetic resonance spectra (1H NMR and 13C NMR) were recorded on a Bruker model DRX 
400 or a Bruker AVANCE III 600 CryoProbe (1H NMR at 400 MHz or 600 MHz, 13C NMR 
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at 100 or 150 MHz, 31P NMR at 160 or 243 MHz and 19F NMR at 376 or 564 MHz) 
spectrometer with solvent resonance as the internal standard (1H NMR: CDCl3 at 7.26 ppm, 
CD2Cl2 at 5.30 ppm, C6D6 at 7.16 ppm, CD3CN at 1.94 ppm; 13C NMR: CDCl3 at 77.16 ppm, 
C6D6 at 128.4 ppm, CD3CN at 1.31 ppm).  NMR data are reported as follows: chemical shift, 
integration, multiplicity (s = singlet, d = doublet, t = triplet, dd = doublet of doublets, td = 
triplet of doublets, dt = doublet of triplets, ddd = doublet of doublet of doublets, septetd = 
septet of doublets, m = multiplet, bs = broad singlet, bm = broad multiplet), and coupling 
constants (Hz).  X-ray diffraction studies were conducted on a Bruker-AXS SMART APEXII 
diffractometer.  Crystals were selected and mounted using Paratone oil on a MiteGen Mylar 
tip.  
 
Solvents:  Solvents were purged with argon and purified under a positive pressure of dry 
argon by a SG Waters purification system: dichloromethane (EMD Millipore) and THF 
(EMD Millipore) were passed through activated alumina columns.  Chlorobenzene (Alfa 
Aesar) was dried over K2CO3, distilled under vacuum and stored over activated 5 Å 
molecular sieves in a dry box. 
 
Reagents:   
Acetonitrile – d3 was purchased from Cambridge Isotope Labs, dried over CaH2, and stored 
in a dry box over activated 4 Å molecular sieves. 
Aniline was purchased from Aldrich, dried on CaH2, distilled under vacuum, and stored in a 
dry box freezer at -30 oC. 
	 18	
Chloroform – d1 was purchased from Cambridge Isotope Labs, dried over CaH2 and stored 
in a dry box over activated 4 Å molecular sieves. 
Chloro(1,5-cyclooctadiene)rhodium(I) dimer was purchased from Pressure Chemicals, 
stored in a dry box, and used as received.  
Chlorodiisopropyl phosphine was purchased from Acros Organics and used as received. 
Chlorodiphenylphosphine was purchased from Alfa Aesar and used as received. 
Dichloromethane – d2 was purchased from Cambridge Isotope Labs, dried over CaH2 and 
stored in a dry box over activated 4 Å molecular sieves. 
Silver tetrafluoroborate was purchased from Strem, stored in a dry box, and used without 
further purification. 
Sodium methoxide was purchased from Strem, stored in a dry box, and used as received. 
Tetrafluoroboric acid was purchased from Alfa Aesar and used as received. 
Triethylamine was purchased from Fisher, dried over CaH2, and distilled immediately prior 
to use. 
 
Synthesis of Ph(CDC)-BF4 salt 1.12 
A 250 mL round-bottom flask with a stir bar was charged with diazepinium salt 1.1111 (2.00 
g, 7.52 mmol), sealed with a septum and purged with nitrogen.  Dichloromethane (12.0 mL, [ 
] = 0.640 M) and triethylamine (12.0 mL, 860 mmol) were added via syringe and the solution 
was allowed to stir for 5 min.  To the yellow heterogenous solution, 
chlorodiphenylphosphine (4.05 mL, 22.6 mmol) was added via syringe and the reaction was 
N N
N N
Ph2P PPh2
BF4
N N
N
H
N
H
BF4
ClPPh2
DCM/Et3N (1:1, 0.32 M), 
22 oC, 18 h 1.12
85% Yield
1.11
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allowed to stir at 22 oC for 18 h.  The reaction was triturated with diethyl ether (100 mL) and 
filtered to isolate a yellow solid.  The yellow solid was purified by SiO2 column 
chromatography (20:1 to 9:1 CH2Cl2:MeOH).  After concentrating the solution to a solid, the 
resulting yellow residue was dissolved in benzene (5 mL) before being triturated with toluene 
(150 mL) to produce 1.12 as a white powder, which was filtered off (4.10 g, 6.39 mmol 85% 
yield).  Excess water was removed by azeotropic distillation with benzene (3 x 3 mL). 
1H NMR (600 MHz, CDCl3): δ 7.41 (20H, m), 6.17 (1H, t, J = 7.3 Hz), 3.80 (4H, s), 3.77 
(4H, t, J = 8.8 Hz), 3.34 (4H, t, J = 8.8 Hz).  13C NMR (150 MHz, CDCl3): δ 163.90 (d, J = 
19.2 Hz), 132.98 (d, J = 9.2 Hz), 132.50 (d, J = 17.0 Hz), 130.43, 129.18 (d, J = 5.4 Hz), 
62.21 (t, J = 26.4 Hz), 50.92, 47.52, 44.40 (d, J = 7.3 Hz).  31P NMR (243 MHz, CDCl3): δ 
41.4.  19F NMR (376 MHz): δ -153.33 (d, J  = 19.8 Hz).  IR (ν/cm-1): 3057 (w), 2891 (w), 
1594 (w), 1557 (s), 1524 (s), 1508 (w), 1478 (m), 1436 (m), 1312 (w), 1292 (m), 1227 (m), 
1161 (w), 1097 (w), 1054 (s).  HRMS (ES+) [M+H]+ calcd for C33H33N4P2+ 547.2175, found: 
547.2172. 
 
Synthesis of iPr(CDC)-BF4 salt 1.13 
A 250 mL round-bottom flask with a stir bar was charged with diazepinium salt 1.1111 (2.00 
g, 7.52 mmol), sealed with a septum, and purged with nitrogen.  Dichloromethane (12.0 mL, 
[ ] = 0.640 M) and triethylamine (12.0 mL, 860 mmol) were added via syringe and the 
solution was allowed to stir for 5 min.  To the yellow heterogeneous solution, 
chlorodiisopropylphosphine (3.6 mL, 22.6 mmol) was added via syringe and the reaction was 
N N
N N
(iPr)2P P(iPr)2
BF4
N N
N
H
N
H
BF4
ClP(iPr)2
DCM/Et3N (1:1, 0.32 M), 
22 oC, 18 h 1.13
71% Yield
1.11
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allowed to stir at 22 oC for 18 h.  The reaction was filtered through a pad of Celite, which 
was washed with dichloromethane (100 mL).  The filtrate was concentrated and purified by 
SiO2 column chromatography (30:1 CH2Cl2/MeOH).  The resulting off-white solid was 
dissolved in a minimal amount of dichloromethane and triturated with hexanes to produce 
1.13 as a white powdery solid, which was filtered off (2.65 g, 71% yield).  Excess water was 
removed by azeotropic distillation with benzene (3 x 3 mL). 
1H NMR (400 MHz, CDCl3): δ 5.70 (1H, t, J = 7.0 Hz), 3.73 (4H, m), 3.65, (4H, s), 3.59 
(4H, m), 2.08 (4H, septetd, J = 7.0, 1.6 Hz), 1.11 (12H, dd, J = 16.8, 7.0 Hz), 1.03 (12H, dd, 
J = 12.5, 7.0 Hz).  13C NMR (100 MHz, CDCl3): δ 165.04 (d, J = 21.3 Hz), 63.63 (t, J = 29.7 
Hz), 51.13, 47.27, 44.55, 25.11 (d, J = 15.1 Hz), 19.21 (d, J = 19.21 Hz), 18.80 (d, J = 22.9 
Hz).  31P NMR (162 MHz, CDCl3): δ 63.24.  19F NMR (376 MHz): δ -153.64 (d, J  = 18.8 
Hz).  IR (ν/cm-1): 2952 (m), 2924 (w), 2867 (m), 1557 (s), 1523 (m), 1507 (w), 1457 (w), 
1436 (w), 1386 (m), 1291 (m), 1227 (m), 1163 (w), 1053 (s).  HRMS (ES+) [M+H] + calcd 
for C21H41N4P2+ 411.2801, found: 411.2799. 
 
Synthesis of dicationic Ph(CDC)-(BF4)2 salt 1.14 
In a N2 filled dry box, an 8-mL vial was charged with 1.12 (10.0 mg, 0.016 mmol) and 
CD2Cl2 (0.25 mL). The solution was transferred to an NMR tube and the vial was washed 
with CD2Cl2 (2 x 0.25 mL). The tube was capped with a septum lined lid and brought outside 
the dry box. Tetrafluoroboric acid (5.1 µL, 0.019 mmol) was added via syringe which incited 
N N
N N
Ph2P PPh2
BF4
1.12
HBF4•OEt2
CD2Cl2, 10 min
N N
N N
Ph2P PPh2
2 BF4
1.14
>95% conversion
H H
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an immediate color change from pale yellow to almost colorless and the tube was shaken for 
5 min before being analyzed.  
1H NMR (600 MHz, CD2Cl2): δ 7.44-7.7.52 (m, 20H), 5.36 (t, J = 4.9 Hz), 4.05-4.09 (m, 
8H), 3.64 (t, 4H, J = 10.9 Hz). 
 
General procedure for the preparation of (CDC)-Rh(I)Cl complexes 1.15 and 1.16   
In a N2 filled dry box, a 20-mL scintillation vial with a stir bar was charged with (CDC)-BF4 
salt (1.0 equiv) and chloro(1,5-cyclooctadiene)rhodium(I) dimer (0.50 equiv).  
Tetrahydrofuran was added, the vial capped, and the resulting mixture was allowed to stir for 
3 h at 22 °C.  The solution was concentrated in vacuo.  Residual 1,5-cyclooctadiene was 
removed by azeotropic distillation with benzene (3 x 1 mL).  Sodium methoxide (1.0 equiv) 
and THF were added to the reaction vial.  The resulting heterogeneous mixture was allowed 
to stir for 3 h at 22 °C.  
 
Synthesis of Ph(CDC)RhCl complex 1.15 
Following the general procedure for the preparation of (CDC)-Rh(I)Cl complexes, Ph(CDC)-
BF4 1.12 (258 mg, 0.406 mmol) and chloro(1,5-cyclooctadiene)rhodium(I) dimer (100 mg, 
0.203 mmol) were solvated with THF (10 mL, [ ] = 0.020 M).  After concentration, NaOMe 
(21.9 mg, 0.406 mmol) was added and solvated with THF (10 mL, [ ] = 0.020 M).  After 
reaction was complete, acetonitrile (4.0 mL) was added to the solution, which was then 
N N
N N
Ph2P PPh2
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N N
Ph2P PPh2Rh
Cl
1.15
>98% Yield
1. [Rh(cod)Cl]2; 
THF (0.020 M), 22 oC, 3 h;
2.NaOMe
THF (0.05 M), 22 oC, 3 h
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filtered through a pad of Celite®.   The Celite® pad was washed with a 1:1 mixture of 
THF:MeCN (5 mL) to dissolve the solid.  The resulting filtrate was concentrated to afford 
orange solid 1.15 in >98% yield (141.8 mg, 0.207 mmol). 
1H NMR (600 MHz, CD3CN): δ 7.65-7.68 (8H, m), 7.50-7.56 (12H, m), 4.01 (4H, t, J = 8.1 
Hz), 3.45 (4H, s), 3.30 (4H, t, J = 8.3 Hz).  13C NMR (150 MHz, CD3CN): δ 173.11 (td, J = 
18.1, 1.3 Hz), 134.61, (t, J = 17.0 Hz), 133.15 (t, J = 6.8 Hz), 131.70, 129.82 (t, J = 3.8 Hz), 
72.98 (dt, J = 29.9, 9.7 Hz), 58.88, 47.32, 42.24.  31P NMR (243 MHz, CD3CN): δ 79.20 (d, J 
= 170.4 Hz).  HRMS (ES+) [M–Cl]+ calcd for C33H32N4P2Rh+ 649.1157, found: 649.1155.  
When formic acid was added to neutral complex 1.5 the protonated N2 adduct was formed.  
HRMS (ES+) [M+H+N2]+ calcd for C33H33N6P2RhCl+ 713.0985, found: 713.1317. 
 
 
Synthesis of  iPr(CDC)RhCl complex 1.16 
Following the general procedure for the preparation of (CDC)-Rh(I)Cl complexes, 
iPr(CDC)BF4 1.13 (100 mg, 0.201 mmol) and chloro(1,5-cyclooctadiene)rhodium(I) dimer 
(49.5 mg, 0.100 mmol) were solvated with THF (5.0 mL, [ ] = 0.020].  After concentration, 
NaOMe (10.9 mg, 0.201 mmol) was added and solvated with THF (5 mL, [ ] = 0.020 M).  
The resulting yellow powder was filtered through a pad of Celite® and washed with THF (4 
x 1 mL).  The yellow solid was dissolved off the Celite® pad using acetonitrile (5 mL) and 
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concentrated in vacuo to afford 1.16 in >98% yield (110 mg, 0.100 mmol) as a canary yellow 
powder.   
1H NMR (600 MHz, CD3CN): δ 3.88 (4H, t, J = 8.2 Hz), 3.42 (4H, t, J = 8.2 Hz), 3.31 (4H, 
s), 2.29 (4H, septetd, J = 7.0, 1.0 Hz), 1.27 (12H, m), 1.20 (12H, m).  13C NMR (150 MHz, 
CD3CN): δ 173.95 (t, J = 15.1 Hz), 73.76 (dt, J = 30.1, 8.7 Hz), 58.69, 47.40, 42.66, 27.91 (t, 
J = 8.1 Hz), 19.37, 18.89 (t, J = 4.4 Hz).  31P NMR (162 MHz, CD3CN): 110.44 (d, J = 167.1 
Hz).  HRMS (ES+) [M–Cl]+ calcd for C21H40N4P2Rh+ 513.1783, found: 513.1795. 
 
Synthesis of cationic Ph(CDC)Rh-MeCN BF4 complex 1.17 
An 8-mL amber vial equipped with a stir bar was charged with 1.12 (40.0 mg, 0.0584 mmol) 
and AgBF4 (17.1 mg, 0.0876 mmol).  Acetonitrile (2.0 mL, [ ] = 0.029) was added to the vial 
and the heterogeneous solution was allowed to stir for 2 h at 22 °C.  The resulting solution 
was filtered through a pad of Celite® and concentrated to afford 1.17 (39.0 mg, 0.0502 
mmol, 86% yield) as a dark orange powder.  X-ray quality crystals of 1.17 were grown from 
a slow salt metathesis of 1.15 and NaBF4 in a 5:1 mixture of benzene:MeCN. 
1H NMR (600 MHz, CD3CN): δ 7.75-7.78 (12H, m), 7.68-7.70 (8H, m), 4.31 (4H, t, J = 8.5 
Hz), 3.78-3.80 (8H, m).  13C NMR (150 MHz, CD3CN): δ 168.67 (t, J = 16.6 Hz), 134.75, 
133.60 (t, J = 7.1 Hz), 130.94 (t, J = 5.8 Hz), 125.40, (t, J = 29.8 Hz), 58.29, 56.33 (dt, J = 
28.1, 4.5 Hz), 47.51, 44.55.  31P NMR (162 MHz, CD3CN): 67.63 (d, J = 58.4 Hz).  19F NMR 
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(376 MHz): δ -152.24 (d, J = 20.0 Hz).  HRMS (ES+) [M+H]+ calcd for C35H35N5P2Rh+ 
690.1423, found: 690.1435. 
 
 
Synthesis of Ph(CDC)Rh-CO complex 1.19 
In an N2 filled dry box, an 8-mL vial with a stir bar was charged with 1.12 (16.3 mg, 0.026 
mmol) and dicarbonylchlororhodium(I) dimer (5.0 mg, 0.013 mmol), and tetrahydrofuran 
(0.50 mL, [ ] = 0.050 M). The vial was capped and the resulting mixture was allowed to stir 
for 18 h at 22 °C.  The resulting solution was concentrated to afford a yellow powder. To this 
solid, NaOMe (1.4 mg, 0.026 mmol) was added followed by tetrahydrofuran (0.50 mL, [ ] = 
0.05 M). The yellow heterogeneous solution was allowed to stir for 6 h at 22 °C. The 
solution was concentrated in vacuo, dissolved in CHCl3 (1 mL), and filtered through a cotton 
plug which was washed with CHCl3 (2 x 1 mL). The filtrate was concentrated in vacuo to 
afford 1.19 in 80% yield (15.8 mg, 0.021 mmol) as a burnt yellow powder.  
1H NMR (600 MHz, CD3CN): δ 7.67-7.70 (8H, m), 7.52-7.57 (4H, m), 7.50-7.54 (8H, m), 
4.19 (4H, t, J = 8.4 Hz), 3.65 (4H, s), 3.36 (4H, t, J = 14.4 Hz).  13C NMR (150 MHz, 
CD3CN): δ 194.6 (dt, J = 57.2, 12.7 Hz), 174.4 (t, J = 21.6 Hz), 133.4 (t, J = 7.9 Hz), 132.9, 
132.2, (t, J = 27.1 Hz), 130.2, (t, J = 5.4 Hz), 86.4 (dt, J = 28.1, 11.0 Hz), 59.5, 47.2, 42.4.  
31P NMR (162 MHz, CD3CN): δ 87.99 (d, J = 103.6 Hz).  IR (ν/cm-1) (CH2Cl2):  1986 (νCO), 
N N
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BF4
	 25	
1537 (m), 1475 (w), 1375 (w), 1267 (w).  HRMS (ES+) [M-CO]+ calcd for C34H32N4OP2Rh+ 
677.1101, found: 677.1809.   
 
Synthesis of iPr(CDC)Rh-CO complex 1.20 
In an N2 filled dry box, an 8-mL vial with a stir bar was charged with 1.13 (13.0 mg, 0.026 
mmol) and dicarbonylchlororhodium(I) dimer (5.0 mg, 0.013 mmol), and tetrahydrofuran 
(0.50 mL, [ ] = 0.050 M). The vial was capped, and the resulting mixture was allowed to stir 
for 18 h at 22 °C.  The resulting solution was concentrated to afford a yellow powder. To this 
solid, NaOMe (1.4 mg, 0.026 mmol) was added followed by tetrahydrofuran (0.50 mL, [ ] = 
0.05 M). The yellow heterogeneous solution was allowed to stir for 6 h at 22 °C. The 
solution was concentrated in vacuo to afford 1.20 in 83% yield (16.5 mg, 0.0216 mmol) as a 
canary yellow powder. 
1H NMR (600 MHz, CDCl3): δ 4.11 (4H, t, J = 8.52 Hz), 3.55 (4H, t, J = 8.52 Hz), 3.53 (4H, 
s), 2.38 (4H, m), 1.28-1.32 (12H, m), 1.2-1.24 (12H, m).  13C NMR (150 MHz, CDCl3): δ 
195.36 (dt, J = 34.5, 19.0 Hz), 174.15 (t, J = 19.1 Hz), 85.16 (dt, J = 19.0, 9.3 Hz), 58.24, 
46.37, 42.26, 27.31 (t, J = 12.3 Hz), 18.95, 18.73 (t, J = 4.3 Hz).  31P NMR (162 MHz, 
CDCl3): δ 119.97 (d, J = 98.8 Hz).  IR (ν/cm-1) (CH2Cl2): 2966 (w), 2885 (w), 1970 (νCO), 
1529 (m), 1475 (w), 1375 (w), 1182 (w), 1055 (s).  HRMS (ES+) [M-CO]+ calcd for 
C22H40N4OP2Rh+ 541.1727, found: 541.1715.  
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For additional information on bond lengths, please see published structure.24 
 
Crystal structure data for 1.17 
Identification code  x1312005_0m_p21onc 
Empirical formula C47 H44 B F4 N5 P2 Rh  
Formula weight 930.53 
Temperature 100 K 
Wavelength 1.54178 
Crystal system monoclinic 
Space group P 21/c  
Unit cell dimensions  a = 17.0682(4) Å α= 90 
 
b = 16.9409(4) Å β= 110.952(1) 
 
c = 17.3070(5) Å γ = 90 
Volume  4673.5(2) 
Z 4 
Density (calculated) 1.322 Mg/m3 
Absorption coefficient 4.041 (mm-1) 
F(000) 1908 
Crystal size 0.086 x 0.124 x 0.279 
Theta range for data collection 77.10-2.77 
Index ranges  Hmax = 20, kmax = 20, lmax = 20 
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Reflections collected 8846 
Independent reflections 7985 
Completeness to theta  99.5 
Max. and min. transmission 0.2815, 0.6907 
Refinement method  XS least squares 
Goodness-of-fit on F2 0 1.2983 
Final R indices [I>2sigma(I)]  R1 = 0.0477, wR2 = 0.1542 
R indices (all data) R1 = 0.0435, wR2 = 0.1542 
 
 
 
Crystal structure data for 1.18 
Identification code  X1402009_P21onN 
Empirical formula C23 H43 B F4 N5 P2 Rh  
Formula weight 641.28 
Temperature 100 K 
Wavelength 1.54178 
Crystal system monoclinic 
Space group P 21/n  
Unit cell dimensions  a = 11.7597(3) Å α= 90 
 
b = 9.0287(2) Å β= 92.888(1) 
 
c = 26.9848(6) Å γ = 90 
Volume  2861.47 
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Z 4 
Density (calculated) 1.489 Mg/m3 
Absorption coefficient 6.298 (mm-1) 
F(000) 1328.0 
Theta range for data collection 66.640-3.28 
Index ranges  Hmax = 14, kmax = 10, lmax = 32 
Reflections collected 5052 
Independent reflections 4914 
Completeness to theta  97.3 
Max. and min. transmission 0.282, 0.691 
Refinement method  XS least squares 
Goodness-of-fit on F2 0 1.053 
Final R indices [I>2sigma(I)]  R1 = 0.1584, wR2 = 0.4139 
R indices (all data) R1 = 0.0241, wR2 = 0.0617 
  
 
Bond distances: 
Number Atom1 Atom2 Length 
1 Rh1 P1 2.2480(5) 
2 Rh1 P2 2.2539(5) 
3 Rh1 C2 2.045(2) 
4 Rh1 N3 2.041(2) 
5 P1 N11 1.716(2) 
6 P1 C12 1.838(2) 
7 P1 C14 1.849(2) 
8 P2 C3 1.840(2) 
9 P2 C17 1.839(2) 
10 P2 N9 1.719(2) 
11 C1 C7 1.529(3) 
12 C1 N9 1.470(3) 
13 C1 H1a 0.990(3) 
14 C1 H1b 0.990(3) 
15 C2 C6 1.398(3) 
16 C2 C16 1.400(3) 
17 N3 C20 1.142(3) 
18 C3 C4 1.524(3) 
19 C3 C5 1.528(3) 
20 C3 H3 1.000(3) 
21 C4 H4a 0.98(1) 
22 C4 H4b 0.980(6) 
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Number Atom1 Atom2 Length 
23 C4 H4c 0.979(8) 
24 C5 H5a 0.981(8) 
25 C5 H5b 0.980(9) 
26 C5 H5c 0.98(1) 
27 C6 N9 1.368(2) 
28 C6 N7 1.372(2) 
29 C7 N7 1.473(2) 
30 C7 H7a 0.990(3) 
31 C7 H7b 0.990(3) 
32 C8 C9 1.517(3) 
33 C8 N7 1.453(3) 
34 C8 H8a 0.990(3) 
35 C8 H8b 0.990(3) 
36 C9 N8 1.448(3) 
37 C9 H9a 0.990(3) 
38 C9 H9b 0.990(3) 
39 N8 C10 1.467(2) 
40 N8 C16 1.365(2) 
41 C10 C11 1.523(3) 
42 C10 H10a 0.990(3) 
43 C10 H10b 0.990(4) 
44 C11 N11 1.475(3) 
45 C11 H11a 0.990(3) 
46 C11 H11b 0.990(3) 
47 N11 C16 1.369(3) 
48 C12 C13 1.532(3) 
49 C12 C1b 1.529(3) 
50 C12 H12 1.000(3) 
51 C13 H13a 0.980(4) 
52 C13 H13b 0.980(7) 
53 C13 H13c 0.980(8) 
54 C14 C15 1.530(3) 
55 C14 C1a 1.529(4) 
56 C14 H14 1.000(3) 
57 C15 H15a 0.980(8) 
58 C15 H15b 0.98(1) 
59 C15 H15c 0.980(5) 
60 C17 C18 1.533(3) 
61 C17 C19 1.528(3) 
62 C17 H17 1.000(3) 
63 C18 H18a 0.979(7) 
64 C18 H18b 0.980(6) 
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Number Atom1 Atom2 Length 
65 C18 H18c 0.98(1) 
66 C19 H19a 0.980(4) 
67 C19 H19b 0.98(1) 
68 C19 H19c 0.98(1) 
69 C20 C21 1.457(3) 
70 C21 H21a 0.98(1) 
71 C21 H21b 0.980(8) 
72 C21 H21c 0.980(4) 
73 C1a H1aa 0.981(9) 
74 C1a H1ab 0.980(8) 
75 C1a H1ac 0.980(4) 
76 C1b H1ba 0.979(6) 
77 C1b H1bb 0.980(7) 
78 C1b H1bc 0.98(1) 
79 F4 B3 1.368(3) 
80 F5 B3 1.373(3) 
81 F6 B3 1.377(3) 
82 B3 F1 1.396(3) 
 
Bond Angles: 
Number Atom1 Atom2 Atom3 Angle 
1 P1 Rh1 P2 165.63(2) 
2 P1 Rh1 C2 82.77(5) 
3 P1 Rh1 N3 98.27(5) 
4 P2 Rh1 C2 82.96(5) 
5 P2 Rh1 N3 95.92(5) 
6 C2 Rh1 N3 177.27(7) 
7 Rh1 P1 N11 102.34(6) 
8 Rh1 P1 C12 120.93(6) 
9 Rh1 P1 C14 119.10(7) 
10 N11 P1 C12 102.70(8) 
11 N11 P1 C14 104.47(9) 
12 C12 P1 C14 104.76(9) 
13 Rh1 P2 C3 122.00(6) 
14 Rh1 P2 C17 117.31(6) 
15 Rh1 P2 N9 102.16(6) 
16 C3 P2 C17 104.67(8) 
17 C3 P2 N9 102.45(8) 
18 C17 P2 N9 106.15(8) 
19 C7 C1 N9 101.8(1) 
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Number Atom1 Atom2 Atom3 Angle 
20 C7 C1 H1a 111.4(2) 
21 C7 C1 H1b 111.4(2) 
22 N9 C1 H1a 111.4(2) 
23 N9 C1 H1b 111.4(2) 
24 H1a C1 H1b 109.3(2) 
25 Rh1 C2 C6 118.4(1) 
26 Rh1 C2 C16 118.9(1) 
27 C6 C2 C16 122.6(2) 
28 Rh1 N3 C20 174.9(2) 
29 P2 C3 C4 109.4(1) 
30 P2 C3 C5 108.9(1) 
31 P2 C3 H3 108.8(2) 
32 C4 C3 C5 112.1(2) 
33 C4 C3 H3 108.8(2) 
34 C5 C3 H3 108.8(2) 
35 C3 C4 H4a 109.5(6) 
36 C3 C4 H4b 109.5(5) 
37 C3 C4 H4c 109.5(6) 
38 H4a C4 H4b 109.5(7) 
39 H4a C4 H4c 109.5(8) 
40 H4b C4 H4c 109.5(7) 
41 C3 C5 H5a 109.5(5) 
42 C3 C5 H5b 109.5(6) 
43 C3 C5 H5c 109.5(6) 
44 H5a C5 H5b 109.5(8) 
45 H5a C5 H5c 109.4(8) 
46 H5b C5 H5c 109.4(8) 
47 C2 C6 N9 119.7(2) 
48 C2 C6 N7 132.0(2) 
49 N9 C6 N7 108.4(2) 
50 C1 C7 N7 102.2(1) 
51 C1 C7 H7a 111.3(2) 
52 C1 C7 H7b 111.3(2) 
53 N7 C7 H7a 111.3(2) 
54 N7 C7 H7b 111.3(2) 
55 H7a C7 H7b 109.2(2) 
56 C9 C8 N7 112.6(2) 
57 C9 C8 H8a 109.1(2) 
58 C9 C8 H8b 109.1(2) 
59 N7 C8 H8a 109.1(2) 
60 N7 C8 H8b 109.1(2) 
61 H8a C8 H8b 107.8(3) 
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Number Atom1 Atom2 Atom3 Angle 
62 C8 C9 N8 112.5(2) 
63 C8 C9 H9a 109.1(2) 
64 C8 C9 H9b 109.1(2) 
65 N8 C9 H9a 109.1(2) 
66 N8 C9 H9b 109.1(2) 
67 H9a C9 H9b 107.8(2) 
68 C9 N8 C10 118.6(2) 
69 C9 N8 C16 125.6(2) 
70 C10 N8 C16 110.3(2) 
71 N8 C10 C11 102.2(2) 
72 N8 C10 H10a 111.3(2) 
73 N8 C10 H10b 111.3(2) 
74 C11 C10 H10a 111.4(2) 
75 C11 C10 H10b 111.3(2) 
76 H10a C10 H10b 109.2(3) 
77 C10 C11 N11 101.6(2) 
78 C10 C11 H11a 111.4(2) 
79 C10 C11 H11b 111.5(2) 
80 N11 C11 H11a 111.5(2) 
81 N11 C11 H11b 111.5(2) 
82 H11a C11 H11b 109.3(3) 
83 P1 N11 C11 131.6(1) 
84 P1 N11 C16 117.1(1) 
85 C11 N11 C16 111.1(2) 
86 P1 C12 C13 109.2(1) 
87 P1 C12 C1b 109.9(1) 
88 P1 C12 H12 108.9(2) 
89 C13 C12 C1b 111.2(2) 
90 C13 C12 H12 108.8(2) 
91 C1b C12 H12 108.8(2) 
92 C12 C13 H13a 109.4(5) 
93 C12 C13 H13b 109.5(6) 
94 C12 C13 H13c 109.5(6) 
95 H13a C13 H13b 109.4(8) 
96 H13a C13 H13c 109.5(7) 
97 H13b C13 H13c 109.4(8) 
98 P1 C14 C15 117.3(2) 
99 P1 C14 C1a 108.6(2) 
100 P1 C14 H14 106.3(2) 
101 C15 C14 C1a 111.2(2) 
102 C15 C14 H14 106.3(2) 
103 C1a C14 H14 106.3(2) 
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Number Atom1 Atom2 Atom3 Angle 
104 C14 C15 H15a 109.5(6) 
105 C14 C15 H15b 109.5(6) 
106 C14 C15 H15c 109.5(5) 
107 H15a C15 H15b 109.5(8) 
108 H15a C15 H15c 109.4(8) 
109 H15b C15 H15c 109.5(8) 
110 C2 C16 N8 133.1(2) 
111 C2 C16 N11 118.8(2) 
112 N8 C16 N11 108.1(2) 
113 P2 C17 C18 108.7(1) 
114 P2 C17 C19 116.6(1) 
115 P2 C17 H17 106.5(2) 
116 C18 C17 C19 111.4(2) 
117 C18 C17 H17 106.6(2) 
118 C19 C17 H17 106.5(2) 
119 C17 C18 H18a 109.5(5) 
120 C17 C18 H18b 109.5(5) 
121 C17 C18 H18c 109.4(6) 
122 H18a C18 H18b 109.5(7) 
123 H18a C18 H18c 109.5(8) 
124 H18b C18 H18c 109.4(7) 
125 C17 C19 H19a 109.5(5) 
126 C17 C19 H19b 109.5(6) 
127 C17 C19 H19c 109.5(6) 
128 H19a C19 H19b 109.5(7) 
129 H19a C19 H19c 109.5(7) 
130 H19b C19 H19c 109.4(8) 
131 N3 C20 C21 177.9(2) 
132 C20 C21 H21a 109.5(6) 
133 C20 C21 H21b 109.5(6) 
134 C20 C21 H21c 109.5(5) 
135 H21a C21 H21b 109.5(9) 
136 H21a C21 H21c 109.4(8) 
137 H21b C21 H21c 109.5(8) 
138 P2 N9 C1 131.7(1) 
139 P2 N9 C6 116.7(1) 
140 C1 N9 C6 111.3(2) 
141 C6 N7 C7 109.3(2) 
142 C6 N7 C8 121.0(2) 
143 C7 N7 C8 117.2(2) 
144 C14 C1a H1aa 109.4(6) 
145 C14 C1a H1ab 109.4(6) 
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Number Atom1 Atom2 Atom3 Angle 
146 C14 C1a H1ac 109.4(5) 
147 H1aa C1a H1ab 109.5(8) 
148 H1aa C1a H1ac 109.6(7) 
149 H1ab C1a H1ac 109.5(8) 
150 C12 C1b H1ba 109.5(5) 
151 C12 C1b H1bb 109.4(5) 
152 C12 C1b H1bc 109.5(6) 
153 H1ba C1b H1bb 109.5(7) 
154 H1ba C1b H1bc 109.5(8) 
155 H1bb C1b H1bc 109.5(8) 
156 F4 B3 F5 110.4(2) 
157 F4 B3 F6 108.9(2) 
158 F4 B3 F1 109.5(2) 
159 F5 B3 F6 109.5(2) 
160 F5 B3 F1 109.3(2) 
161 F6 B3 F1 109.2(2) 
 
Torsion Angles: 
Number Atom1 Atom2 Atom3 Atom4 Torsion 
1 P2 Rh1 P1 N11 5.2(1) 
2 P2 Rh1 P1 C12 -108.0(1) 
3 P2 Rh1 P1 C14 119.7(1) 
4 C2 Rh1 P1 N11 -1.51(8) 
5 C2 Rh1 P1 C12 -114.68(9) 
6 C2 Rh1 P1 C14 113.0(1) 
7 N3 Rh1 P1 N11 175.95(7) 
8 N3 Rh1 P1 C12 62.77(9) 
9 N3 Rh1 P1 C14 -69.56(9) 
10 P1 Rh1 P2 C3 -117.7(1) 
11 P1 Rh1 P2 C17 111.1(1) 
12 P1 Rh1 P2 N9 -4.5(1) 
13 C2 Rh1 P2 C3 -111.02(9) 
14 C2 Rh1 P2 C17 117.78(9) 
15 C2 Rh1 P2 N9 2.22(8) 
16 N3 Rh1 P2 C3 71.48(9) 
17 N3 Rh1 P2 C17 -59.72(8) 
18 N3 Rh1 P2 N9 -175.28(7) 
19 P1 Rh1 C2 C6 177.9(1) 
20 P1 Rh1 C2 C16 0.9(1) 
21 P2 Rh1 C2 C6 -0.4(1) 
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Number Atom1 Atom2 Atom3 Atom4 Torsion 
22 P2 Rh1 C2 C16 -177.4(1) 
23 N3 Rh1 C2 C6 65(1) 
24 N3 Rh1 C2 C16 -112(1) 
25 P1 Rh1 N3 C20 -115(2) 
26 P2 Rh1 N3 C20 62(2) 
27 C2 Rh1 N3 C20 -3(3) 
28 Rh1 P1 N11 C11 176.6(2) 
29 Rh1 P1 N11 C16 2.2(1) 
30 C12 P1 N11 C11 -57.4(2) 
31 C12 P1 N11 C16 128.3(1) 
32 C14 P1 N11 C11 51.8(2) 
33 C14 P1 N11 C16 -122.6(1) 
34 Rh1 P1 C12 C13 -67.4(1) 
35 Rh1 P1 C12 C1b 54.8(2) 
36 Rh1 P1 C12 H12 173.9(2) 
37 N11 P1 C12 C13 179.6(1) 
38 N11 P1 C12 C1b -58.2(2) 
39 N11 P1 C12 H12 60.9(2) 
40 C14 P1 C12 C13 70.6(2) 
41 C14 P1 C12 C1b -167.2(1) 
42 C14 P1 C12 H12 -48.1(2) 
43 Rh1 P1 C14 C15 173.2(1) 
44 Rh1 P1 C14 C1a -59.6(2) 
45 Rh1 P1 C14 H14 54.5(2) 
46 N11 P1 C14 C15 -73.4(2) 
47 N11 P1 C14 C1a 53.7(2) 
48 N11 P1 C14 H14 167.8(2) 
49 C12 P1 C14 C15 34.2(2) 
50 C12 P1 C14 C1a 161.4(1) 
51 C12 P1 C14 H14 -84.6(2) 
52 Rh1 P2 C3 C4 52.4(2) 
53 Rh1 P2 C3 C5 -70.5(1) 
54 Rh1 P2 C3 H3 171.1(1) 
55 C17 P2 C3 C4 -171.3(1) 
56 C17 P2 C3 C5 65.8(2) 
57 C17 P2 C3 H3 -52.6(2) 
58 N9 P2 C3 C4 -60.7(2) 
59 N9 P2 C3 C5 176.4(1) 
60 N9 P2 C3 H3 58.0(2) 
61 Rh1 P2 C17 C18 -52.1(1) 
62 Rh1 P2 C17 C19 -178.9(1) 
63 Rh1 P2 C17 H17 62.4(2) 
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Number Atom1 Atom2 Atom3 Atom4 Torsion 
64 C3 P2 C17 C18 169.2(1) 
65 C3 P2 C17 C19 42.4(2) 
66 C3 P2 C17 H17 -76.3(2) 
67 N9 P2 C17 C18 61.3(1) 
68 N9 P2 C17 C19 -65.5(2) 
69 N9 P2 C17 H17 175.7(2) 
70 Rh1 P2 N9 C1 -177.4(2) 
71 Rh1 P2 N9 C6 -4.2(1) 
72 C3 P2 N9 C1 -50.4(2) 
73 C3 P2 N9 C6 122.9(1) 
74 C17 P2 N9 C1 59.1(2) 
75 C17 P2 N9 C6 -127.6(1) 
76 N9 C1 C7 N7 23.8(2) 
77 N9 C1 C7 H7a 142.7(2) 
78 N9 C1 C7 H7b -95.2(2) 
79 H1a C1 C7 N7 142.6(2) 
80 H1a C1 C7 H7a -98.5(3) 
81 H1a C1 C7 H7b 23.7(3) 
82 H1b C1 C7 N7 -95.1(2) 
83 H1b C1 C7 H7a 23.8(3) 
84 H1b C1 C7 H7b 145.9(2) 
85 C7 C1 N9 P2 158.3(1) 
86 C7 C1 N9 C6 -15.3(2) 
87 H1a C1 N9 P2 39.4(3) 
88 H1a C1 N9 C6 -134.1(2) 
89 H1b C1 N9 P2 -82.9(2) 
90 H1b C1 N9 C6 103.6(2) 
91 Rh1 C2 C6 N9 -2.3(2) 
92 Rh1 C2 C6 N7 177.4(2) 
93 C16 C2 C6 N9 174.6(2) 
94 C16 C2 C6 N7 -5.8(3) 
95 Rh1 C2 C16 N8 179.6(2) 
96 Rh1 C2 C16 N11 0.3(2) 
97 C6 C2 C16 N8 2.7(3) 
98 C6 C2 C16 N11 -176.6(2) 
99 Rh1 N3 C20 C21 -5(7) 
100 P2 C3 C4 H4a -56.2(6) 
101 P2 C3 C4 H4b 63.8(5) 
102 P2 C3 C4 H4c -176.2(6) 
103 C5 C3 C4 H4a 64.7(6) 
104 C5 C3 C4 H4b -175.2(5) 
105 C5 C3 C4 H4c -55.2(6) 
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Number Atom1 Atom2 Atom3 Atom4 Torsion 
106 H3 C3 C4 H4a -174.9(6) 
107 H3 C3 C4 H4b -54.9(6) 
108 H3 C3 C4 H4c 65.1(6) 
109 P2 C3 C5 H5a -64.8(6) 
110 P2 C3 C5 H5b 55.3(6) 
111 P2 C3 C5 H5c 175.2(6) 
112 C4 C3 C5 H5a 174.0(6) 
113 C4 C3 C5 H5b -65.9(6) 
114 C4 C3 C5 H5c 54.0(6) 
115 H3 C3 C5 H5a 53.6(6) 
116 H3 C3 C5 H5b 173.7(6) 
117 H3 C3 C5 H5c -66.3(6) 
118 C2 C6 N9 P2 4.5(2) 
119 C2 C6 N9 C1 179.1(2) 
120 N7 C6 N9 P2 -175.2(1) 
121 N7 C6 N9 C1 -0.6(2) 
122 C2 C6 N7 C7 -162.2(2) 
123 C2 C6 N7 C8 -21.3(3) 
124 N9 C6 N7 C7 17.5(2) 
125 N9 C6 N7 C8 158.3(2) 
126 C1 C7 N7 C6 -26.1(2) 
127 C1 C7 N7 C8 -168.7(2) 
128 H7a C7 N7 C6 -145.1(2) 
129 H7a C7 N7 C8 72.4(3) 
130 H7b C7 N7 C6 92.8(2) 
131 H7b C7 N7 C8 -49.7(3) 
132 N7 C8 C9 N8 -76.7(2) 
133 N7 C8 C9 H9a 44.6(3) 
134 N7 C8 C9 H9b 162.1(2) 
135 H8a C8 C9 N8 44.6(3) 
136 H8a C8 C9 H9a 165.8(2) 
137 H8a C8 C9 H9b -76.6(3) 
138 H8b C8 C9 N8 162.1(2) 
139 H8b C8 C9 H9a -76.7(3) 
140 H8b C8 C9 H9b 40.9(3) 
141 C9 C8 N7 C6 64.9(2) 
142 C9 C8 N7 C7 -157.1(2) 
143 H8a C8 N7 C6 -56.3(3) 
144 H8a C8 N7 C7 81.6(2) 
145 H8b C8 N7 C6 -173.8(2) 
146 H8b C8 N7 C7 -35.9(3) 
147 C8 C9 N8 C10 -161.4(2) 
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Number Atom1 Atom2 Atom3 Atom4 Torsion 
148 C8 C9 N8 C16 47.3(2) 
149 H9a C9 N8 C10 77.3(2) 
150 H9a C9 N8 C16 -73.9(3) 
151 H9b C9 N8 C10 -40.2(3) 
152 H9b C9 N8 C16 168.5(2) 
153 C9 N8 C10 C11 -180.0(2) 
154 C9 N8 C10 H10a -61.0(3) 
155 C9 N8 C10 H10b 61.1(3) 
156 C16 N8 C10 C11 -24.6(2) 
157 C16 N8 C10 H10a 94.4(3) 
158 C16 N8 C10 H10b -143.5(2) 
159 C9 N8 C16 C2 -12.0(3) 
160 C9 N8 C16 N11 167.4(2) 
161 C10 N8 C16 C2 -165.3(2) 
162 C10 N8 C16 N11 14.1(2) 
163 N8 C10 C11 N11 24.2(2) 
164 N8 C10 C11 H11a 143.0(2) 
165 N8 C10 C11 H11b -94.6(3) 
166 H10a C10 C11 N11 -94.7(3) 
167 H10a C10 C11 H11a 24.1(3) 
168 H10a C10 C11 H11b 146.4(3) 
169 H10b C10 C11 N11 143.1(2) 
170 H10b C10 C11 H11a -98.1(3) 
171 H10b C10 C11 H11b 24.3(3) 
172 C10 C11 N11 P1 167.5(1) 
173 C10 C11 N11 C16 -17.9(2) 
174 H11a C11 N11 P1 48.7(3) 
175 H11a C11 N11 C16 -136.7(2) 
176 H11b C11 N11 P1 -73.7(3) 
177 H11b C11 N11 C16 100.9(3) 
178 P1 N11 C16 C2 -1.8(2) 
179 P1 N11 C16 N8 178.7(1) 
180 C11 N11 C16 C2 -177.3(2) 
181 C11 N11 C16 N8 3.3(2) 
182 P1 C12 C13 H13a -57.0(5) 
183 P1 C12 C13 H13b 62.9(6) 
184 P1 C12 C13 H13c -177.1(6) 
185 C1b C12 C13 H13a -178.5(5) 
186 C1b C12 C13 H13b -58.5(6) 
187 C1b C12 C13 H13c 61.5(6) 
188 H12 C12 C13 H13a 61.7(6) 
189 H12 C12 C13 H13b -178.3(6) 
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Number Atom1 Atom2 Atom3 Atom4 Torsion 
190 H12 C12 C13 H13c -58.4(6) 
191 P1 C12 C1b H1ba -60.7(6) 
192 P1 C12 C1b H1bb 59.3(6) 
193 P1 C12 C1b H1bc 179.3(6) 
194 C13 C12 C1b H1ba 60.3(6) 
195 C13 C12 C1b H1bb -179.6(5) 
196 C13 C12 C1b H1bc -59.6(6) 
197 H12 C12 C1b H1ba -179.8(5) 
198 H12 C12 C1b H1bb -59.8(6) 
199 H12 C12 C1b H1bc 60.2(6) 
200 P1 C14 C15 H15a -56.8(6) 
201 P1 C14 C15 H15b 63.3(6) 
202 P1 C14 C15 H15c -176.7(5) 
203 C1a C14 C15 H15a 177.3(6) 
204 C1a C14 C15 H15b -62.6(7) 
205 C1a C14 C15 H15c 57.4(6) 
206 H14 C14 C15 H15a 62.0(6) 
207 H14 C14 C15 H15b -177.9(6) 
208 H14 C14 C15 H15c -58.0(6) 
209 P1 C14 C1a H1aa -75.0(6) 
210 P1 C14 C1a H1ab 44.9(7) 
211 P1 C14 C1a H1ac 164.9(5) 
212 C15 C14 C1a H1aa 55.5(6) 
213 C15 C14 C1a H1ab 175.5(6) 
214 C15 C14 C1a H1ac -64.5(6) 
215 H14 C14 C1a H1aa 170.9(6) 
216 H14 C14 C1a H1ab -69.2(7) 
217 H14 C14 C1a H1ac 50.8(6) 
218 P2 C17 C18 H18a -68.9(6) 
219 P2 C17 C18 H18b 51.1(5) 
220 P2 C17 C18 H18c 171.0(6) 
221 C19 C17 C18 H18a 60.8(6) 
222 C19 C17 C18 H18b -179.1(5) 
223 C19 C17 C18 H18c -59.2(6) 
224 H17 C17 C18 H18a 176.6(6) 
225 H17 C17 C18 H18b -63.3(5) 
226 H17 C17 C18 H18c 56.6(7) 
227 P2 C17 C19 H19a -57.7(5) 
228 P2 C17 C19 H19b 62.3(6) 
229 P2 C17 C19 H19c -177.8(6) 
230 C18 C17 C19 H19a 176.8(5) 
231 C18 C17 C19 H19b -63.2(6) 
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Number Atom1 Atom2 Atom3 Atom4 Torsion 
232 C18 C17 C19 H19c 56.7(6) 
233 H17 C17 C19 H19a 61.0(5) 
234 H17 C17 C19 H19b -179.0(6) 
235 H17 C17 C19 H19c -59.1(6) 
236 N3 C20 C21 H21a -43(6) 
237 N3 C20 C21 H21b 77(6) 
238 N3 C20 C21 H21c -163(6) 
 
 
 
Please note: Due to the quality of the crystal, one of the chloride counterions could not be 
fully refined and is not represented in the chemical formula listed below. 
 
Crystal structure data for 1.21 
Identification code  pcprhcl_8 
Empirical formula C23 H44 Cl5 N3 P2 Rh  
Formula weight 718.72 
Temperature 100 K 
Wavelength 1.54178 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions  a = 13.9330(3) Å α= 97.476(2) 
 
b = 15.1172(3) Å β= 94.715 
 
c = 16.7570(4) Å γ = 101.493(2) 
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Volume  3408.02(13) 
Z 4 
Density (calculated) 1.401 Mg/m3 
Absorption coefficient 4.041 (mm-1) 
F(000) 1480.0 
Theta range for data collection 70.120-2.68 
Index ranges  Hmax = 16, kmax = 18, lmax = 20 
Reflections collected 12971 
Independent reflections 12175 
Completeness to theta  93.9 
Max. and min. transmission 0.436, 0.795 
Refinement method  XS least squares 
Goodness-of-fit on F2 0 1.005 
Final R indices [I>2sigma(I)]  R1 = 0.0563, wR2 = 0.1509 
R indices (all data) R1 = 0.0562, wR2 = 0.1509 
  
Bond lengths 
Number Atom1 Atom2 Length 
1 C9 C1h 1.51(1) 
2 C9 H9a 0.99(5) 
3 C9 H9b 0.98(1) 
4 C9 H9c 0.98(2) 
5 N7 C1n 1.310(7) 
6 N7 C23 1.458(9) 
7 N7 C2a 1.466(8) 
8 N5 C1t 1.49(1) 
9 N5 C29 1.339(9) 
10 N5 P4 1.720(6) 
11 N8 C1n 1.335(8) 
12 N8 C2j 1.493(9) 
13 N8 P2 1.730(5) 
14 N6 C1j 1.454(9) 
15 N6 C1z 1.48(1) 
16 N6 C29 1.281(7) 
17 C1h C2d 1.511(9) 
18 C1h P2 1.834(7) 
19 C1h H1h 1.00(1) 
20 C1j C2a 1.50(1) 
21 C1j H1ja 0.99(1) 
22 C1j H1jb 0.991(9) 
23 C1m C28 1.55(1) 
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Number Atom1 Atom2 Length 
24 C1m C2n 1.533(9) 
25 C1m P2 1.826(7) 
26 C1m H1m 1.000(8) 
27 C1n C8 1.46(1) 
28 C1t C1z 1.53(1) 
29 C1t H1ta 0.99(1) 
30 C1t H1tb 0.99(1) 
31 C1z H1za 0.99(1) 
32 C1z H1zb 0.99(1) 
33 C23 C2j 1.509(8) 
34 C23 H23a 0.990(9) 
35 C23 H23b 0.99(1) 
36 C28 H28a 0.98(4) 
37 C28 H28b 0.98(1) 
38 C28 H28c 0.98(2) 
39 C29 C8 1.501(9) 
40 C2a H2aa 0.99(1) 
41 C2a H2ab 0.99(1) 
42 C2d H2da 0.98(3) 
43 C2d H2db 0.98(2) 
44 C2d H2dc 0.98(4) 
45 C2e C2v 1.51(1) 
46 C2e C13 1.49(1) 
47 C2e P4 1.878(9) 
48 C2e H2e 1.00(1) 
49 C1g C2r 1.55(1) 
50 C1g C11 1.51(1) 
51 C1g P4 1.828(9) 
52 C1g H1g 1.00(1) 
53 C2j H2ja 0.99(1) 
54 C2j H2jb 0.99(1) 
55 C2n H2na 0.98(3) 
56 C2n H2nb 0.98(1) 
57 C2n H2nc 0.98(4) 
58 C2r H2ra 0.98(2) 
59 C2r H2rb 0.98(4) 
60 C2r H2rc 0.98(4) 
61 Cl4 Rh1 2.336(2) 
62 C2v H2va 0.97(5) 
63 C2v H2vb 0.99(3) 
64 C2v H2vc 0.98(3) 
65 C11 H11a 0.98(3) 
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Number Atom1 Atom2 Length 
66 C11 H11b 0.98(4) 
67 C11 H11c 0.98(2) 
68 C13 H13a 0.98(4) 
69 C13 H13b 0.98(4) 
70 C13 H13c 0.98(5) 
71 C7 C8 1.442(9) 
72 C7 Rh1 2.079(7) 
73 C7 H7a 0.99(1) 
74 C7 H7b 0.99(1) 
75 C8 Rh1 2.086(6) 
76 P2 Rh1 2.290(2) 
77 P4 Rh1 2.308(2) 
 
Bond angles 
Number Atom1 Atom2 Atom3 Angle 
1 C1h C9 H9a 109(2) 
2 C1h C9 H9b 110(2) 
3 C1h C9 H9c 110(2) 
4 H9a C9 H9b 109(3) 
5 H9a C9 H9c 109(3) 
6 H9b C9 H9c 109(2) 
7 C1n N7 C23 110.6(5) 
8 C1n N7 C2a 122.1(5) 
9 C23 N7 C2a 126.2(5) 
10 C1t N5 C29 109.1(6) 
11 C1t N5 P4 128.5(5) 
12 C29 N5 P4 122.0(5) 
13 C1n N8 C2j 108.8(5) 
14 C1n N8 P2 118.3(4) 
15 C2j N8 P2 132.2(4) 
16 C1j N6 C1z 118.7(6) 
17 C1j N6 C29 130.2(6) 
18 C1z N6 C29 110.9(6) 
19 C9 C1h C2d 109.6(6) 
20 C9 C1h P2 110.1(5) 
21 C9 C1h H1h 109.0(7) 
22 C2d C1h P2 109.9(5) 
23 C2d C1h H1h 109.1(7) 
24 P2 C1h H1h 109.1(6) 
25 N6 C1j C2a 115.3(6) 
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Number Atom1 Atom2 Atom3 Angle 
26 N6 C1j H1ja 108.5(7) 
27 N6 C1j H1jb 108.4(7) 
28 C2a C1j H1ja 108.6(7) 
29 C2a C1j H1jb 108.4(7) 
30 H1ja C1j H1jb 107.4(8) 
31 C28 C1m C2n 111.2(6) 
32 C28 C1m P2 115.2(5) 
33 C28 C1m H1m 106.8(7) 
34 C2n C1m P2 109.5(5) 
35 C2n C1m H1m 106.8(7) 
36 P2 C1m H1m 106.9(6) 
37 N7 C1n N8 112.5(5) 
38 N7 C1n C8 125.1(6) 
39 N8 C1n C8 122.1(6) 
40 N5 C1t C1z 102.0(6) 
41 N5 C1t H1ta 111.3(8) 
42 N5 C1t H1tb 111.4(8) 
43 C1z C1t H1ta 111.3(9) 
44 C1z C1t H1tb 111.4(9) 
45 H1ta C1t H1tb 109(1) 
46 N6 C1z C1t 102.6(6) 
47 N6 C1z H1za 111.2(8) 
48 N6 C1z H1zb 111.3(8) 
49 C1t C1z H1za 111.2(9) 
50 C1t C1z H1zb 111.3(9) 
51 H1za C1z H1zb 109(1) 
52 N7 C23 C2j 103.6(5) 
53 N7 C23 H23a 111.0(7) 
54 N7 C23 H23b 111.1(7) 
55 C2j C23 H23a 111.0(7) 
56 C2j C23 H23b 111.1(7) 
57 H23a C23 H23b 109.0(8) 
58 C1m C28 H28a 110(2) 
59 C1m C28 H28b 110(2) 
60 C1m C28 H28c 110(2) 
61 H28a C28 H28b 110(3) 
62 H28a C28 H28c 109(3) 
63 H28b C28 H28c 109(3) 
64 N5 C29 N6 113.4(6) 
65 N5 C29 C8 118.0(6) 
66 N6 C29 C8 128.5(6) 
67 N7 C2a C1j 111.5(6) 
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Number Atom1 Atom2 Atom3 Angle 
68 N7 C2a H2aa 109.4(7) 
69 N7 C2a H2ab 109.3(7) 
70 C1j C2a H2aa 109.3(7) 
71 C1j C2a H2ab 109.3(7) 
72 H2aa C2a H2ab 108.0(9) 
73 C1h C2d H2da 109(2) 
74 C1h C2d H2db 109(2) 
75 C1h C2d H2dc 110(2) 
76 H2da C2d H2db 110(3) 
77 H2da C2d H2dc 109(3) 
78 H2db C2d H2dc 110(3) 
79 C2v C2e C13 114.9(7) 
80 C2v C2e P4 115.6(6) 
81 C2v C2e H2e 105.2(9) 
82 C13 C2e P4 109.6(6) 
83 C13 C2e H2e 105.3(9) 
84 P4 C2e H2e 105.2(8) 
85 C2r C1g C11 112.9(7) 
86 C2r C1g P4 109.0(6) 
87 C2r C1g H1g 108.5(9) 
88 C11 C1g P4 109.6(6) 
89 C11 C1g H1g 108.4(9) 
90 P4 C1g H1g 108.3(8) 
91 N8 C2j C23 102.4(5) 
92 N8 C2j H2ja 111.3(7) 
93 N8 C2j H2jb 111.3(7) 
94 C23 C2j H2ja 111.2(7) 
95 C23 C2j H2jb 111.3(7) 
96 H2ja C2j H2jb 109.2(9) 
97 C1m C2n H2na 109(2) 
98 C1m C2n H2nb 109(2) 
99 C1m C2n H2nc 109(2) 
100 H2na C2n H2nb 110(2) 
101 H2na C2n H2nc 109(3) 
102 H2nb C2n H2nc 109(3) 
103 C1g C2r H2ra 109(2) 
104 C1g C2r H2rb 109(2) 
105 C1g C2r H2rc 109(2) 
106 H2ra C2r H2rb 110(3) 
107 H2ra C2r H2rc 109(3) 
108 H2rb C2r H2rc 109(3) 
109 C2e C2v H2va 109(2) 
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Number Atom1 Atom2 Atom3 Angle 
110 C2e C2v H2vb 110(2) 
111 C2e C2v H2vc 110(2) 
112 H2va C2v H2vb 110(3) 
113 H2va C2v H2vc 110(3) 
114 H2vb C2v H2vc 109(3) 
115 C1g C11 H11a 110(2) 
116 C1g C11 H11b 110(3) 
117 C1g C11 H11c 110(3) 
118 H11a C11 H11b 109(4) 
119 H11a C11 H11c 109(3) 
120 H11b C11 H11c 109(4) 
121 C2e C13 H13a 110(3) 
122 C2e C13 H13b 110(2) 
123 C2e C13 H13c 109(3) 
124 H13a C13 H13b 109(3) 
125 H13a C13 H13c 110(4) 
126 H13b C13 H13c 109(4) 
127 C8 C7 Rh1 70.0(4) 
128 C8 C7 H7a 116.6(7) 
129 C8 C7 H7b 116.6(7) 
130 Rh1 C7 H7a 116.7(6) 
131 Rh1 C7 H7b 116.7(6) 
132 H7a C7 H7b 113.5(8) 
133 C1n C8 C29 120.0(6) 
134 C1n C8 C7 114.5(6) 
135 C1n C8 Rh1 113.6(4) 
136 C29 C8 C7 116.6(6) 
137 C29 C8 Rh1 112.2(4) 
138 C7 C8 Rh1 69.5(4) 
139 N8 P2 C1h 104.4(3) 
140 N8 P2 C1m 105.8(3) 
141 N8 P2 Rh1 100.8(2) 
142 C1h P2 C1m 107.3(3) 
143 C1h P2 Rh1 124.0(2) 
144 C1m P2 Rh1 112.5(2) 
145 N5 P4 C2e 103.1(3) 
146 N5 P4 C1g 101.5(3) 
147 N5 P4 Rh1 97.7(2) 
148 C2e P4 C1g 109.7(4) 
149 C2e P4 Rh1 119.7(3) 
150 C1g P4 Rh1 120.5(3) 
151 Cl4 Rh1 C7 150.2(2) 
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Number Atom1 Atom2 Atom3 Angle 
152 Cl4 Rh1 C8 168.8(2) 
153 Cl4 Rh1 P2 90.48(6) 
154 Cl4 Rh1 P4 98.12(6) 
155 C7 Rh1 C8 40.5(3) 
156 C7 Rh1 P2 93.3(2) 
157 C7 Rh1 P4 85.8(2) 
158 C8 Rh1 P2 84.6(2) 
159 C8 Rh1 P4 84.6(2) 
160 P2 Rh1 P4 164.22(6) 
 
Torsion Angles 
Number Atom1 Atom2 Atom3 Atom4 Torsion 
1 H9a C9 C1h C2d -64(3) 
2 H9a C9 C1h P2 57(3) 
3 H9a C9 C1h H1h 176(3) 
4 H9b C9 C1h C2d 56(2) 
5 H9b C9 C1h P2 177(2) 
6 H9b C9 C1h H1h -63(2) 
7 H9c C9 C1h C2d 176(2) 
8 H9c C9 C1h P2 -63(2) 
9 H9c C9 C1h H1h 57(2) 
10 C23 N7 C1n N8 1.7(7) 
11 C23 N7 C1n C8 175.2(6) 
12 C2a N7 C1n N8 -167.5(5) 
13 C2a N7 C1n C8 6.0(9) 
14 C1n N7 C23 C2j -10.1(7) 
15 C1n N7 C23 H23a 109.1(8) 
16 C1n N7 C23 H23b -129.5(7) 
17 C2a N7 C23 C2j 158.5(6) 
18 C2a N7 C23 H23a -82.2(9) 
19 C2a N7 C23 H23b 39(1) 
20 C1n N7 C2a C1j -70.3(8) 
21 C1n N7 C2a H2aa 51(1) 
22 C1n N7 C2a H2ab 168.8(7) 
23 C23 N7 C2a C1j 122.3(6) 
24 C23 N7 C2a H2aa -116.7(8) 
25 C23 N7 C2a H2ab 1(1) 
26 C29 N5 C1t C1z 13.6(8) 
27 C29 N5 C1t H1ta 132.4(9) 
28 C29 N5 C1t H1tb -105.4(9) 
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Number Atom1 Atom2 Atom3 Atom4 Torsion 
29 P4 N5 C1t C1z -172.9(5) 
30 P4 N5 C1t H1ta -54(1) 
31 P4 N5 C1t H1tb 68(1) 
32 C1t N5 C29 N6 -8.9(8) 
33 C1t N5 C29 C8 171.6(6) 
34 P4 N5 C29 N6 177.1(5) 
35 P4 N5 C29 C8 -2.5(9) 
36 C1t N5 P4 C2e -63.1(7) 
37 C1t N5 P4 C1g 50.5(7) 
38 C1t N5 P4 Rh1 173.9(6) 
39 C29 N5 P4 C2e 109.7(6) 
40 C29 N5 P4 C1g -136.7(6) 
41 C29 N5 P4 Rh1 -13.2(6) 
42 C2j N8 C1n N7 7.9(7) 
43 C2j N8 C1n C8 -165.9(6) 
44 P2 N8 C1n N7 178.8(4) 
45 P2 N8 C1n C8 5.1(8) 
46 C1n N8 C2j C23 -13.4(7) 
47 C1n N8 C2j H2ja 105.5(8) 
48 C1n N8 C2j H2jb -132.4(8) 
49 P2 N8 C2j C23 177.3(5) 
50 P2 N8 C2j H2ja -63.7(9) 
51 P2 N8 C2j H2jb 58.3(9) 
52 C1n N8 P2 C1h -128.7(5) 
53 C1n N8 P2 C1m 118.2(5) 
54 C1n N8 P2 Rh1 0.9(5) 
55 C2j N8 P2 C1h 39.8(6) 
56 C2j N8 P2 C1m -73.4(6) 
57 C2j N8 P2 Rh1 169.3(5) 
58 C1z N6 C1j C2a 155.8(6) 
59 C1z N6 C1j H1ja -82.2(8) 
60 C1z N6 C1j H1jb 34.1(9) 
61 C29 N6 C1j C2a -19(1) 
62 C29 N6 C1j H1ja 103.0(9) 
63 C29 N6 C1j H1jb -140.7(8) 
64 C1j N6 C1z C1t -166.7(6) 
65 C1j N6 C1z H1za -48(1) 
66 C1j N6 C1z H1zb 74(1) 
67 C29 N6 C1z C1t 9.0(8) 
68 C29 N6 C1z H1za 128.0(9) 
69 C29 N6 C1z H1zb -110.1(9) 
70 C1j N6 C29 N5 174.7(6) 
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Number Atom1 Atom2 Atom3 Atom4 Torsion 
71 C1j N6 C29 C8 -6(1) 
72 C1z N6 C29 N5 -0.5(8) 
73 C1z N6 C29 C8 179.0(7) 
74 C9 C1h C2d H2da -56(2) 
75 C9 C1h C2d H2db 64(2) 
76 C9 C1h C2d H2dc -176(2) 
77 P2 C1h C2d H2da -178(2) 
78 P2 C1h C2d H2db -57(2) 
79 P2 C1h C2d H2dc 63(2) 
80 H1h C1h C2d H2da 63(2) 
81 H1h C1h C2d H2db -177(2) 
82 H1h C1h C2d H2dc -57(2) 
83 C9 C1h P2 N8 70.8(5) 
84 C9 C1h P2 C1m -177.2(5) 
85 C9 C1h P2 Rh1 -43.2(5) 
86 C2d C1h P2 N8 -168.4(4) 
87 C2d C1h P2 C1m -56.4(5) 
88 C2d C1h P2 Rh1 77.6(5) 
89 H1h C1h P2 N8 -48.9(7) 
90 H1h C1h P2 C1m 63.2(7) 
91 H1h C1h P2 Rh1 -162.9(5) 
92 N6 C1j C2a N7 69.1(7) 
93 N6 C1j C2a H2aa -51.9(9) 
94 N6 C1j C2a H2ab -169.9(7) 
95 H1ja C1j C2a N7 -52.7(9) 
96 H1ja C1j C2a H2aa -173.7(8) 
97 H1ja C1j C2a H2ab 68(1) 
98 H1jb C1j C2a N7 -169.1(7) 
99 H1jb C1j C2a H2aa 70(1) 
100 H1jb C1j C2a H2ab -48(1) 
101 C2n C1m C28 H28a -65(3) 
102 C2n C1m C28 H28b 56(2) 
103 C2n C1m C28 H28c 175(2) 
104 P2 C1m C28 H28a 170(3) 
105 P2 C1m C28 H28b -70(2) 
106 P2 C1m C28 H28c 50(2) 
107 H1m C1m C28 H28a 51(3) 
108 H1m C1m C28 H28b 172(2) 
109 H1m C1m C28 H28c -69(2) 
110 C28 C1m C2n H2na -67(2) 
111 C28 C1m C2n H2nb 53(2) 
112 C28 C1m C2n H2nc 173(2) 
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Number Atom1 Atom2 Atom3 Atom4 Torsion 
113 P2 C1m C2n H2na 61(2) 
114 P2 C1m C2n H2nb -178(2) 
115 P2 C1m C2n H2nc -59(2) 
116 H1m C1m C2n H2na 177(2) 
117 H1m C1m C2n H2nb -63(2) 
118 H1m C1m C2n H2nc 57(2) 
119 C28 C1m P2 N8 63.9(5) 
120 C28 C1m P2 C1h -47.2(6) 
121 C28 C1m P2 Rh1 173.1(4) 
122 C2n C1m P2 N8 -62.4(5) 
123 C2n C1m P2 C1h -173.4(5) 
124 C2n C1m P2 Rh1 46.8(5) 
125 H1m C1m P2 N8 -177.7(6) 
126 H1m C1m P2 C1h 71.2(7) 
127 H1m C1m P2 Rh1 -68.5(6) 
128 N7 C1n C8 C29 41.3(9) 
129 N7 C1n C8 C7 -104.7(7) 
130 N7 C1n C8 Rh1 178.1(5) 
131 N8 C1n C8 C29 -145.8(6) 
132 N8 C1n C8 C7 68.2(8) 
133 N8 C1n C8 Rh1 -9.0(8) 
134 N5 C1t C1z N6 -12.9(7) 
135 N5 C1t C1z H1za -131.9(9) 
136 N5 C1t C1z H1zb 106.3(9) 
137 H1ta C1t C1z N6 -131.7(9) 
138 H1ta C1t C1z H1za 109(1) 
139 H1ta C1t C1z H1zb -13(1) 
140 H1tb C1t C1z N6 106.1(9) 
141 H1tb C1t C1z H1za -13(1) 
142 H1tb C1t C1z H1zb -135(1) 
143 N7 C23 C2j N8 13.5(6) 
144 N7 C23 C2j H2ja -105.5(8) 
145 N7 C23 C2j H2jb 132.5(7) 
146 H23a C23 C2j N8 -105.7(7) 
147 H23a C23 C2j H2ja 135.3(9) 
148 H23a C23 C2j H2jb 13(1) 
149 H23b C23 C2j N8 132.9(7) 
150 H23b C23 C2j H2ja 14(1) 
151 H23b C23 C2j H2jb -108.2(9) 
152 N5 C29 C8 C1n 157.0(6) 
153 N5 C29 C8 C7 -57.7(8) 
154 N5 C29 C8 Rh1 19.6(8) 
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Number Atom1 Atom2 Atom3 Atom4 Torsion 
155 N6 C29 C8 C1n -22(1) 
156 N6 C29 C8 C7 122.8(8) 
157 N6 C29 C8 Rh1 -159.8(6) 
158 C13 C2e C2v H2va -62(3) 
159 C13 C2e C2v H2vb 58(2) 
160 C13 C2e C2v H2vc 178(2) 
161 P4 C2e C2v H2va 67(3) 
162 P4 C2e C2v H2vb -172(2) 
163 P4 C2e C2v H2vc -53(3) 
164 H2e C2e C2v H2va -177(3) 
165 H2e C2e C2v H2vb -57(3) 
166 H2e C2e C2v H2vc 63(3) 
167 C2v C2e C13 H13a -62(3) 
168 C2v C2e C13 H13b 58(3) 
169 C2v C2e C13 H13c 177(3) 
170 P4 C2e C13 H13a 166(3) 
171 P4 C2e C13 H13b -74(3) 
172 P4 C2e C13 H13c 45(3) 
173 H2e C2e C13 H13a 53(3) 
174 H2e C2e C13 H13b 173(3) 
175 H2e C2e C13 H13c -67(3) 
176 C2v C2e P4 N5 78.7(7) 
177 C2v C2e P4 C1g -28.9(7) 
178 C2v C2e P4 Rh1 -174.4(5) 
179 C13 C2e P4 N5 -149.6(6) 
180 C13 C2e P4 C1g 102.9(6) 
181 C13 C2e P4 Rh1 -42.7(7) 
182 H2e C2e P4 N5 -36.9(8) 
183 H2e C2e P4 C1g -144.4(8) 
184 H2e C2e P4 Rh1 70.0(8) 
185 C11 C1g C2r H2ra -52(3) 
186 C11 C1g C2r H2rb 68(3) 
187 C11 C1g C2r H2rc -172(3) 
188 P4 C1g C2r H2ra -174(2) 
189 P4 C1g C2r H2rb -54(3) 
190 P4 C1g C2r H2rc 66(3) 
191 H1g C1g C2r H2ra 68(3) 
192 H1g C1g C2r H2rb -172(3) 
193 H1g C1g C2r H2rc -52(3) 
194 C2r C1g C11 H11a -61(3) 
195 C2r C1g C11 H11b 60(3) 
196 C2r C1g C11 H11c 179(3) 
	 52	
Number Atom1 Atom2 Atom3 Atom4 Torsion 
197 P4 C1g C11 H11a 61(2) 
198 P4 C1g C11 H11b -179(3) 
199 P4 C1g C11 H11c -59(3) 
200 H1g C1g C11 H11a 179(2) 
201 H1g C1g C11 H11b -61(3) 
202 H1g C1g C11 H11c 59(3) 
203 C2r C1g P4 N5 -173.3(6) 
204 C2r C1g P4 C2e -64.8(7) 
205 C2r C1g P4 Rh1 80.4(6) 
206 C11 C1g P4 N5 62.7(6) 
207 C11 C1g P4 C2e 171.2(6) 
208 C11 C1g P4 Rh1 -43.6(7) 
209 H1g C1g P4 N5 -55.4(8) 
210 H1g C1g P4 C2e 53.1(9) 
211 H1g C1g P4 Rh1 -161.7(7) 
212 Rh1 C7 C8 C1n -107.5(5) 
213 Rh1 C7 C8 C29 105.3(5) 
214 H7a C7 C8 C1n 3(1) 
215 H7a C7 C8 C29 -144.0(8) 
216 H7a C7 C8 Rh1 110.6(7) 
217 H7b C7 C8 C1n 141.9(8) 
218 H7b C7 C8 C29 -5(1) 
219 H7b C7 C8 Rh1 -110.7(7) 
220 C8 C7 Rh1 Cl4 174.5(3) 
221 C8 C7 Rh1 P2 77.6(4) 
222 C8 C7 Rh1 P4 -86.6(4) 
223 H7a C7 Rh1 Cl4 63.9(8) 
224 H7a C7 Rh1 C8 -110.5(8) 
225 H7a C7 Rh1 P2 -32.9(7) 
226 H7a C7 Rh1 P4 162.9(7) 
227 H7b C7 Rh1 Cl4 -75.0(8) 
228 H7b C7 Rh1 C8 110.5(8) 
229 H7b C7 Rh1 P2 -171.8(7) 
230 H7b C7 Rh1 P4 24.0(7) 
231 C1n C8 Rh1 Cl4 -57(1) 
232 C1n C8 Rh1 C7 108.6(6) 
233 C1n C8 Rh1 P2 7.0(4) 
234 C1n C8 Rh1 P4 -161.6(5) 
235 C29 C8 Rh1 Cl4 83(1) 
236 C29 C8 Rh1 C7 -111.3(6) 
237 C29 C8 Rh1 P2 147.1(5) 
238 C29 C8 Rh1 P4 -21.4(4) 
	 53	
Number Atom1 Atom2 Atom3 Atom4 Torsion 
239 C7 C8 Rh1 Cl4 -165.7(8) 
240 C7 C8 Rh1 P2 -101.6(4) 
241 C7 C8 Rh1 P4 89.9(4) 
242 N8 P2 Rh1 Cl4 165.9(2) 
243 N8 P2 Rh1 C7 -43.7(3) 
244 N8 P2 Rh1 C8 -4.1(3) 
245 N8 P2 Rh1 P4 42.6(3) 
246 C1h P2 Rh1 Cl4 -78.4(3) 
247 C1h P2 Rh1 C7 72.1(3) 
248 C1h P2 Rh1 C8 111.7(3) 
249 C1h P2 Rh1 P4 158.3(3) 
250 C1m P2 Rh1 Cl4 53.6(2) 
251 C1m P2 Rh1 C7 -156.0(3) 
252 C1m P2 Rh1 C8 -116.4(3) 
253 C1m P2 Rh1 P4 -69.7(3) 
254 N5 P4 Rh1 Cl4 -151.9(2) 
255 N5 P4 Rh1 C7 57.8(3) 
256 N5 P4 Rh1 C8 17.2(3) 
257 N5 P4 Rh1 P2 -29.5(3) 
258 C2e P4 Rh1 Cl4 98.2(3) 
259 C2e P4 Rh1 C7 -52.0(4) 
260 C2e P4 Rh1 C8 -92.7(4) 
261 C2e P4 Rh1 P2 -139.4(4) 
262 C1g P4 Rh1 Cl4 -43.6(3) 
263 C1g P4 Rh1 C7 166.2(4) 
264 C1g P4 Rh1 C8 125.5(4) 
265 C1g P4 Rh1 P2 78.8(4) 
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Chapter 2 Carbodicarbene-Rh Catalyzed Hydroamination of Dienes2  
2.1 Introduction 
Nitrogen containing compounds are of great medicinal importance. Over 80% of 
pharmaceuticals approved in the United States contain a nitrogen.1 There are multiple 
strategies to incorporate nitrogen into molecules, including C-N cross coupling, reductive 
amination, and hydroamination.2–6 
 
 
 
Hydroamination is the addition of an N-H bond across a C-C π-bond to form C-H and C-N σ-
bonds (Figure 2-1).6 This transformation is atom-economical as both the amine component 
and hydrogen are incorporated in the product. The scope of the π-component includes 
alkenes, alkynes, allenes, and dienes. These π-components provide a variety of aminated 
products including alkyl, allyl, and vinyl amines. We envisioned that carbodicarbene-Rh(I) 
pincer complexes (Chapter 1), would be suitable catalysts for the intermolecular 
hydroamination of dienes, enabling the synthesis of potentially medicinally relevant 
nitrogen-containing compounds. 																																																								
2 A portion of this chapter appeared as a communication in the Journal of the American 
Chemical Society. The original citation is as follows: *Goldfogel, M. J.; *Roberts, C. C.; 
Meek, S. J. J. Am. Chem. Soc. 2014, 136, 6227-6230. (*Authors contributed equally.) Author 
contributions: CCR and SJM designed and synthesized the ligands and catalysts. CCR (with 
special focus on amine scope) and MJG (with special focus on diene scope and initial 
optimization) ran catalytic reactions. 
+
NR2H
R' R'
H-NR2
[M]
Figure 2-1 Hydroamination of an olefin 
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2.2 Background 
Hydroamination can be accomplished by both early and late transition metal catalysis, as 
well as lanthanide and actinide complexes.3 Early transition metal catalysts are often 
inhibited by Lewis basic functional groups. Therefore, late transition metal-catalyzed 
hydroamination is a particularly attractive strategy due to the potential for functional group 
tolerance in the reaction. Group 8, 9, 10, and 11 metals have been utilized for this 
transformation.7–17 There are many examples of intramolecular hydroaminations which form 
pyrrolidine and piperidine rings.6,9,11–13,18 Intermolecular examples are less common and still 
provide a synthetic challenge.8,10 
2.2.1 Mechanisms of late transition metal-catalyzed hydroamination 
There are two reaction mechanisms that are usually invoked to describe late transition metal-
catalyzed hydroamination (Scheme 2-1). Either Markovnikov (pictured) or anti-
Markovnikov selectivity can be achieved. The selectivity depends on the mechanism, catalyst 
structure, or directing group on the amine substrate.7,19,20   
In an N-H insertion mechanism (Scheme 2-1, left), an amine binds to a transition metal 
complex which undergoes oxidative addition to form an amido hydride complex. This 
oxidized complex binds to an alkene and either the amine (pictured) or hydride insert to form 
a metal-alkyl complex. The product is formed after the metal center undergoes reductive 
elimination. This mechanism is common with metals that easily undergo redox changes, such 
as iridium.21,22  
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Scheme 2-1 Late transition metal-catalyzed mechanisms for hydroamination 
	
  
 In an electrophilic activation mechanism (Scheme 2-1, right), a metal complex binds 
to an olefin and activates it towards nucleophilic addition. The electron density and charge of 
the complex changes the amount of activation of the bound olefin as described in the Dewar-
Chatt-Duncanson model.23 A nucleophile can add to the activated alkene to form a metal-
alkyl complex. Direct protonation of the metal-alkyl bond or proton transfer to the metal 
followed by reductive elimination furnishes the product and regenerates the catalyst. Late 
transition metals such as cationic Rh(I), Pd(II), and Pt(II) have been shown to operate under 
this mechanism.9,12–15,24,25 Our group was interested in developing electrophilic catalysts 
using carbodicarbene ligands that catalyze intermolecular hydroamination.  
[M]
[M]
H
R2N
[M]
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R'
[M]
R'
H
NHR2
R'
[M]
Me NR2
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R'
Me NR2
R'
NR2
R'
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2.2.2 Group 10-catalyzed hydroamination 
Scheme 2-2 PNP-Pd-catalyzed intramolecular hydroamination of alkenes 
 Michael and coworkers reported a Pd-catalyzed intramolecular hydroamination 
(Scheme 2-2).12,13 Using 5 mol% of Pd-pincer complex 2.3 and 10 mol% silver 
tetrafluoroborate to abstract the chlorides to form a dicationic complex, electron poor amines 
underwent a hydroamination to form pyrrolidine or piperidine products. The tridentate 
structure of the ligand prevents β-hydride elimination by occupying three sites of the square 
planar complex. Due to inhibition by more coordinating solvents, dichloromethane or toluene 
were found to work for this reaction. A variety of electron-deficient amines with protecting 
groups such as Boc (tert-butyloxycarbonyl), Cbz (carboxybenzyl), and acyl were tolerated. 
Due to the electrophilic nature of catalyst 2.3 and its susceptibility to being inhibited by 
Lewis basic functional groups, the substrate scope is limited. The Michael group also 
investigated the mechanism of this reaction and found that the alkene binds to the Pd catalyst, 
which activates the alkene for nucleophilic addition. After addition of the amine to the 
alkene, protonation of the metal-alkyl bond was found to be rate-limiting. Pt(II) has also been 
used to catalyze the hydroamination of olefins.18,26 
Group 9-catalyzed hydroamination 
 Hartwig and coworkers demonstrated the intramolecular hydroamination of 
unprotected amines to form pyrrolidine products using a Rh complex ligated by Xantphos 
derived ligand 2.6 (Scheme 2-3, top).9,11 A variety of unprotected or protected electron rich 
N
PPh2
PPh2
Pd Cl
Cl
NHBoc BocN
Me
5 mol% 2.3
10 mol% AgBF4, 
10 mol% Cu(OTF)2, MgSO4 
22 °C, CH2Cl2, 2-16 h
88% yield
2.1 2.2 2.3
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amines were tolerated to form 5- and 6-membered N-heterocycles such as 2.5. The 
mechanism of the reaction was probed and the rate-limiting step was found to be the attack of 
the amine on the alkene. The resting state of the catalyst was identified as the amine bound to 
the complex. Thus, in order for productive reactivity to occur, the alkene must displace the 
amine and bind to the metal. This substitution was accelerated by using a polar, protic 
solvent such as t-BuOH.  
Scheme 2-3 Rh-catalyzed intra- and intermolecular hydroamination of alkenes 
  
 The Hartwig group also disclosed an intermolecular hydroamination of styrenes 
(Scheme 2-3, bottom).27 Using 5 mol% of a cationic Rh-DPEPhos complex, electron-rich 
amines such as morpholine underwent anti-Markovnikov hydroamination in good yields. The 
products were a mixture of the desired alkyl amine and enamine, a byproduct formed from β-
hydride elimination.   
 
O
PP
Me Me
tBu tBu
Et2N
Et2N
NEt2
NEt2
NH2
Ph
H
N
Ph
Me
3 mol% [Rh(MeCN)2COD]BF4]
4 mol% 2.6
70 oC, tBuOH, 15 h 66% yield
+
N
H
O
N
O
71% yield 
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5 mol% [RhCOD(DPEphos)]BF4
70 °C, PhMe, 48 h
O
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Ph
Ph
Ph
Ph
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2.4 2.5 2.6
2.7
	 86	
2.3 Carbodicarbene Rh-catalyzed hydroamination 
2.3.1 Development of hydroamination catalysts 						
 
 
 
 Our group envisioned that the Rh-carbodicarbene complexes 2.7 - 2.9 (Figure 2-2) 
that I had developed and synthesized (Chapter 1) would be excellent candidates as 
hydroamination catalysts. Abstraction of the chloride from 2.7 and 2.8 would produce a 
cationic complex with one coordination site that would be open for alkene binding. This 
cationic complex would activate the coordinated olefin for nucleophilic attack. The electron-
rich carbodicarbene donor trans to the open coordination site would induce significant back 
donation to a bound alkene and would labilize any nucleophiles, such an amines, which could 
bind to the catalyst and inhibit catalysis. The tridentate structure of the ligand would prevent 
β-hydride elimination, minimizing enamine byproduct formation.9,12 We chose to examine 
the reaction between dienes and aryl or dialkylamines, which would result in allylic amine 
products, which are useful synthetic intermediates that can be further functionalized through 
the remaining alkene. 
N
N
N
N P
P
R
R R
R
Rh Cl
R = Ph 2.7
R = iPr 2.8
N
N
N
N P
P
Ph
PhPh
Ph
Rh N Me
BF4
2.9
 Figure 2-2 Rh-Carbodicarbene complexes 
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2.3.2 Optimization of CDC Rh-catalyzed hydroamination of phenylbuta-1,3-diene 
Table 2-1 Hydroamination of dienes with Rh-carbodicarbene catalysts 2.7 and 2.8
  
 The hydroamination of phenylbuta-1,3-diene with aniline to form allylic amine 2.10 
was tested using the Rh(I) complexes that I developed (Table 2-1). Chlorobenzene was 
found to be a suitable solvent.  Using 5 mol% of either complex 2.7 or 2.8 without the use of 
a silver salt to abstract the halide did not produce any product (Entries 1-2). By adding 5 
mol% of AgBF4 and 5 mol% 2.7 or 2.8 to the reaction under the same conditions, allylic 
amine 2.10 was produced in 66% or 65% yield respectively (Entries 3-4).  Other silver salts 
(PF6, SbF6 and OTf ) were tested (Entries 5-7) but did not result in increased yields. 
Lowering the catalyst loading with complex 2.7 only diminished the yield slightly (Entry 8). 
Entrya
1
2
3
4
5
6
7
8
9
10
11
12
13
Complex
2.7
2.8
2.7
2.8
2.7
2.7
2.7
2.7
2.9
-
-
-
-
X mol%
5
5
5
5
5
5
5
1
5
5
5
20
50
Additive
-
-
AgBF4
AgBF4
AgPF6
AgSbF6
AgOTf
AgBF4
-
HBF4•OEt2
AgBF4
NH4BF4
HCl
Conv. (%)b
<2
<2
75
73
70
40
60
63
72
<2
<2
<2
<2
Yield (%)c
nd
nd
66
65
59
31
51
59
67
nd
nd
nd
nd
a. See experimental for details; all reactions performed under N2; >98% site selectivity, b. 
conversion to product based on 1H NMR analysis using a DMF internal standard. c. Isolated 
yields after purification uisng silica gel chromatography; average of 2 runs
Ph + PhNH2 Ph Me
X mol% complex
X mol% additive
C6H5Cl, 80 °C, 24 h
NHPh
1 equiv. 1 equiv. 2.10
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Cationic complex 2.9 was found to be a competent catalyst and produced 2.10 in 67% yield 
without the need for a silver salt. Running the reaction with 2.9 at lower temperatures 
drastically decreased the yield, but complexes 2.8 and 2.9 still function at lower temperatures 
(vide infra). Control reactions (Entries 10-13) were run to ensure that no background 
reactions were occurring. 
2.3.3 Substrate scope 
 The substrate scope of the reaction was examined using PhCl as solvent (Chart 2-1). 
Using only 1 mol% of 2.7 at 60 °C, allylic substituted aniline 2.10 was formed in 71% yield. 
Varying the electronics of the diene by incorporating either a fluoro (2.11) or methoxy group 
(2.12) in the 4-position of the phenyl ring generated functionalized allylic amines in 85% and 
94% yields respectively. Although both reactions gave high yields, the 4-
methoxyphenylbuta-1,3-diene required higher temperatures  (60 °C) in order to react in 
contrast to the 4-fluorophenylbuta-1,3-diene which only required 35 °C. Substitution at the 
ortho-postion of the aniline was well tolerated (2.13 and 2.16). Electron-poor as well as 
electron-rich anilines reacted at 60 °C to give allylic amines 2.14 and 2.15 in 91% and 64% 
yields respectively. Aryl bromides performed well in this reaction and did not produce side 
products (2.16) unless heated higher than 50 °C. Disubstituted anilines, such as N-allyl 
aniline did not work in the reaction, most likely due to increased bulk and unfavorable steric 
interactions.  
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Chart 2-1 Aryl and alkyl amine substrate scope 
 A variety of secondary alkyl amines were examined as well. Usually higher 
temperatures (80 °C) were required for the strongly basic alkyl amines. Cyclic amines such 
as morpholine and pyrrolidine generated allylic amines 2.17 and 2.18 with good conversion 
HN
Me
HN
Me
HN
Me
HN
Me
HN
Me
CF3 OMe
Br
Me
N
Me
N
Me
N
Me
Bn N
Me
Me N
Me
O
Bn Bn EtEt
HN
Me
HN
Me
F MeO
1 mol% 2.7
60 °C, 24 h
88% conv, 71% yield
5 mol% 2.7
35 °C, 48 h
97% conv, 85% yield
5 mol% 2.7
60 °C, 48 h
96% conv, 94% yield
5 mol% 2.8
60 °C, 48 h
89% conv, 80% yield
2 mol% 2.8
60 °C, 24 h
96% conv, 91% yield
3 mol% 2.8
60 °C, 48 h
68% conv, 64% yield
3 mol% 2.7
50 °C, 48 h
86% conv, 85% yield
3 mol% 2.8
80 °C, 48 h
92% conv, 89% yield
5 mol% 2.7
80 °C, 48 h
80% conv, 75% yielda
2 mol% 2.8
80 °C, 48 h
58% conv, 56% yield
5 mol% 2.8
80 °C, 48 h
74% conv, 72% yield
5 mol% 2.8
80 °C, 48 h
14% conv, 6% yield
2.10 2.11 2.12
2.13 2.14 2.15
2.16 2.17 2.18
2.19 2.20 2.21
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(89% and 80%, respectively). To form 2.18 in good yield, 20 mol% of NH4BF4 was added. 
The effect of additives will be discussed in Chapter 3. Dibenzylamine, which is an ammonia 
equivalent after deprotection, can be used as an amine and produces product 2.19 in 56% 
yield after 48 hours. Methylbenzylamine was also tolerated. When a more hindered dialkyl 
amine such as dipropylamine was tested, the product 2.21 was only generated in trace 
quantities. In general, either catalyst 2.7 or 2.8 could be used in these reactions and both 
catalysts were always tested. The optimized results are shown. Primary amines were tested in 
this reaction, but were not tolerated.  
 Next, functional group tolerance and diene substrate scope was examined (Chart 2-
2). Lewis basic functional groups such as esters (2.22, 2.28, 2.31), protected N-heterocycles 
(2.23), and free alcohols (2.33) were all tolerated under the reaction conditions. Complex 2.8 
was necessary for the reaction to form 2.23 because complex 2.7 isomerized the starting 
material to form the aromatized pyrrole. Alkyl dienes reacted with both aryl (2.25, 2.27, 2.30, 
and 2.32) and dialkyl (2.24 and 2.29) amines. Alkenes were left untouched as in the case of 
geraniol-derived diene to produce 2.26. No other substitution patterns on the diene were 
tolerated under the reaction conditions.  
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Chart 2-2 Diene substrate scope 	
NHPh
Me
n-hexyl
NHPh
Me
NHPh
Me
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Me
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Me
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MeMeMe
Me MeMe
O
EtO
NHPh
Me
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O
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Me
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EtO
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R1
R2
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R1
Me
R2
NR1R25 mol% 2.7 or 2.8
5 mol% AgBF4
C6H5Cl, temp, 24-48 h
5 mol% 2.7, 100 °C
91% yield
5 mol% 2.8, 65 °C
69% yield
5 mol% 2.7, 100 °C
91% yield
5 mol% 2.7, 70 °C
70% yield
5 mol% 2.7, 60 °C
97% yield
5 mol% 2.7, 60 °C
96% yield
5 mol% 2.7, 80 °C
78% yield
5 mol% 2.7, 70 °C
62% yield
5 mol% 2.7, 60 °C
89% yield
5 mol% 2.7, 120 °C
30% yield
5 mol% 2.7, 60 °C
77% yield
5 mol% 2.7, 80 °C
74% yield
2.22 2.23 2.24 2.25
2.26 2.27 2.28 2.29
2.30 2.31 2.32 2.33
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2.3.4 Mechanistic insights 
Scheme 2-4 Reaction of 2.9 and aniline
 
 In order to investigate the mechanism of the reaction, preliminary mechanistic studies 
were performed. By taking acetonitrile complex 2.9 and adding aniline, the aniline complex 
was formed in situ at room temperature in 2 hours (Scheme 2-4). Upon heating the reaction 
for 2 hours at 45 °C, no hydride was observed in the NMR spectrum, which would be the 
result of oxidative addition into the N-H bond. The hydroamination of phenylbuta-1,3-diene 
proceeds at 45 °C, which suggests that the mechanism of the reaction proceeds through 
electrophilic activation of the olefin followed by nucleophilic attack. 
2.4 Conclusion 
 Carbodicarbene ligands have been demonstrated in catalysis for the first time. The 
hydroamination reactions proceeded efficiently using between 1 – 5 mol% of readily 
prepared carbodicarbene complexes 2.7 and 2.8. The substrate scope encompasses both aryl 
as well as alkyl amines. A variety of functional groups are tolerated (esters, alcohols, ethers, 
halides, etc.) in this reaction.  
Experimental 
n  General: All reactions were carried out in flame or oven (140 oC) dried glassware that had 
been cooled under vacuum.  Unless otherwise stated, all reactions were carried out under an 
inert N2 atmosphere. All reagents were purged or sparged with N2 for 20 min prior to 
N
N
N
N PPh2
PPh2
Rh N
N
N
N
N PPh2
PPh2
Rh Ph
H2
N
N
N
N
N PPh2
PPh2
Rh Ph
H
N
H
CMe
PhNH2
CD2Cl2, 
1h, 22 °C
45 °C
CD2Cl2, 3 h
BF4 BF4 BF4
2.9 2.34 2.35
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distillation or use.  All solid reagents were dried by azeotropic distillation with benzene three 
times prior to use.  Infrared (IR) spectra were obtained using a Jasco 460 Plus Fourier 
transform infrared spectrometer or a ASI ReactIR 1000, Model: 001-1002 for air sensitive 
rhodium carbonyl complexes.  Mass spectra were obtained using a Micromass Quattro-II 
triple quadrupole mass spectrometer in combination with an Advion NanoMate chip-based 
electrospray sample introduction system and nozzle for low-res or Waters Q-ToF Ultima 
Tandem Quadrupole/Time-of-Flight Instrument UE521 at University of Illinois at Urbana 
Champaign for high-res or Waters Q-ToF Xevo Tandem Quadrupole/Time-of-Flight 
Instrument.  The Q-Tof Ultima mass spectrometer was purchased in part with a grant from 
the National Science Foundation, Division of Biological Infrastructure (DBI-0100085).  All 
samples were prepared in MeOH or MeCN for metal complexes.  Proton and carbon 
magnetic resonance spectra (1H NMR and 13C NMR) were recorded on a Bruker model DRX 
400 or a Bruker AVANCE III 600 CryoProbe (1H NMR at 400 MHz or 600 MHz, 13C NMR 
at 100 or 150 MHz, 31P NMR at 160 or 243 MHz and 19F NMR at 376 or 564 MHz) 
spectrometer with solvent resonance as the internal standard (1H NMR: CDCl3 at 7.26 ppm, 
CD2Cl2 at 5.30 ppm, C6D6 at 7.16 ppm, CD3CN at 1.94 ppm; 13C NMR: CDCl3 at 77.16 ppm, 
C6D6 at 128.4 ppm, CD3CN at 1.31 ppm).  NMR data are reported as follows: chemical shift, 
integration, multiplicity (s = singlet, d = doublet, t = triplet, dd = doublet of doublets, td = 
triplet of doublets, dt = doublet of triplets, ddd = doublet of doublet of doublets, septetd = 
septet of doublets, m = multiplet, bs = broad singlet, bm = broad multiplet), and coupling 
constants (Hz).  X-ray diffraction studies were conducted on a Bruker-AXS SMART APEXII 
diffractometer.  Crystals were selected and mounted using Paratone oil on a MiteGen Mylar 
tip.  
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(E)-phenyl-1,3-butadiene,28 (E)-1-(buta-1,3-diene-1-yl)-4-methoxybenzene,29 (E)-1-(buta-
1,3-diene-1-yl)-4-fluorobenzene,28,30 (E)/(Z)-1-buta-1,3-dien-1-ylcylohexane,29 (E)-deca-1,3-
diene,31 (E)-4,8-dimethylnona-1,3,7-triene, (E)-ethyl-2,2-dimethylhexa-3,5-dienoate,32,33 (E)-
2,2-dimethylhexa-3,5-dien-1-ol,34 allylidenecyclohexane35 were synthesized according to a 
literature method or a modified literature method and matched reported spectra. 
 
n  Solvents:  Solvents were purged with argon and purified under a positive pressure of dry 
argon by a SG Waters purification system: dichloromethane (EMD Millipore) and THF 
(EMD Millipore) were passed through activated alumina columns.  Chlorobenzene (Alfa 
Aesar) was dried over K2CO3, distilled under vacuum and stored over activated 5 Å 
molecular sieves in a dry box. 
 
n  Reagents:   
Acetonitrile – d3 was purchased from Cambridge Isotope Labs, dried over CaH2 and stored 
in a dry box over activated 4 Å molecular sieves. 
AgNO3 Doped Silica Gel was prepared as a 1% mixture by weight as described in the 
literature. 
Aniline was purchased from Aldrich, dried on CaH2, distilled under vacuum, and stored in a 
dry box freezer at -30 oC. 
p-Anisidine was purchased from Alfa Aesar, dried over CaCl2, distilled under vacuum, and 
stored in a dry box. 
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Benzylmethylamine was purchased from Alfa Aesar, dried over K2CO3, distilled under 
vacuum, and stored in a dry box. 
2-Bromoaniline was purchased from Alfa Aesar, dried over CaCl2, distilled under vacuum, 
and stored in a dry box. 
Chlorobenzene was dried over K2CO3, distilled under vacuum and stored over activated 5 Å 
molecular sieves in a dry box. 
Chloroform – d1 was purchased from Cambridge Isotope Labs, dried over CaH2 and stored 
in a dry box over activated 4 Å molecular sieves. 
Chloro(1,5-cyclooctadiene)rhodium(I) dimer was purchased from Pressure Chemicals, 
stored in a dry box and used as received.  
Chlorodiisopropyl phosphine was purchased from Acros Organics and used as received. 
Chlorodiphenylphosphine was purchased from Alfa Aesar and used as received. 
Cyclohexa-1,3-diene was purchased from Alfa Aesar and was distilled and stored under N2 
at -20 °C.  
Dichloromethane – d2 was purchased from Cambridge Isotope Labs, dried over CaH2 and 
stored in a dry box over activated 4 Å molecular sieves. 
Dibenzyl amine was purchased from Alfa Aesar, passed through a plug of alumina onto 
activated 5 Å molecular sieves for 24 h and transferred to a vial in a dry box. 
Di-n-propyl amine was purchased from Aldrich, dried over KOH, and distilled under 
reduced pressure and stored in a dry box. 
Morpholine was purchased from Alfa Aesar, dried over KOH, distilled under reduced 
pressure and stored in a dry box. 
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Pyrrolidine was purchased from Alfa Aesar, dried over Na, distilled under reduced pressure 
and stored in a dry box. 
Silver tetrafluoroborate was purchased from Strem, stored in a dry box, and used without 
further purification. 
4-(Trifluoromethyl)aniline was purchased from Alfa Aesar, distilled over CaH2, and stored 
at -30 oC in a dry box freezer. 
Sodium methoxide was purchased from Strem, stored in a dry box, and used as received. 
o-Toluidine was purchased from Alfa Aesar, dried over CaH2, distilled under vacuum, and 
stored in a dry box. 
Tetrafluoroboric acid was purchased from Alfa Aesar and used as received. 
Triethylamine was purchased from Fisher, dried over CaH2, and distilled immediately prior 
to use. 
 
n  General procedure for Rh-catalyzed hydroaminations in Scheme 2 and Tables 2, 3, 
and 4 
In an N2 filled dry box, an 8-mL vial equipped with a stir bar was charged with (CDC)-RhCl, 
AgBF4, and chlorobenzene.  The vial was capped and the mixture allowed to stir at 22 °C for 
1 h, to generate a heterogeneous purple or blue solution.  The appropriate amine was added 
via syringe (or weighed into the vial) followed by the 1,3-diene.  The vial was capped with a 
Teflon® lined lid, sealed with electrical tape, brought outside the dry box, and heated to the 
indicated temperature for the appropriate amount of time.  The reaction was allowed to cool 
to 22 °C, and an aliquot was taken to determine the conversion by 1H NMR using an internal 
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DMF standard.   The remaining solvent was removed in vacuo.  The products were purified 
by SiO2 column chromatography to give isolated yields.   
 
 
Synthesis of (E)-N-(4-phenylbut-3-en-2-yl)aniline 2.10 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, aniline (18.6 mg, 
0.200 mmol) and phenyl 1,3-butadiene (26.0 mg, 0.200 mmol) were added to a solution of 
2.7 (1.4 mg, 0.0020 mmol) and AgBF4 (0.4 mg, 0.0020 mmol) in chlorobenzene (200 µL, [ ] 
= 1.00 M), and the reaction allowed to stir at 60 °C for 24 h.  The resulting oil was purified 
by SiO2 column chromatography (20:1 Hex/Et2O) to afford 2.10 (31.3 mg, 0.142 mmol, 71% 
yield) as a colorless oil. 
1H NMR (600 MHz, CDCl3): δ 7.36 (2H, d, J = 7.4 Hz), 7.30 (2H, t, J = 7.6 Hz), 7.22 (1H, t, 
J = 7.3 Hz), 7.17 (2H, t, J = 8.0 Hz), 6.69 (1H t, J = 7.3 Hz), 6.66 (2H, d, J = 7.9 Hz), 6.58 
(1H, d, J = 16.0 Hz), 6.22 (1H, dd, J = 15.9, 5.9 Hz), 4.14-4.17 (1H, m), 3.72 (1H, bs), 1.41 
(3H, d, J = 6.6 Hz).  13C NMR (150 MHz, CDCl3): δ 147.53, 137.09, 133.31, 129.39, 129.34, 
128.65, 127.49, 126.45, 117.46, 113.50, 50.98, 22.25.  IR (ν/cm-1): 3412 (br, m), 3081 (w), 
3056 (w), 3023 (m), 2968 (m), 2926 (w), 2867 (w), 1602 (s), 1506 (s), 1456 (w), 1429 (w), 
1317 (m), 1257 (m), 1178 (m), 1156 (w).  LRMS (ES+) [M+H]+ calcd for C16H18N+ 224.14, 
found: 224.04. 
Me
HN
Ph
N N
N N
Ph2P PPh2Rh
Cl
1 mol %
1 mol % AgBF4
PhCl (1.0 M), 35 oC, 48 h
H2N
+
2.10
71% Yield
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Synthesis of (E)-N-(4-(4-fluorophenyl)but-3-en-2-yl)aniline 2.11 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, aniline (18.6 mg, 
0.200 mmol) and (E)-1-(buta-1,3-diene-1-yl)-4-fluorobenzene (59.3 mg, 0.400 mmol) were 
added to a solution of 2.7 (6.8 mg, 0.0099 mmol) and AgBF4 (1.9 mg, 0.0098 mmol) in 
chlorobenzene (200 µL, [ ] = 1.00 M), and the reaction allowed to stir at 60 °C for 48 h.  The 
resulting oil was purified by SiO2 column chromatography with a layer of 1% (by weight) 
AgNO3 doped silica gel (20:1 Hex/EtOAc) to afford 2.11 (45.4 mg, 0.188 mmol, 94% yield) 
as a light yellow solid. 
1H NMR (600 MHz, CDCl3): δ 7.31 (2H, m), 7.16 (2H, t, J = 7.9 Hz), 6.98 (2H, t, J = 8.7 
Hz), 6.69 (1H, t, J = 7.2 Hz), 6.64 (2H, d, J = 7.6 Hz),  6.53 (1H, d, J = 15.9 Hz), 6.13 (1H, 
dd, J = 15.9, 5.8 Hz), 4.13 (1H, m, J = 6.2 Hz), 3.72 (1H, bs), 1.4 (1H, d, J = 6.6 Hz).  13C 
NMR (150 MHz, CDCl3): δ 147.35, 133.12, 132.91, 132.89, 129.23, 128.10, 127.82, 127.77, 
117.38, 115.47, 115.32, 113.35, 50.79, 22.13.  IR (ν/cm-1): 3407 (br, m), 3052 (w), 3021 (w), 
2967 (m), 2922 (m), 2865 (w), 1602 (s), 1507 (s), 1316 (m), 1227 (s), 1157 (m).  LRMS 
(ES+) [M+H]+ calcd for C16H17FN+ 242.13, found: 242.14. 
Me
HN
Ph
FF
N N
N N
Ph2P PPh2Rh
Cl
5 mol %
5 mol % AgBF4
PhCl (1.0 M), 60 oC, 48 h
H2N
+
2.11
94% Yield
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Synthesis of (E)-N-(4-(4-methoxyphenyl)but-3-en-2-yl)aniline 2.12 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, aniline (18.6 mg, 
0.200 mmol) and (E)-1-(buta-1,3-dien-1-yl)-4-methoxybenzene (64.1 mg, 0.400 mmol) were 
added to a solution of 2.7 (6.8 mg, 0.0099 mmol) and AgBF4 (1.9 mg, 0.0098 mmol) in 
chlorobenzene (200 µL, [ ] = 1.00 M), and the reaction allowed to stir at 35 °C for 48 h.  The 
resulting oil was purified by SiO2 column chromatography (20:1 Hex/Et2O) to afford 2.12 
(43.1 mg, 0.170 mmol, 85% yield) as a light yellow solid. 
1H NMR (600 MHz, CDCl3): δ 7.30 (2H, d, J = 8.7 Hz), 7.17 (2H, t, J = 8.0 Hz), 6.85 (2H, d, 
J = 8.7 Hz), 6.70 (1H, t, J = 7.3 Hz), 6.66 (2H, d, J = 7.6), 6.53 (1H, d, J = 15.8), 6.09 (1H, 
dd, J = 15.9, 5.9), 4.13-4.16 (1H, m), 3.81 (3H, s), 3.72 (1H, bs), 1.41 (3H, d, J = 6.6 Hz).  
13C NMR (150 MHz, CDCl3): δ 158.98, 147.42, 130.95, 129.72, 129.14, 128.63, 127.41, 
117.22, 113.88, 113.35, 55.25, 50.83, 22.12.  IR (ν/cm-1): 3407 (br, m), 3052 (w), 3021 (w), 
2967 (m), 2922 (m), 2865 (w), 1602 (s), 1507 (s), 1316 (m), 1227 (s), 1157 (m).  LRMS 
(ES+) [M+H]+ calcd for C17H19NO+ 254.15, found: 254.11. 
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Synthesis of (E)-2-methyl-N-(4-phenylbut-3-en-2-yl)aniline 2.13 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, o-toluidine (21.4 
mg, 0.200 mmol) and phenyl 1,3-butadiene (39.0 mg, 0.300 mmol) were added to a solution 
of 2.8 (5.5 mg, 0.010 mmol) and AgBF4 (1.9 mg, 0.0098 mmol) in chlorobenzene (100 µL, [ 
] = 2.00 M), and the reaction allowed to stir at 60 °C for 48 h.  The resulting oil was purified 
by SiO2 column chromatography (15:1 Hex/Et2O) to afford 2.13 (38.0 mg, 0.160 mmol, 80% 
yield) as a colorless oil. 
1H NMR (600 MHz, CDCl3): δ 7.36 (2H, d, J = 7.2 Hz), 7.30 (2H, t, J = 7.2 Hz), 7.22 (1H, t, 
J = 7.8 Hz), 6.66 (2H, m), 6.58 (1H, d, J = 16.2 Hz), 6.25 (1H, dd, J = 16.2, 6.0 Hz), 4.20 
(1H, bm), 3.26 (1H, s), 2.19 (3H, s), 1.46 (3H, d, J = 7.2 Hz).  13C NMR (150 MHz, CDCl3): 
δ 145.47, 137.14, 133.51, 130.23, 129.37, 128.65, 127.48, 127.24, 126.48, 121.84, 116.99, 
110.97, 50.85, 22.45, 17.77.  IR (ν/cm-1): 3429 (br, m), 3056 (w), 3024 (m), 2967 (m), 2924 
(m), 2861 (w), 1605 (s), 1585 (m), 1510 (s), 1477 (w), 1445 (w), 1371 (m), 1314 (m), 1259 
(m), 1163 (m), 1050 (m).  LRMS (ES+) [M+H]+ calcd for C17H20N+ 238.16, found: 238.13. 
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Synthesis of (E)-N-(4-phenylbut-3-en-2-yl)-4-(trifluoromethyl)aniline 2.14 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, 4-
(trifluoromethyl)aniline (32.2  mg, 0.200 mmol) and phenyl 1,3-butadiene (31.2 mg, 0.240 
mmol) were added to a solution of 2.8 (1.4 mg, 0.0020 mmol) and AgBF4 (0.4 mg, 0.0020 
mmol) in chlorobenzene (200 µL, [ ] = 1.00 M) and the reaction allowed to stir at 60 oC for 
48 h.  The resulting oil was purified by SiO2 column chromatography (10:1 Hex/EtOAc) to 
afford 2.14 (53.0 mg, 0.182 mmol, 91% yield) as a colorless oil. 
1H NMR (600 MHz, CDCl3): δ 7.41 (2H, d, J = 8.4 Hz), 7.38 (2H, dd, J = 8.2, 1.2 Hz), 7.33 
(2H, t, J = 7.8 Hz) 7.25 (1H, tt, J = 7.2, 1.8 Hz), 6.66 (2H, d, J = 8.4 Hz), 6.58 (1H, d, J = 6.2 
Hz), 6.20 (1H, dd, J = 15.9, 5.7 Hz), 4.19-4.22 (1H, m), 4.1 (1H, bs) 1.45 (3H, d, J = 6.6 Hz).  
13C NMR (150 MHz, CDCl3): δ 149.75, 131.95, 129.72, 128.56, 127.57, 126.52 (q, J = 2.5 
Hz), 126.32, 124.97 (q, J = 223.8 Hz), 118.68 (q, J = 27.5 Hz), 112.38, 50.53, 21.91.  19F 
NMR (564 MHz, CDCl3): δ 60.89.  IR (ν/cm-1): 3418 (br, s), 3083 (w), 3062 (w), 3027 (m), 
2973 (m), 2928 (m), 2871 (m), 1616 (s), 1531 (s), 1491 (w), 1327 (s), 1266 (m), 1188 (m), 
1159 (m), 1110 (s).  LRMS (ES+) [M+H]+ calcd for C17H17NF3+ 292.13, found: 292.06. 
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Synthesis of (E)-4-methoxy-N-(4-phenylbut-3-en-2-yl)aniline 2.15 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, 4-methoxyaniline 
(24.6 mg, 0.200 mmol) and phenyl 1,3-butadiene (26.0 mg, 0.200 mmol) were added to a 
solution of 2.8 (3.3 mg, 0.0060 mmol) and AgBF4 (1.2 mg, 0.0062 mmol) in chlorobenzene 
(400 µL, [ ] = 0.500 M), and the reaction allowed to stir at 60 °C for 48 h.  The resulting oil 
was purified by SiO2 column chromatography (10:1 Hex/EtOAc) to afford 2.15 (32.5 mg, 
0.128 mmol, 64% yield) as a colorless oil. 
1H NMR (600 MHz, CDCl3): δ 7.37 (2H, dd, J = 8.1, 1.2 Hz), 7.31 (2H, t, J = 7.8 Hz), 7.23 
(1H, tt, J = 7.2, 1.2 Hz), 6.77-6.80 (2H, m), 6.63-6.66 (2H, m), 6.58 (1H, d, J = 15.6 Hz), 
6.23 (1H, dd, J = 16.2, 6.0 Hz), 4.07-4.10 (1H, m), 3.75 (3H, s), 1.40 (3H, d, J = 6.6 Hz).  13C 
NMR (150 MHz, CDCl3): δ 152.04, 141.56, 136.98, 133.53, 129.19, 128.47, 127.27, 126.26, 
114.89, 114.76, 55.72, 51.80, 22.09.  IR (ν/cm-1): 3396 (br, m), 3059 (w), 3025 (m), 2964 
(m), 2928 (m), 2831 (m), 1502 (s), 1448 (m), 1291 (m), 1234 (s), 1177 (m), 1038 (m).  
LRMS (ES+) [M+H]+ calcd for C17H20NO+ 254.15, found: 254.05. 
Me
HN
N N
N N
(iPr)2P P(iPr)2Rh
Cl
3 mol %
3 mol % AgBF4
PhCl (0.5 M), 60 oC, 48 h
H2N
+
OMe
OMe
2.15
64% Yield
	 103	
 
 
Synthesis of (E)-2-bromo-N-(4-phenylbut-3-en-2-yl)aniline 2.16 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, 2-bromoaniline 
(34.4 mg, 0.200 mmol) and phenyl 1,3-butadiene (39.0 mg, 0.300 mmol) were added to a 
solution of 2.7 (4.1 mg, 0.0059 mmol) and AgBF4 (1.2 mg, 0.0062 mmol) in chlorobenzene 
(100 µL, [ ] = 2.00 M), and the reaction allowed to stir at 50 °C for 48 h.  The resulting oil 
was purified by SiO2 column chromatography (15:1 Hex/Et2O) to afford 2.16 (51.2 mg, 
0.172 mmol, 86% yield) as a colorless oil. 
1H NMR (400 MHz, CDCl3): δ 7.43 (1H, dd, J = 7.9, 1.4 Hz), 7.35-7.37 (2H, m), 7.30 (2H, t, 
J = 7.3 Hz), 7.22 (1H, tt, J = 6.9, 2.0 Hz), 7.13 (1H, td, J = 7.7, 1.3 Hz), 6.69 (1H, dd, J = 
8.2, 1.1 Hz), 6.53-6.58 (2H, m), 6.21 (1H, dd, J = 15.9, 5.9 Hz), 4.41 (1H, bd, J = 6.1 Hz), 
4.15-4.20 (1H, m), 1.47 (3H, d, J = 6.6 Hz).  13C NMR (100 MHz, CDCl3): δ 144.15, 136.78, 
132.47, 132.34, 129.54, 128.53, 128.39, 127.46, 126.36, 117.72, 112.45, 109.72, 50.98, 
22.14.  IR (ν/cm-1): 3409 (br, m), 3060 (w), 3025 (m), 2967 (m), 2922 (m), 2867 (w), 1595 
(s), 1504 (s), 1459 (m), 1426 (m), 1319 (s), 1165 (m), 1018 (m).  LRMS (ES+) [M+H]+ calcd 
for C16H17BrN+ 302.05, found: 302.00. 
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Synthesis of (E)-4-(4-phenylbut-3-en-2-yl)morpholine 2.17 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, morpholine (17.4 
mg, 0.200 mmol) and phenyl 1,3-butadiene (39.0 mg, 0.300 mmol) were added to a solution 
of 2.8 (3.5 mg, 0.0064 mmol) and AgBF4 (1.2 mg, 0.0062 mmol) in chlorobenzene (100 µL, 
[ ] = 2.00 M), and the reaction allowed to stir at 80 °C for 48 h.  The resulting oil was 
purified by SiO2 column chromatography (20:1 CH2Cl2:MeOH) to afford 2.17 (38.8 mg, 
0.178 mmol, 89% yield) as a yellow oil. 
1H NMR (600 MHz, CDCl3): δ 7.37 (2H, d, J = 7.2 Hz), 7.31 (2H, t, J = 7.8 Hz), 7.23 (1H, t, 
J = 7.2 Hz), 6.46 (1H, d, J = 16.2 Hz), 6.17 (1H, dd, J = 15.9, 8.1 Hz), 3.74 (4H, t, J = 6.6 
Hz), 3.01-3.04 (1H, m), 2.57 (4H, bt, J = 5.1Hz), 1.26 (3H, d, J = 6.6 Hz).  13C NMR (150 
MHz, CDCl3): δ 137.04, 132.27, 131.36, 128.72, 127.61, 126.40, 67.36, 63.27, 50.92, 17.90.  
IR (ν/cm-1): 3058 (w), 3025 (m), 2961 (s), 2891 (w), 2852 (m), 2806 (m), 2755 (w), 2687 
(w), 1494 (m), 1448 (m), 1315 (w), 1266 (m), 1142 (w), 1119 (s), 1069 (w), 1040 (m).  
LRMS (ES+) [M+H]+ calcd for C14H20NO+ 218.15, found: 218.01. 
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Synthesis of (E)-1-(4-phenylbut-3-en-2-yl)pyrrolidine 2.18 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, pyrrolidine (14.2 
mg, 0.200 mmol), phenyl 1,3-butadiene (52.1 mg, 0.400 mmol) and NH4BF4 (4.2 mg, 0.040 
mmol) were added to a solution of 2.7 (6.8 mg, 0.0099 mmol) and AgBF4 (1.9 mg, 0.0098 
mmol) in chlorobenzene (100 µL, [ ] = 2.00 M), and the reaction allowed to stir at 80 °C for 
48 h.  The resulting oil was purified by SiO2 column chromatography (50:1 CH2Cl2/MeOH) 
to afford 2.18 (30.2 mg, 0.150 mmol, 75% yield) as a colorless oil. 
1H NMR (600 MHz, CDCl3): δ 7.37 (2H, d, J = 7.3 Hz), 7.29 (2H, t, J = 7.7 Hz), 7.21 (1H, t, 
J = 7.3 Hz), 6.47 (1H, d, J = 15.8 Hz), 6.24 (1H, dd, J = 15.8, 8.5 Hz), 2.90-2.92 (1H, m), 
2.56-2.61 (4H, m), 1.77-1.82 (4H, m), 1.3 (3H, d, J = 6.5 Hz).  13C NMR (150 MHz, CDCl3): 
δ 137.33, 134.07, 129.86, 128.70, 127.44, 126.41, 63.26, 52.40, 23.50, 21.16.  IR (ν/cm-1): 
3057 (w), 3025 (m), 2968 (s), 2929 (w), 2873 (m), 2781 (s), 1495 (m), 1457 (m), 1370 (w), 
1311 (m), 1167 (m), 1139 (m), 1070 (m), 1025 (m).  LRMS (ES+) [M+H]+ calcd for 
C14H20N+ 202.16, found: 202.13.   
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Synthesis of (E)-N,N-dibenzyl-4-phenylbut-3-en-2-amine 2.19 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, dibenzylamine 
(39.4 mg, 0.200 mmol) and phenyl 1,3-butadiene (52.0 mg, 0.400 mmol) were added to a 
solution of 2.8 (2.2 mg, 0.0040 mmol) and AgBF4 (0.80 mg, 0.0041mmol) in chlorobenzene 
(100 µL, [ ] = 2.00 M), and the reaction allowed to stir at 80 °C for 48 h.  The resulting oil 
was purified by SiO2 column chromatography (5:1 Hex/EtOAc) to afford 2.19 (38.2 mg, 
0.116 mmol, 58% yield) as a colorless oil. 
1H NMR (600 MHz, CDCl3): δ 7.41-7.44 (6H, m), 7.32-7.36 (6H, m), 6.46 (1H, d, J = 16.1 
Hz), 6.34 (1H, dd, J = 13.5, 6.7 Hz), 3.73 (2H, d, J = 14.0 Hz), 3.62 (2H, d, J = 13.9 Hz), 
3.49-3.52 (1H, m), 1.32 (3H, d, J = 6.7 Hz).  13C NMR (150 MHz, CDCl3): δ 140.58, 137.30, 
131.64, 130.93, 128.53, 128.51, 128.17, 127.25, 126.67, 126.25, 54.53, 53.64, 15.80.  IR 
(ν/cm-1): 3061 (w), 3025 (m), 2967 (m), 2928 (m), 2799 (m), 1601 (m), 1494 (m), 1451 (m), 
1366 (m), 1144 (m), 1057 (m), 1024 (m).  LRMS (ES+) [M+H]+ calcd for C24H26N+ 328.21, 
found: 328.17. 
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Synthesis of (E)-N-benzyl-N-methyl-4-phenylbut-3-en-2-amine 2.20 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, 
benzylmethylamine (24.2 mg, 0.200 mmol) and phenyl 1,3-butadiene (39.0 mg, 0.300 mmol) 
were added to a solution of 2.8 (5.5 mg, 0.010 mmol) and AgBF4 (1.9 mg, 0.0098 mmol) in 
chlorobenzene (100 µL, [ ] = 2.00 M), and the reaction allowed to stir at 80 °C for 48 h.  The 
resulting oil was purified by SiO2 column chromatography (10:1 Hex/EtOAc to 100% 
EtOAc) to afford 2.20 (37.0 mg, 0.148 mmol, 74% yield) as a colorless oil. 
1H NMR (600 MHz, CDCl3): δ 7.42 (2H, d, J = 7.2 Hz), 7.32-7.37 (6H, m), 7.23-7.27 (2H, 
m), 6.49 (1H, d, J = 16.2 Hz), 6.33 (1H, dd, J = 16.2, 7.2 Hz), 3.67 (1H, d, J = 13.2 Hz), 3.53 
(1H, d, J = 13.2 Hz), 3.37-3.40 (1H, m), 2.24 (3H, s), 1.32 (3H, d, J = 6.6Hz).  13C NMR 
(150 MHz, CDCl3): δ 140.06, 137.40, 132.25, 130.89, 129.00, 128.68, 128.35, 127.41, 
126.91, 126.40, 60.52, 58.39, 38.06, 17.11.  IR (ν/cm-1): 3082 (w), 3060 (w), 3026 (m), 2970 
(s), 2932 (w), 2876 (w), 2839 (m), 2788 (s), 1601 (m), 1494 (m), 1450 (s), 1368 (m), 1311 
(m), 1209 (w), 1156 (w), 1129 (w), 1073 (m), 1027 (m).  LRMS (ES+) [M+H]+ calcd for 
C18H22N+ 252.17, found: 252.07. 
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Synthesis of (E)-4-phenyl-N,N-dipropylbut-3-en-2-amine 2.21 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, di-n-propyl amine 
(20.2 mg, 0.200 mmol) and phenyl 1,3-butadiene (39.0 mg, 0.300 mmol) were added to a 
solution of 2.8 (5.5 mg, 0.010 mmol) and AgBF4 (1.9 mg, 0.0098 mmol) in chlorobenzene 
(50 µL, [ ] = 4.00 M), and the reaction allowed to stir at 80 °C for 48 h.  The resulting oil was 
purified by SiO2 column chromatography (100% CH2Cl2 to 20:1 CH2Cl2:MeOH) to afford 
2.21 (2.7 mg, 0.012 mmol, 6% yield) as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ 7.43 (2H, d, J = 9.1 Hz), 7.32-7.37 (3H, m), 6.74 (1H, d,  J = 
15.9 Hz), 6.26 (1H, dd, J = 15.9, 8.5 Hz), 4.10-4.17 (1H, m), 3.09-3.11 (4H, m), 1.82 (4H, 
quintet, J = 8.2 Hz), 1.60 (3H, d, J = 6.7 Hz), 0.99 (6H, t, J = 7.3 Hz).  13C NMR (100 MHz, 
CDCl3): δ 138.03, 134.83, 129.35, 129.00, 127.18, 121.68, 62.89, 53.04, 18.24, 16.19, 11.2.  
IR (ν/cm-1): 3140 (br, m), 2972 (m), 2932 (m), 2883 (w), 2852 (w), 1652 (m), 1457 (m), 
1061 (s).  LRMS (ES+) [M+H]+ calcd for C16H26N+ 232.21, found: 232.18.   
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Synthesis of (E)-ethyl 2,2-dimethyl-5-morpholinohex-3-enoate 2.22 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, morpholine (17.0 
mg, 0.200 mmol) and (E)-ethyl 2,2-dimethylhexa-3,5-dienoate (67.3 mg, 0.400 mmol) were 
added to a solution of 2.7 (6.8 mg, 0.0099 mmol) and AgBF4 (1.9 mg, 0.0098 mmol) in 
chlorobenzene (100 µL, [ ] = 2.00 M), and the reaction allowed to stir at 100 °C for 48 h.  
The resulting oil was purified by SiO2 column chromatography (10:1 Hex/Et2O) to afford 
2.22 (46.5 mg, 0.182 mmol, 91% yield) as a clear oil. 
1H NMR (600 MHz, CDCl3): δ 5.73 (1H, dd, J = 15.7, 0.5 Hz), 5.43 (1H, dd, J = 15.8, 8.3 
Hz), 4.11 (2H, q, J = 6.1 Hz), 3.71 (4H, t, J = 4.7 Hz), 2.82-2.85 (1H, m), 2.45-2.52 (4H, m), 
1.29 (6H, d, J = 5.8 Hz), 1.23 (3H, t, J = 7.1 Hz), 1.15 (3H, d, J = 6.5 Hz).  13C NMR (125 
MHz, CDCl3): δ 176.46, 136.59, 130.30, 67.23, 62.71, 60.63, 50.60, 44.04, 25.11, 17.90, 
14.15.  IR (ν/cm-1): 2975 (s), 2852 (m), 2805 (m), 1731 (s), 1558 (w), 1541 (w), 1507 (w), 
1457 (m), 1226 (br, m), 1144 (s), 1119 (m), 1029 (m).  LRMS (ES+) [M+H]+ calcd for 
C14H26NO3+ 256.19, found: 256.07. 
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Synthesis of N-(1-(1-tosyl-2,5-dihydro-1H-pyrrol-3-yl)ethyl)aniline 2.23 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, aniline (18.6 mg, 
0.200 mmol) and 1-tosyl-3-vinyl-2,5-dihydro-1H-pyrrole (99.7 mg, 0.400 mmol) were added 
to a solution of 2.8 (5.5 mg, 0.010 mmol) and AgBF4 (1.9 mg, 0.0098 mmol) in 
chlorobenzene (100 µL, [ ] = 2.00 M), and the reaction allowed to stir at 65 °C for 48 h.  The 
resulting oil was purified by SiO2 column chromatography (20:1 to 100% Et2O) to afford 
2.23 (47.1mg, 0.138 mmol, 69% yield) as a light yellow oil. 
1H NMR (600 MHz, CDCl3): δ 7.66 (2H, d, J = 8.2 Hz), 7.27 (2H, d, J = 8.0 Hz), 7.09 (2H, t, 
J = 7.9 Hz), 6.69 (1H, t, J = 7.3 Hz), 6.45 (2H, d, J = 7.9 Hz), 5.48-5.49 (1H, m), 4.03-4.18 
(4H, m), 4.00 (1H, m), 3.52 (1H, bs), 2.43 (3H, m), 1.29 (2H, d, J = 6.7 Hz).  13C NMR (150 
MHz, CDCl3): δ 146.72, 143.34, 142.50, 134.09, 129.71, 129.19, 127.33, 119.30, 117.73, 
113.06, 55.04, 54.32, 47.84, 21.51, 20.57.  IR (ν/cm-1): 3391 (br, m), 3052 (w), 3019 (w), 
2962 (w), 2923 (m), 2859 (m), 1602 (s), 1506 (s), 1338 (s), 1254 (m), 1162 (s), 1099 (m).  
LRMS (ES+) [M+H]+ calcd for C19H23N2O2S+ 343.15, found: 343.14 
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Synthesis of (E)-4-(4-cyclohexylbut-3-en-2-yl)morpholine 2.24 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, morpholine (17.4 
mg, 0.200 mmol) and buta-1,3-dien-1-ylcyclohexane (54.5 mg, 0.400 mmol, 2:1 E/Z) were 
added to a solution of 2.7 (6.8 mg, 0.0099 mmol) and AgBF4 (1.9 mg, 0.0098 mmol) in 
chlorobenzene (100 µL, [ ] = 2.00 M), and the reaction allowed to stir at 90 °C for 48 h.  The 
resulting oil was purified by SiO2 column chromatography (3:1 Hex/Et2O) to afford a 89:11 
mixture of 2.24 and an unidentifiable constitutional isomer (33.5 mg, 0.150 mmol, 75% 
combined yield) as a clear oil. 
Data is reported for the major product (E)-4-(4-cyclohexylbut-3-en-2-yl)morpholine.  1H 
NMR (600 MHz, CDCl3): δ 5.45 (1H, dd, J = 15.5, 6.5 Hz), 5.28 (1H, ddd, J = 15.5, 8.2, 1.2 
Hz), 3.69-3.71 (4H, m), 2.74-2.78 (1H, m), 2.41-2.53 (4H, m), 1.90-1.95 (1H, m), 1.67-1.71 
(4H, m), 1.60-1.65 (1H, m), 1.23-1.30 (2H, m), 1.13-1.18 (1H, m), 1.13 (3H, d, J = 6.5 Hz), 
1.01-1.09 (2H, m).  13C NMR (150 MHz, CDCl3): δ 138.52, 128.92, 67.22, 62.89, 50.52, 
40.41, 33.04, 32.97, 26.14, 25.98, 18.06.  IR (ν/cm-1): 2958 (w), 2924 (s), 2851 (s), 2802 (m), 
1448 (m), 1265 (m) 1245 (w), 1198 (s).  LRMS (ES+) [M+H]+ calcd for C24H32N+ 224.20, 
found: 224.16. 
Me
N
N N
N N
Ph2P PPh2Rh
Cl
5 mol %
5 mol % AgBF4
PhCl (2.0 M), 70 oC, 48 h
N
H
+
2:1 E/Z
O
O
2.24
75% Yield
	 112	
 
Synthesis of (E)-N-(dec-3-en-2-yl)aniline and (E)-N-(dec-2-en-4-yl) 2.25 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, aniline (18.6 mg, 
0.200 mmol) and (E)-deca-1,3-diene (55.3 mg, 0.400 mmol) were added to a solution of 2.7 
(6.8 mg, 0.0099 mmol) and AgBF4 (1.9 mg, 0.0098 mmol)  in chlorobenzene (200 µL, [ ] = 
1.00 M), and the reaction allowed to stir at 60 °C for 48 h.  The resulting oil was purified by 
SiO2 column chromatography (20:1 Hex/Et2O) to afford 2.25 (32.4 mg, 0.140 mmol, 70% 
combined yield, 3:2 β/δ isomers) as a clear oil.   
Reported as a 3:2 mixture of (E)-N-(dec-3-en-2-yl)aniline and (E)-N-(dec-2-en-4-yl)aniline: 
The regio-isomers were characterized by 1H COSY NMR (spectra included).  1H NMR (400 
MHz, CDCl3): δ [N-(dec-3-en-2-yl)aniline: 7.15 (2H, t, J = 7.9 Hz), 6.67 (1H, m), 6.60 (2H, 
t, J = 7.5 Hz), 5.62 (1H, td, J = 15.4, 7.0 Hz), 5.41 (1H, dd, J = 15.4, 6.0 Hz), 3.90-3.97 (1H, 
m), 3.59 (1H, bs), 2.02 (2H, q, J = 7.1 Hz), 1.27-1.39 (8H, m) 1.29 (3H, d, J = 6.6 Hz), 0.88 
(3H, t, J = 7.1 Hz)], [(E)-N-(dec-2-en-4-yl)aniline: 7.15 (2H, t, J = 7.9 Hz), 6.67 (1H, m), 
6.60 (2H, t, J = 7.5 Hz), 5.62 (1H, td, J = 15.4, 7.0 Hz), 5.33 (1H, ddd, J = 15.3, 6.6, 1.4 Hz), 
3.69-3.75 (1H, m), 3.59 (1H, bs), 1.45-1.64 (2H, m), 1.68 (3H, d, J = 6.4 Hz), 1.27-1.39 (8H, 
m), 0.88 (3H, t, J = 6.6 Hz)].  13C NMR (100 MHz, CDCl3): δ [Reported as a mixture of N-
(dec-3-en-2-yl)aniline and (E)-N-(dec-2-en-4-yl)aniline: 147.76, 147.54, 133.16, 132.91, 
130.66, 129.05, 125.89, 117.00, 116.81, 113.38, 113.20, 55.30, 50.51, 36.22, 32.19, 31.68, 
29.23, 28.74, 25.94, 22.60, 22.09, 17.70, 14.07].  IR (ν/cm-1): 3410 (br, m), 3053 (w), 3021 
n-hexyl Me
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(w), 2956 (m), 2926 (s), 2855 (s), 1601 (s), 1504 (s), 1457 (m), 1428 (w), 1374 (w), 1318 
(m), 1253 (m), 1179 (w), 1154 (w).  LRMS (ES+) [M+H]+ calcd for C16H26N+ 232.21, found: 
232.18. 
 
Synthesis of (E)-N-(4,8-dimethylnona-3,7-dien-2-yl)aniline 2.26 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, aniline (18.6 mg, 
0.200 mmol) and (E)-4,8-dimethylnona-1,3,7-triene (60.1  mg, 0.400 mmol, 92:8 E/Z) were 
added to a solution of 2.7 (6.8 mg, 0.0099 mmol) and AgBF4 (1.9 mg, 0.0098 mmol) in 
chlorobenzene (200 µL, [ ] = 1.00 M), and the reaction allowed to stir at 70 °C for 48 h.  The 
resulting oil was purified by SiO2 column chromatography (20:1 Hex/Et2O) to afford 2.26 
(47.2 mg, 0.194 mmol, 97% yield, 92:8 E/Z) as a clear oil. 
Data for the E isomer is reported.  1H NMR (600 MHz, CDCl3): δ 7.15 (2H, dt, J = 7.0, 1.7 
Hz), 6.67 (1H, dt, J = 7.3, 0.9 Hz), 6.58 (2H, dd, J = 8.5, 0.9 Hz), 5.05-5.07 (2H, m), 4.14 
(1H, m), 3.57 (1H, s), 1.98-2.09 (4H, m), 1.73 (3H, d, J = 1.2 Hz), 1.66 (3H, d, J = 0.8 Hz), 
1.59 (3H, s), 1.25 (3H, d, J = 6.5 Hz).  13C NMR (150 MHz, CDCl3): δ 147.79, 136.12, 
131.53, 129.59, 129.11, 124.00, 117.03, 113.30, 47.25, 39.43, 26.39, 25.69, 22.01, 17.72, 
16.38.  IR (ν/cm-1): 3406 (br, m), 3052 (w), 2966 (s), 2924 (s), 2859 (w), 1602 (s), 1502 (s), 
1443 (m), 1424 (m), 1378 (m), 1318 (m), 1254 (m), 1150 (m), 1105 (m), 1072 (m).  LRMS 
(ES+) [M+H] + calcd for C17H26N+ 244.21, found: 244.09. 
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Synthesis of N-(cyclohex-2-en-1-yl)aniline 2.27 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, aniline (18.6 mg, 
0.200 mmol) and cyclohexa-1,3-diene (64.1 mg, 0.800 mmol) were added to a solution of 2.7 
(6.8 mg, 0.0099 mmol) and AgBF4 (1.9 mg, 0.0098 mmol) in chlorobenzene (200 µL, [ ] = 
1.00 M), and the reaction allowed to stir at 60 °C for 48 h.  The resulting oil was purified by 
SiO2 column chromatography (20:1 Hex/Et2O) to afford 2.27 (33.3 mg, 0.192 mmol, 96% 
yield) as a clear oil. 
1H NMR (600 MHz, CDCl3): δ 7.17 (2H, dt, J = 7.0, 1.6 Hz), 6.69 (1H, t, J = 7.1 Hz), 6.62 
(2H, d, J = 5.0 Hz), 5.84-5.87 (1H, m), 5.75-5.77 (1H, m), 4.00 (1H, bs), 3.63 (1H, bs), 1.99-
2.09 (2H, m), 1.89-1.93 (1H, m), 1.69-1.75 (1H, m), 1.60-1.67 (2H, m).  13C NMR (150 
MHz, CDCl3): δ 147.20, 130.15, 129.33, 128.59, 117.14, 113.23, 47.86, 28.90, 25.18, 19.67.  
IR (ν/cm-1): 3404 (br, m), 3083 (w), 3050 (w), 3021 (m), 2925 (s), 2859 (m), 2360 (w), 1603 
(s), 1558 (s), 1504 (m), 1429 (m), 1309 (m), 1257 (m), 1179 (w), 1102 (m).  LRMS (ES+) 
[M+H]+ calcd for C12H16N+174.13, found: 174.05.   
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Synthesis of (E)-ethyl 2,2-dimethyl-5-(phenylamino)hex-3-enoate 2.28  
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, aniline (18.6 mg, 
0.200 mmol) and (E)-ethyl-2,2-dimethylhexa-3,5-dienoate (67.3 mg, 0.400 mmol) were 
added to a solution of 2.7 (6.8 mg, 0.0099 mmol) and AgBF4 (1.9 mg, 0.0098 mmol) in 
chlorobenzene (200 µL, [ ] = 1.00 M), and the reaction allowed to stir at 80 °C for 48 h.  The 
resulting oil was purified by SiO2 column chromatography with a layer of 1% (by weight) 
AgNO3 doped silica (20:1 Hex/Et2O) to afford 2.28 (40.8 mg, 0.156 mmol, 78% yield) as a 
clear oil. 
1H NMR (600 MHz, CDCl3): δ 7.13 (2H, t, J = 7.8 Hz), 6.67 (1H, t, J = 7.2 Hz), 6.59 (2H, d, 
J = 7.7 Hz), 5.83 (1H, dd, J = 15.7, 0.5 Hz), 5.47 (1H, dd, J = 15.7, 5.9 Hz), 4.08 (2H, q, J = 
7.1 Hz), 3.95-3.98 (1H, m), 1.29 (3H, d, J = 6.5 Hz), 1.27 (6H, s), 1.2 (3H, t, J = 7.1 Hz).  
13C NMR (150 MHz, CDCl3): δ 176.46, 147.35, 134.73, 131.39, 129.07, 117.31, 113.55, 
60.63, 50.76, 43.82, 25.01, 21.99, 14.13.  IR (ν/cm-1): 3399 (br, m), 2977 (w), 2933 (s), 2874 
(m), 1726 (s), 1603 (s), 1503 (s), 1318 (m), 1254 (m), 1144 (s), 1027 (m).  LRMS (ES+) 
[M+H]+ calcd for C16H24NO2+ 262.18, found: 262.13. 
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Synthesis of (E)-N,N-dibenzyl-4-cyclohexylbut-3-en-2-amine 2.29 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, dibenzylamine 
(39.5 mg, 0.200 mmol) and buta-1,3-dien-1-ylcyclohexane (54.5 mg, 0.400 mmol, 2:1 E/Z) 
were added to a solution of 2.7 (6.8 mg, 0.0099 mmol) and AgBF4 (1.9 mg, 0.0098 mmol) in 
chlorobenzene (100 µL, [ ] = 2.00 M), and the reaction allowed to stir at 70 °C for 48 h.  The 
resulting oil was purified by SiO2 column chromatography with a layer of 1% (by weight) 
AgNO3 doped silica (20:1 Hex/Et2O) to afford 2.29 (41.4 mg, 0.124 mmol, 62% yield) as a 
colorless oil. 
1H NMR (600 MHz, CDCl3): δ 7.38 (4H, d, J = 7.4 Hz), 7.28 (4H, t, J = 7.5 Hz), 7.20 (2H, t, 
J = 7.2 Hz), 5.39-5.47 (2H, m), 3.62 (2H, d, J = 13.9 Hz), 3.48 (2H, d, J = 13.9 Hz), 3.21-
3.24 (1H, m), 1.95-2.00 (1H, m), 1.66-1.75 (4H, m), 1.64-1.66 (1H, m), 1.25-1.33 (3H, m), 
1.15 (2H, d, J = 6.7 Hz), 1.05-1.18 (2H, m).  13C NMR (150 MHz, CDCl3): δ 140.94, 138.41, 
128.57, 128.09, 127.99, 126.54, 54.50, 53.45, 40.78, 33.39, 33.31, 26.23, 26.10, 16.16.  IR 
(ν/cm-1): 3063 (w), 3026 (m), 2963 (w), 2923 (s), 2850 (m), 2796 (w), 1494 (w), 1450 (m), 
1376 (m), 1147 (w), 1073 (w), 1028 (w).  LRMS (ES+) [M+H]+ calcd for C24H32N+ 334.25, 
found: 334.21. 
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Synthesis of (E)-N-(4-cyclohexylbut-3-en-2-yl)aniline 2.30 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, aniline (18.6 mg, 
0.200 mmol) and buta-1,3-dien-1-ylcyclohexane (54.5 mg, 0.400 mmol, 2:1 mixture of E/Z 
isomers) were added to a solution of 2.7 (6.8 mg, 0.0099 mmol) and AgBF4 (1.9 mg, 0.0098 
mmol) in chlorobenzene (200 µL, [ ] = 1.00 M), and the reaction allowed to stir at 60 °C for 
24 h.  The resulting oil was purified by SiO2 column chromatography (100% hexanes) to 
afford an 88:12 mixture of 2.30 and an unidentifiable constitutional isomer (40.8 mg, 0.178 
mmol, 89% combined yield) as a clear oil. 
Data is reported for the major product (E)-N-(4-cyclohexylbut-3-en-2-yl)aniline.  1H NMR 
(600 MHz, CDCl3): δ 7.17 (2H, t, J = 7.8 Hz), 6.69 (1H, t, J = 7.3 Hz), 6.63 (2H, d, J = 8.2 
Hz), 5.61 (1H, dd, J = 15.5, 6.7 Hz), 5.39 (1H, dd, J = 15.6, 6.0 Hz), 3.94-3.97 (1H, m), 3.61 
(1H, bs), 1.98-1.93 (1H, m), 1.78-1.65 (6H, m), 1.30 (2H, d, J = 6.6 Hz), 1.28-1.26 (1H, m), 
1.21-1.15 (1H, m), 1.12-1.06 (2H, m).  13C NMR (150 MHz, CDCl3): δ 147.54, 136.43, 
130.32, 113.39, 50.59, 40.27, 32.90, 26.04, 22.04.  IR (ν/cm-1): 3405 (br, m), 3048 (w), 3017 
(w), 2923 (s), 2850 (s), 1601 (s), 1503 (s), 1448 (m), 1318 (m), 1254 (w), 1179 (w).  LRMS 
(ES+) [M+H]+ calcd for C16H24N+ 230.19, found: 230.11.   
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Synthesis of (E)-ethyl 5-(dibenzylamino)-2,2-dimethylhex-3-enoate 2.31 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, dibenzylamine 
(19.7 mg, 0.100 mmol), (E)-ethyl 2,2-dimethylhexa-3,5-dienoate (33.6 mg, 0.200 mmol) and 
NH4BF4 (2.1 mg, 0.02 mmol) were added to a solution of 2.7 (3.4 mg, 0.0050 mmol) and 
AgBF4 (1.0 mg, 0.0051 mmol) in chlorobenzene (50 µL, [ ] = 2.0 M), and the reaction 
allowed to stir at 120 °C for 48 h.  The resulting oil was purified by SiO2 column 
chromatography (100:1 Hex/Et2O) to afford 2.31 (11.0 mg, 0.030 mmol, 30% yield) as a 
colorless oil. 
1H NMR (600 MHz, CDCl3): δ 7.37 (4H, d, J = 7.1 Hz), 7.30 (4H, t, J = 3.6 Hz), 7.20 (2H, t, 
J = 7.2 Hz), 5.69 (1H, dd, J = 15.9, 1.0 Hz), 5.56 (1H, dd, J = 15.9, 6.7 Hz), 4.12 (2H, q, J = 
7.1 Hz), 3.63 (1H, d, J = 13.9 Hz), 3.47 (1H, d, J = 13.9 Hz), 3.25-3.35 (1H, m), 1.30 (6H, d, 
J = 16.4 Hz), 1.22 (3H, t, J = 7.1 Hz), 1.17 (3H, d, J = 6.8 Hz).  13C NMR (150 MHz, 
CDCl3): δ 176.68, 140.66, 136.39, 129.29, 128.56, 128.14, 126.65, 60.64, 54.40, 53.50, 
44.11, 25.38, 25.10, 15.88, 14.20.  IR (ν/cm-1): 3061 (w), 3027 (w), 2965 (m), 2927 (m), 
2866 (w), 2801 (w), 1731 (s), 1495 (w), 1455 (m), 1363 (m), 1249 (m), 1143 (s), 1029 (m).  
LRMS (ES+) [M+H]+ calcd for C24H31NO2+ 366.24, found: 366.22. 
Me
N
N N
N N
Ph2P PPh2Rh
Cl
5 mol %
5 mol % AgBF4
20 mol% NH4BF4
PhCl (2.0 M), 120 oC, 48 h
+EtO EtO
Me Me Me Me
O O
BnBn
2.31
30% Yield
Bn
N
H
Bn
	 119	
 
Synthesis of N-(1-cyclohexylidenepropan-2-yl)aniline 2.32 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, aniline (18.6 mg, 
0.200 mmol) and allylidenecylohexane (48.9 mg, 0.400 mmol) were added to a solution of 
2.7 (6.8 mg, 0.0099 mmol) and AgBF4 (1.9 mg, 0.0098 mmol) in chlorobenzene (200 µL, [ ] 
= 1.00 M), and the reaction allowed to stir at 60 °C for 48 h.  The resulting oil was purified 
by SiO2 column chromatography (20:1 Hex/Et2O) to afford 2.32 (33.2 mg, 0.154 mmol, 77% 
yield) as colorless oil. 
1H NMR (400 MHz, CDCl3): δ 7.15 (2H, dt, J = 8.0, 2.1 Hz), 6.66 (2H, t, J = 7.3 Hz), 6.59 
(2H, dd, J = 8.6, 1.0 Hz), 4.99 (3H, d, J = 8.4 Hz), 4.17-4.24 (1H, m), 3.57 (1H, bs), 2.20-
2.28 (2H, m), 2.04-2.07 (2H, m), 1.48-1.61 (6H, bm), 1.25 (3H, d, J = 6.5 Hz).  13C NMR 
(100 MHz, CDCl3): δ 140.68, 129.09, 126.20, 117.02, 113.36, 46.36, 36.92, 29.27, 28.51, 
27.78, 26.78, 22.60.  IR (ν/cm-1): 3405 (br, m), 3083 (w), 3050 (w), 3018 (w), 2926 (s), 2852 
(s), 1666 (w), 1601 (s), 1503 (s), 1447 (m), 1374 (w), 1317 (m), 1253 (w), 1179 (w), 1154 
(w), 1111 (w), 1074 (w), 1029 (w).  LRMS (ES+) [M+K]+ calcd for C15H21NK+ 254.13, 
found: 254.03.   
 
Me
HN
Ph
N N
N N
Ph2P PPh2Rh
Cl
5 mol %
5 mol % AgBF4
PhCl (1.0 M), 60 oC, 48 h
H2N
+
2.32
77% Yield
	 120	
 
Synthesis of (E)-2,2-dimethyl-5-(phenylamino)hex-3-en-1-ol 2.33 
Following the general procedure for (CDC)-Rh-catalyzed hydroamination, aniline (18.6 mg, 
0.200 mmol) and (E)-2,2-dimethylhexa-3,5-dien-1-ol (50.5 mg, 0.400 mmol) were added to a 
solution of 2.7 (6.8 mg, 0.099 mmol) and AgBF4 (1.9 mg, 0.098 mmol) in chlorobenzene 
(200 µL, [ ] = 1.00 M), and the reaction allowed to stir at 80 °C for 48 h.  The resulting oil 
was purified by SiO2 column chromatography with a layer of 1% (by weight) AgNO3 doped 
silica (10:1 Hex/Et2O) to afford 2.33 (32.5 mg, 0.148 mmol, 74% yield) as a clear oil. 
1H NMR (600 MHz, CDCl3): δ 7.16 (2H, dt, J = 7.0, 1.6 Hz), 6.69 (1H, dt, J = 7.3, 0.9 Hz), 
6.59 (2H, dd, J = 8.5, 0.9 Hz), 5.54 (1H, dd, J = 15.8, 0.9 Hz), 5.39 (1H, dd, J = 15.8, 6.3 
Hz), 3.96-3.99 (1H, m), 3.58 (1H, bs), 3.25 (2H, dd, J = 14.2, 10.6 Hz), 1.31 (3H, d, J = 6.6 
Hz), 0.98 (6H, d, J = 4.0 Hz).  13C NMR (150 MHz, CDCl3): δ 147.37, 136.92, 132.10, 
129.15, 117.47, 113.73, 71.54, 51.02, 38.29, 23.92, 23.57, 22.21.  IR (ν/cm-1): 3360 (br, s), 
2959 (s), 2926 (s), 2869 (m), 1743 (s), 1602 (s), 1503 (s), 1461 (m), 1374 (m), 1319 (m), 
1254 (m), 1155 (m), 1041 (m).  LRMS (ES+) [M+H]+ calcd for C14H22NO+ 220.17, found: 
220.11. 
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Chapter 3 Lewis Acid Activation of Carbodicarbene-Rh Catalysts for 
Hydroarylation of Dienes 3 
3.1 Introduction 
 N-heterocycles are important motifs in biologically active molecules. At least 59% of 
the 1086 unique small molecule drugs prescribed in the United States in 1994 contained at 
least one N-heterocycle.1 Therefore, it is imperative to continue to develop efficient 
syntheses of derivatized nitrogen containing rings. Hydroarylation is an atom-economical 
way to site-selectively functionalize indoles and pyrroles. 
 Based on our results with the hydroamination of dienes, we envisioned that 
carbodicarbene (CDC)-Rh pincer complexes 2.1 and 2.2 (Figure 3-1) would be excellent 
catalysts for the hydroarylation of dienes.2 Preliminary mechanistic studies (Chapter 2) 
suggested that the CDC-Rh complex is π-basic enough to activate an alkene for addition by 
an amine. According to Mayr’s reactivity parameters scale, aromatic3 and dialkyl amines3–5 
are more nucleophilic than indole,6 but the limits of reactivity of carbon-based nucleophiles 
with our catalyst were untested. Therefore, we envisioned that there was possibly the need to 
develop a more reactive catalyst. 
																																																								
3 A portion of this chapter appeared as a communication in the Journal of the American 
Chemical Society Roberts, C. C.; Matias, D. M.; Goldfogel, M. J.; Meek, S. J. J. Am. Chem. 
Soc. 2015, 137, 6488-6491. Author contributions: CCR and SJM conceived the ideas. CCR 
developed the catalyst and discovered the additive effect. All catalytic reactions and 
mechanistic experiments that appeared in the publication were performed by CCR and 
DMM. Crystals were obtained by CCR and structures were solved by M. V. Joannou 
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Figure 3-1 CDC-Rh pincer complexes for hydroamination of dienes 
3.2 Background 
3.2.1 Metal-catalyzed hydroarylation
 
Scheme	3-1	Transition	metal-catalyzed	hydroarylation	of	olefins	through	an	electrophilic	activation	mechanism	
 A number of transition metal-catalyzed hydroarylation reactions have been reported 
in the literature7–16. Most reactions are proposed to proceed through an electrophilic metal 
complex binding to an alkene followed by nucleophilic attack on the activated alkene.  
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 In 2008, Che and workers disclosed a report of a cationic PPh3-Au(I) catalyst that 
couples indoles with electron rich dienes (Scheme 3-1a) and alkenes.7 The mechanism of this 
reaction is proposed to go through a Au(I)-alkene complex undergoing nucleophilic attack, 
followed by proton transfer to yield the product. The AgOTf is necessary to abstract the 
halide from Au(I) to open up a coordination site and make a more active cationic catalyst. 
 Bertrand and coworkers reported another gold-catalyzed hydroarylation using 
dialkylanilines (Scheme 3-1b).9 The cationic NHC-Au(I) complex is formed using the halide 
scavenger KB(C6F5)4. Electron rich and neutral monosubstitutued and 1,1-disubstituted 
styrenes, cyclic alkenes, and enones are tolerated.  
 In 2009, the Widenhoefer group demonstrated the hydroheteroarylation of allenes 
using a gold catalyst (Scheme 3-1c).10 The reaction proceeded under mild conditions (22 °C) 
to produce substituted indoles, which added site-selectively to the central allene carbon.  
3.2.2 Bimetallic C(0) complexes 
	
Figure 3-2 Bimetallic C(0) complexes 
 Carbon(0) compounds possess a carbon atom with two lone pairs of electrons that can 
bind to Lewis acids (LAs) (Chapter 1).17 Although there are no reports of bimetallic CDC 
complexes, a number of bimetallic carbodiphosphorane (CDP) complexes have been reported 
(Figure 3-1).18–21 Our group was interested in these bimetallic complexes because the donor 
properties of the CDC ligand would be reduced by having another metal bind, which could 
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enhance the electrophilicity of the metal catalysts, allowing for neutral carbon nucleophiles, 
such as heteroarenes, to react.  
 PCP pincer complex 3.5 was of particular interest (Figure 3-1). The geometry of the 
parent monometallic Pd complex 3.7 (not shown) compared to bimetallic Pd-Au complex 3.5 
shows a large effect. The central carbon donor of the CDP in 3.7 is sp2 hybridized with a 
trigonal planar geometry around the central carbon with the sum of angles around it equaling 
360°.19 In contrast, the Au-C-Pd bond in 3.5 is 86.80(11)°, which shows the distorted 
tetrahedral geometry of the central carbon.21 The Pd-C distance of 3.7 is 2.062(2) Å and is 
elongated to 2.128(3) Å in 3.5. Due to these significant structural changes, it is clear that the 
effect of binding a second metal to a carbon(0) metal pincer complex has the potential to 
modulate reactivity. We envisioned that perhaps the electrophilicity of 2.1 and 2.2 could be 
increased through the binding of a second metal to the CDC donor to expand the scope of 
nucleophiles for hydrofunctionalization.  
3.3 Results and Discussion 
3.3.1 Initial observation of hydroarylation 
Scheme 3-2 Hydroarylation of phenylbuta-1,3-diene with 3.1 
	
 In order to test the feasibility of using carbon nucleophiles, such as indole, in a 
hydrofunctionalization reaction, I first used my original CDC-RhCl complex 3.1 under 
identical reaction conditions as those used for the hydroamination of dienes (Scheme 3-2). 
5 mol % 3.1 
5 mol% AgBF4 or NaBArF4
1,2-dioxane, 80 °C, 24 h
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3.9
with AgBF4 >98% conv.
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Using AgBF4 as a halide scavenger, the reaction proceeded in >98% conversion to product. 
This was a promising result, but due to the insolubility of the catalyst in ethereal solvents, the 
reaction was very heterogeneous and not reproducible. Therefore, I decided to try NaBArF4 to 
abstract the halide and make a more soluble catalyst. After 24 hours, no product was 
observed. This observation led me to believe that either NaBArF4 was not strong enough to 
pull off the halide or that AgCl, the product of the halide abstract with AgBF4, was necessary 
for the reaction. In order to test this hypothesis, I synthesized a more soluble form of 3.1. 
3.3.2 Synthesis of a CDC-Rh styrene complex 
Scheme 3-3 Synthesis of a soluble CDC-Rh styrene complex 3.8 
	 	
 Using 3.1 as precursor, I developed the synthesis of complex 3.8. In the presence of 5 
equivalents of styrene and 1 equivalent of NaBArF4, cationic styrene complex 3.8 was cleanly 
generated in 90% yield. CDC-Rh complex 3.8 is extremely soluble in ethereal, halogenated, 
and aromatic solvents. The 13C NMR of 3.8 indicates that styrene is tightly bound because 
the two carbons of the alkene of free styrene appear at 137.0 and 113.7 ppm and the bound 
styrene in 3.8 appears as two Rh-coupled doublets at 75.6 and 53.4 ppm. A crystal structure 
(Figure 3.3) of 3.8 was obtained by layering a thf solution of 3.8 with hexanes. The bond 
length of styrene in 3.8 is elongated from 1.3245 Å in free styrene to 1.395 Å.22 This, along 
with the NMR data, indicates that there is a large amount of back donation from the metal 
center to the π-bond.23 Due to the pincer structure of the ligand, the bond lengths and angles 
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between the cationic acetonitrile analog of 3.1 (Chapter 1) and 3.8 don’t differ significantly. 
The Rh-C bond in cationic acetonitrile analog of 3.1 is 2.041 Å and 2.075 Å in 3.8; the 
average Rh-P bond length in the acetonitrile complex is 2.236 Å and is 2.262 Å in 3.8.  
	
Figure 3-3 ORTEP drawing of 3.8 						
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3.3.3 Optimization of Lewis acid additive 
 
Table 3-1 Optimization of Lewis acid additives 
 With complex 3.8 in hand, I compared its reactivity to the previously discussed 
reactivity shown for complex 3.1 with AgBF4 and NaBArF4 (Entries 1 and 2, Table 3-1). 
Using 5 mol% of 3.8 and no additive at up to 120 °C, only trace amounts of 3-substituted 
indole 3.9 were observed (Entry 3). Because the 13C NMR and crystal structure data 
Conv. (%)b; δ:αEntrya
1e
2e
3e
4
5
6
7
8
9
10
11
12
13
14f
>98; 98:2
<2; -
6; -
92; 95:5
>98; 90:10
>98; 85:15
87; >98:2
>98; 97:3
<2; -
<2; -
<2; -
60; 81:19
>98; 85:15
>98; 94:6
Additive
AgBF4
NaBArF4
-
AgCl
CuCl
AuCl
LiBArF4•OEt2
LiBF4
NaBArF4
CuCl
AgCl
AuCl
LiBF4
LiBF4, 2,6-(tBu)2pyridine
Temp (oC)
80
80
120
50
50
50
50
50
50
22
22
22
22
50
5 mol % 3.1 or 3.8 
5 mol% additive
Et2O, temp, 24 h
Ph
Me
+ N
H
N
H
Ph
Yield (%)c
-
-
-
89
91
96
76
94
-
-
-
53
98
74
a. See experimental for details; b. Conversion to product; values determined using 1H NMR 
spectra of crude products with a DMF internal standard; c.Isolated yields are an average of 2 
runs with products purified by silica gel chromotography; d. Dioxane as solvent; e. 10 mol% 2,6-
di-t-butylpyridine.
Complex
3.1
3.1
3.8
3.8
3.8
3.8
3.8
3.8
3.8
3.8
3.8
3.8
3.8
3.8
3.9
γ α
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indicated that the styrene was tightly bound, I synthesized the tert-butyl ethylene and 
ethylene complex analogues of 3.8 and tested those for reactivity but saw none. 1H NMR 
studies on CDC-Rh complex 3.8 indicated that phenylbuta-1,3-diene was able to substitute 
styrene at room temperature. Therefore, the silver additive is necessary for the reaction. 
Adding 5 mol% of AgCl back into the reaction restored reactivity and the product was 
obtained in a 92% conversion with a γ:α site-selectivity of 95:5 at 50 °C (Entry 4). No 
reactivity was observed with a AgCl additive at room temperature (Entry 11). Other Lewis 
acids were screened to determine if they also affected reactivity. At 50 °C, CuCl and AuCl 
furnished 3.9 in 91% and 96% yield, respectively (Entries 5-6). Lowering the temperature 
lowered the yield to <2% with CuCl and 60% with AuCl and the site selectivity was eroded 
to 81:19 (Entries 10 and 12). Alkali metal salts were tested. Gratifyingly, lithium salts 
produced indole 3.9 in good yields. LiBArF4 OEt2 yielded 76% of 3.9 at 50 °C (Entry 7). 
LiBF4 was the most active additive; at both 50 and 22 °C, >98% conversion to product was 
observed, although the site selectivity decreased from 97:3 to 85:15 when the temperature 
was lowered (Entries 8 and 13). Sodium salts did not facilitate this reaction. To demonstrate 
that the reaction was not operating by an acid-catalyzed mechanism, the optimal results 
obtained in Entry 8 were used with 10 mol% 2,6-ditertbutlpyridine to scavenge any acid that 
might be formed (Entry 14). The reaction still proceeded to >98% conversion. 
3.3.4 Substrate scope 
 After I obtained optimal conditions for the hydroarylation of phenylbuta-1,3-diene 
with indole, the substrate scope was explored using a variety of N-heterocycles and 
phenylbuta-1,3-diene (Chart 1). All reactions in Chart 1 are run with 5 mol% 3.8 and LiBF4 
in Et2O. Unless substituted, reactivity through the C3 position of indole was observed in 
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>98:2 ratio. N-methyl indole was tolerated under the reaction conditions to produce 3.10 in 
63% yield and >98:2 γ:α site-selectivity at 40 °C. A variety of functional groups are 
compatible with the reaction conditions. 7-Chloro and 6-nitro indole produce products 3.11 
and 3.12 in 71% (96:4 γ:α site-selectivity) and 57% yields (91:9 γ:α site-selectivity), 
respectively. Due to the dampened nucleophilicity of the nitro substituted indole, the reaction 
required 60 °C. Pyrroles are also viable substrates for this reaction. Electron-rich 2,4-
dimethyl pyrrole reacted at room temperature to furnish 3.13 in 88% yield with excellent 
site-selectivity on the diene and 91:9 C2:C3 selectivity on the pyrrole. Bulky TIPS protected 
pyrrole reacted through the 3-position to generate 3.14 in only 38% conversion at 70 °C. 
Substitution at the 3-position of indole produced 3.15 in 33% yield and 92:8 selectivity with 
reaction exclusively through the 2-position of indole. 
 The use of cyclohexylbuta-1,3-diene was also explored (Chart 1). Reaction with 
indole proceeded to form 3.19 in 85% yield in >98:2 γ:α site-selectivity at 50 °C. N-
substituted indoles were also viable reaction partners; N-methyl indole produced 3.16  in 
>98:2 γ:α site-selectivity at 50 °C in a 66% yield; N-benzyl indole required 60 °C to generate 
3.20 in 85% yield and one of the lowest γ:α site-selectivities observed (87:13). Electron rich 
6-methoxyindole was well tolerated under the reaction conditions to give 3.17 in good yield 
(91%) and site-selectivity (98:2). Substitution in the 2-position of the indole did not hinder 
reactivity and 3.18 was produced in 66% yield and excellent γ:α site-selectivity (>98:2). The 
reaction of cyclohexylbuta-1,3-diene and 2,4-dimethylpyrrole proceeded at room temperature 
to generate 3.21 in 53% yield with 85:15 C2:C3 selectivity on pyrrole. 
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Chart 3-1 Hydroarylation of terminal dienes with functionalized indoles and pyrroles 	
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 The scope of internal dienes was explored using N-methylindole and 2,4-
dimethylpyrrole. Internal dienes are readily synthesized using an olefin metathesis protocol.24 
When using 3.1 and 3.2 as catalysts for hydroamination, internal dienes were found to be 
unreactive. Therefore, the discovery of the Lewis acid effect to increase the activity of the 
catalyst was crucial to the development of hydroarylation protocols for the more sterically 
hindered internal dienes.  
Chart 3-2 Hydroarylation of internal dienes with indole and pyrrole 
	
 All reactions in Chart 2 are run with 5 mol% 3.8 and LiBF4 in Et2O. A variety of 
functional groups are tolerated (boronate esters 3.23, ethers 3.24, esters 3.28, aryl (3.24 and 
3.30) and alkyl 3.25 halides). It should be noted, the even dienes with electron withdrawing 
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groups on the diene (3.27 and 3.30) are competent substrates. This was a limitation with 
some Au(I)-catalyzed protocols.7  
3.3.5 Studies of the effect of Lewis acid additives
 
Scheme 3-4 Studies on the effect of Lewis acid additive 
 In order to understand the role of the Lewis acid additive in the reaction, I attempted 
to directly observe the CDC-LA interaction through 1H NMR, representative example in 
Scheme 3-4a. I tried using LiBF4, LiBArF4  OEt2, CuCl, AuCl, AuCl  DMS, AgCl, and 
AgBF4 with both neutral complex 3.1 and cationic complex 3.8 in a variety of solvents 
including thf-d8, benzene-d6 and CD2Cl2 (3.8 only). The NMR spectra showed returned SM, 
C-H activation of thf (using LiBF4 and 3.1), or styrene substitution (Scheme 3-4b). No direct 
interaction between the LA and CDC was ever observed. Attempts to protonate the central 
CDC carbon of 3.1 with HBF4  OEt2 resulted in protonation of the Rh(I) to generate a 
Rh(III) hydride. Protonation of 3.8 with HBF4  OEt2 results in a complex mixture of isomers 
resulting from protonation of different faces of the complex since the styrene ligand makes 
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the complex dissymmetric. Protonation of an ethylene analog resulted in decomposition from 
loss of ethylene. 
	
Scheme 3-5 Effect of acid on CO stretching frequencies 
 Since I couldn’t observe the direct interaction of a metal salt with the CDC, I tried 
using a strong acid, HBF4  OEt2, to protonate the central CDC carbon of 3.33 so that we 
could study the effect of the acid on the CO stretching frequency. Using 1 equivalent of 
HBF4  OEt2 in CD2Cl2, 3.34 was cleanly generated. The 1H NMR shows the protons on the 
diazapine core as inequivalent so the complex is no longer symmetric. The carbonyl 
stretching frequency was evaluated. Complex 3.34 had a stretching frequency of 2016 cm-1 
compared to 1986 cm-1 for the parent complex 3.33.  
 The reaction was further probed through deuterium labeling studies (Scheme 3-6). 
Using 3-deuterio-1-methylindole at room temperature with 5 mol% 3.8 and 5 mol% LiBF4, 
3.10 was generated in 93% conversion and >95% D incorporation at the terminal position of 
the diene. This indicates that there is protonation of a Rh-alkyl bond to generate the product. 
N
N
N
N PPh2
PPh2
Rh CO
2   BF4
H
vRh(CO) 2016 cm-1
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Scheme 3-6 Deuterium labeling studies 
3.4 Conclusion 
 I have developed a protocol for the hydroarylation of terminal and internal dienes 
using a variety of indoles and pyrroles using a CDC-Rh pincer complex and a Lewis acid 
cocatalyst. The reaction proceeds under mild conditions (22 oC to 70 oC) and is functional 
group tolerance. My catalysts and discoveries have directly impacted this project to allow for 
a variety of C-based nucleophiles (oxazaoles and silyl enolethers, see dissertation of M. J. 
Goldfogel) to be tolerated under these reaction conditions. 
3.5 Experimental 
n General: All reactions were carried out in flame or oven (140 oC) dried glassware that 
had been cooled under vacuum.  Unless otherwise stated, all reactions were carried out under 
an inert N2 atmosphere. All reagents were purged or sparged with N2 for 20 min prior to 
distillation or use.  All solid reagents were dried by azeotropic distillation with benzene three 
times prior to use.  Infrared (IR) spectra were obtained using a Jasco 460 Plus Fourier 
transform infrared spectrometer or a ASI ReactIR 1000, Model: 001-1002 for air sensitive 
rhodium carbonyl complexes.  Mass spectra were obtained using a Thermo LTqFT mass 
spectrometer with electrospray ionization and external calibration.  All samples were 
prepared in MeOH, MeCN or CHCl3 for metal complexes.  Proton and carbon magnetic 
resonance spectra (1H NMR and 13C NMR) were recorded on a Bruker model DRX 400 or a 
5 mol % 3.8 
5 mol% LiBF4
Et2O, 22 °C, 24 h
Ph
+ N
Me
N
Me
Ph
D
D
d1-3.10
93% conversion
>95% D incorporation
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Bruker AVANCE III 600 CryoProbe (1H NMR at 400 MHz or 600 MHz, 13C NMR at 100 or 
151 MHz, 31P NMR at 160 or 243 MHz and 19F NMR at 376 or 564 MHz) spectrometer with 
solvent resonance as the internal standard (1H NMR: Chloroform-d at 7.26 ppm, CD2Cl2 at 
5.32 ppm, CD3CN at 1.94 ppm; 13C NMR: Chloroform-d at 77.16 ppm, CD2Cl2 at 53.84 
ppm, CD3CN at 1.32 ppm).  NMR data are reported as follows: chemical shift, integration, 
multiplicity (s = singlet, d = doublet, t = triplet, dd = doublet of doublets, td = triplet of 
doublets, dt = doublet of triplets, ddd = doublet of doublet of doublets, m = multiplet, bs = 
broad singlet, bm = broad multiplet, etc.), and coupling constants (Hz).  X-ray diffraction 
studies were conducted on a Bruker-AXS SMART APEXII diffractometer.  Crystals were 
selected and mounted using Paratone oil on a MiteGen Mylar tip.  
 
(E)-phenyl-1,3-butadiene,25 (1E,3Z/E)-penta-1,3-dien-1-ylbenzene,26 1-methoxy-4-
((1E,3Z/E)-penta-1,3-dien-1-yl)benzene,27 (E)/(Z)-1-buta-1,3-dien-1-ylcylohexane,28 (E)-
dodeca-1,3-diene,29 6-methyl-2-((1E,3E)-penta-1,3-dien-1-yl)-1,3,6,2-dioxazaborocane-4,8-
dione,30–33 (4E,6E)-methyl 7-phenylhepta-4,6-dienoate and ((1E,3E)-8-chloroocta-1,3-dien-
1-yl)benzene,24 1-methoxy-4-((1E,3E)-octa-1,3-dien-1-yl)benzene,24 1-chloro-4-((1E,3E)-
penta-1,3-dien-1-yl)benzene,34,35 TIPS pyrrole,36 1-Benzylindole,37 sodium tetrakis[3,5-
bis(trifluoromethyl)phenyl]borate,38 and complex 3.12 were synthesized according to a 
literature method or a modified literature method and matched reported spectra. 
 
n Solvents:  Solvents were purged with argon and purified under a positive pressure of 
dry argon by a SG Waters purification system: dichloromethane (EMD Millipore), diethyl 
ether (EMD Millipore, hexanes (EMD Millipore), benzene (EMD Millipore), and THF 
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(EMD Millipore) were passed through activated alumina columns.  Chloroform – d1 and   
Dichloromethane – d2 were purchased from Cambridge Isotope Labs, distilled over CaH2 and 
stored in a dry box over activated 4 Å molecular sieves. 
 
n Reagents:   
7-Chloroindole was purchased from Acros, recrystallized from hexanes, and stored in a dry 
box. 
Chloro(1,5-cyclooctadiene)rhodium(I) dimer was purchased from Pressure Chemicals, 
stored in a dry box and used as received.  
Copper(I) Chloride was purchased from Strem, stored in a dry box, and used without 
further purification. 
Copper(II) Chloride was purchased from Sigma Aldrich, stored in a dry box after overnight 
heating under vacuum, and used without further purification. 
Copper(I) hexafluorophosphate tetrakis(acetonitrile) was purchased from Sigma Aldrich, 
stored in the dry box, and used without further purification. 
2,4-Dimethylpyrrole was purchased from Alfa Aesar, distilled from molecular sieves, and 
stored at – 20 oC in the dark. 
2,6-di-tert-butylpyridine was purchased from Alfa Aesar, dried by azeotropic distillation 
with benzene directly after purchase, and stored in a dry box.  
Lithium tetrafluoroborate was purchased from Sigma Aldrich, stored in the dry box after 
overnight heating over P2O5 under vacuum, and used without further purification. 
Lithium tetrakis(pentafluorophenyl)borate - ethyl ether complex was purchased from 
Boulder Scientific, stored in a dry box, and used as received. 
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Indole was purchased from Alfa Aesar, purified by recrystallization from aqueous ethanol, 
dried by azeotropic distillation with benzene, and stored in a dry box. 
5-Methoxyindole was purchased from Matrix Scientific, recrystallized from hexanes/ether, 
and stored in a dry box. 
1-Methylindole was purchased from Alfa Aesar, dried by azeotropic distillation with 
benzene directly after purchase, and stored at – 20 oC in a dry box. 
2-Methylindole was purchased from Alfa Aesar, purified by recrystallization from benzene, 
and stored in a dry box. 
3-Methylindole was purchased from Alfa Aesar, purified by recrystallization from benzene, 
and stored in a dry box. 
5-Nitroindole was purchased from ChemImpex, purified by recrystallization from aqueous 
ethanol, and stored in a dry box. 
Silver tetrafluoroborate was purchased from Strem, stored in a dry box, and used without 
further purification. 
Silver chloride was purchased from Strem, stored in a dry box, and used without further 
purification. 
Sodium methoxide was purchased from Strem, stored in a dry box, and used without further 
purification. 
Styrene was purchased from Alfa Aesar, distilled over CaH2, and stored at – 20 oC in a dry 
box. 
Tetrafluoroboric acid etherate was purchased from Alfa Aesar, stored at -20 oC, and used 
as received. 
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Trityl tetra(pentafluorophenyl)borate was purchased from Strem, stored in a dry box, and 
used as received.  
n Procedure for the preparation of (CDC)-Rh(I)styrene BAr4F-24 complex 3.8   
 
 In an N2 filled dry box, a 20-mL scintillation vial with a stir bar was charged with 
(CDC)-RhCl complex 3.1 (540 mg, 0.788 mmol, 1.0 equiv) and NaBAr4f-24  (733 mg, 0.827 
mmol, 1.05 equiv) Tetrahydrofuran (16 mL, [ ] = 0.049 M) was added followed by the 
addition of styrene (0.451 mL, 3.94 mmol, 5.0 equiv) via syringe.  The vial was capped and 
the resulting dark orange mixture was allowed to stir for 18 h at 22 °C.  After the reaction 
was complete, the NaCl precipitate was allowed to settle and the solution was filtered 
through a Celite® pad followed by washing with 5 mL of THF.  The orange solution was 
concentrated and more THF (2.0 mL) was added to remove excess styrene.  The solvent was 
removed in vacuo and two more aliquots of THF (2.0 mL) and one aliquot (2.0 mL) of ether 
were added to repeat this process. The tacky dark orange solid on the side of the vial was 
crushed into a powder via spatula and left to dry in vacuo for 6 h. The dark orange powder 
was isolated in 90% yield (1.15 g, 0.709 mmol).  1H NMR (600 MHz, Methylene Chloride-
d2) δ 7.81-7.73 (m, 12H), 7.69 – 7.55 (m, 16H), 7.49 (t, J = 7.5 Hz, 4H), 6.79 (t, J = 7.4 Hz, 
1H), 6.58 (t, J = 7.6 Hz, 2H), 5.90 (d, J = 7.7 Hz, 2H), 4.90 (td, J = 8.1, 4.1 Hz, 1H), 4.06 – 
3.94 (m, 4H), 3.44 (m, 5H), 3.27 (m, 4H), 2.99 (d, J = 8.2 Hz, 1H).  13C NMR (151 MHz, 
NaBAr4f-24, styrene
THF (0.049 M), 22 oC, 18 h
3.8
90% Yield
N
N
N
N
PPh2
PPh2
Rh Cl
BAr4f-24
N
N
N
N
PPh2
PPh2
Rh Ph
3.1
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Methylene Chloride-d2) δ 172.82 (t, J = 21.3 Hz), 162.17 (m), 140.89, 135.22, 133.38 (dt, J = 
60.1, 7.5 Hz), 131.97 (d, J = 47.2 Hz), 130.70 (td, J = 22.3, 13.1 Hz), 129.48 (dt, J = 19.8, 
9.9 Hz), 129.19 (m), 128.45, 127.72, 126.38, 125.92, 125.57, 124.11, 122.31, 117.94 (q, J = 
4.2 Hz), 83.76 (dt, J = 34.3, 11.4 Hz), 75.62 (d, J = 6.7 Hz), 58.75, 53.38 (d, J = 8.1 Hz), 
46.85, 41.38.  31P NMR (243 MHz, Methylene Chloride-d2) δ 86.47 (d, J = 164.3 Hz).  
HRMS (ES+) [M]+ calcd for C41H40N4P2Rh+ 753.18 , found: 753.09. 
 
Crystal structure data for 3.8.  
 
For more information, please visit http://www.ccdc.cam.ac.uk/ and enter DOI: 
10.1021/jacs.5b03510  
Identification code  x1411004 
Empirical formula C75 H52 B F24 N4 P2 Rh 
Formula weight 1640.87 
Temperature 100K 
Wavelength 0.71073 
Crystal system triclinic 
Space group P-1 
Unit cell dimensions 
 a = 14.5732(5) Å α= 
72.9946(16) 
 
b = 16.2543(6) Å β= 
69.1536(17) 
 
c = 16.4636(6) Å γ = 
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78.1710(16) 
Volume  3462.92 
Z 2 
Density (calculated) 1.548 g/cm-1 
Absorption coefficient 0.406 (mm-1) 
F(000) 1624.5 
Crystal size 0.193 x 0.238 x 0.283 
Theta max 70.15 
Index ranges  
Hmax = 17, kmax = 19, lmax = 
20 
Reflections collected 13181 
Independent reflections 12784 
Completeness to theta  97 
Max. and min. transmission 0.663, 0.753 
Refinement method  XS least squares 
Goodness-of-fit on F2 0 1.019 
R indices R1 = 0.0336, wR2 = 0.1139 
 
n General procedure for the (CDC)-Rh-catalyzed hydroarylations of 1,3-dienes   
 In an N2 filled dry box, an 8-mL vial equipped with a stir bar was charged with the 
appropriate (CDC)-Rh complex and additive.  The appropriate solvent was added via syringe, 
the vial was capped and the mixture was allowed to stir for 1 h at 22 °C.  If the additive was a 
silver salt, the mixture was allowed to stir in the dark.  The nucleophile was added either as a 
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solid or via syringe followed by addition of the 1,3-diene.  The vial was capped with a 
Teflon® lined lid or septum cap, taped with electrical tape and brought outside the dry box.  
Any highly volatile or acidic compounds (HBF4.OEt2) were added outside the dry box via 
syringe through the Teflon® septa under an atmosphere of N2.  The reaction was allowed to 
warm to the appropriate temperature and stir for 24 h.  Then the reaction was allowed to cool 
to room temperature and an aliquot was taken to determine the conversion by 1H NMR using 
DMF (5.0 µL) as an internal standard.  The remaining solvent was removed in vacuo.  The 
products were purified by SiO2 column chromatography. 
   
 
 
n Control reactions   
 
 
entry
1
2a,b
3
4c
5d
additives (mol%)
3.8 (5), LiBF4 (5), t-Bu lutidine (10)
trityl BArF4 (5)
trityl BArF4 (5), t-Bu lutidine (10)
HBF4
trityl BArF4
conv. (%)
>98
48
-
-
22
92:8
73:27
-
-
44:56
A:B
 Controls
a. Other unknown product in 13% conversion b. No conversion at 22 oC
c. Diene decomposed d. 1-Me indole used
Ph additive
Et2O (0.67 M), 50 oC, 24 h
+ N
H
Me
N
H
Ph
3.9
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Synthesis of (E)-3-(4-phenylbut-3-en-2-yl)-1H-indole (Table 3-1, entries 1-14 and 
controls table above) 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, indole (12.9 mg, 
0.110 mmol) and phenyl 1,3-butadiene (13.0 mg, 0.100  mmol) were added to a solution of 
3.1 or 3.8 (0.0050 mmol) and additive (0.0050 mmol) in diethyl ether or dioxane (150 µL, [ ] 
= 0.67 M), and the reaction was allowed to stir at 22 or 50 °C for 24 h.  The resulting oil was 
purified by SiO2 column chromatography (25:1 Pentane/EtOAc) to afford 3.9 as a colorless 
oil (see Table 3-1 conversions, yields, and selectivity.)   1H NMR (600 MHz, Chloroform-d) 
δ 7.69 (dd, J = 8.0, 1.0 Hz, 1H), 7.42 – 7.33 (m, 3H), 7.33 – 7.27 (m, 3H), 7.23 – 7.15 (m, 
2H), 7.10 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H), 7.03 (dd, J = 2.5, 0.9 Hz, 1H), 3.95 (p, J = 6.9 Hz, 
1H), 1.58 (d, J = 7.0 Hz, 3H).  13C NMR (151 MHz, Chloroform – d1) δ 137.93, 136.71, 
135.57, 128.58, 128.32, 127.02, 126.95, 126.29, 122.13, 120.63, 120.53, 119.78, 119.40, 
111.25, 34.40, 20.84.  IR (ν/cm-1): 3025 (s), 2962 (s), 1492 (s), 1456 (s), 1417 (s), 1337 (s), 
1221 (w), 1095 (w) MS (ES+) [M+H]+ calcd for C18H18N+ 248.14, found: 248.18. 
 
 
Synthesis of (E)-1-methyl-3-(4-phenylbut-3-en-2-yl)-1H-indole 3.10 
Ph
5 mol % LiBF4
Et2O (0.67 M), 40 oC, 24 h
+ N
Me
N
Ph
5 mol %
N
N
N
N
PPh2
PPh2
Rh Ph
BAr4f-24
3.10
74% Conversion
63% Yield
>98:2
Me Me
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Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 1-methylindole 
(14.4 mg, 0.110 mmol) and phenyl 1,3-butadiene (13.0 mg, 0.100  mmol) were added to a 
solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 0.0050 mmol) in diethyl ether 
(150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 40 °C for 24 h.  The resulting 
oil was purified by SiO2 column chromatography (25:1 Pentane/EtOAc) to afford 3.10 (16.4 
mg, 0.064 mmol, 63% yeld) as a colorless oil. 1H NMR (600 MHz, Chloroform-d) δ 7.67 
(dd, J = 7.9, 1.1 Hz, 1H), 7.39 – 7.34 (m, 2H), 7.33 – 7.26 (m, 4H), 7.22 (ddd, J = 8.2, 7.0, 
1.2 Hz, 1H), 7.21 – 7.17 (m, 1H), 7.09 (ddd, J = 7.9, 6.9, 1.1 Hz, 1H), 6.88 (d, J = 0.8 Hz, 
1H), 6.56 – 6.43 (m, 2H), 3.94 (m, 1H), 3.77 (s, 3H), 1.56 (d, J = 7.0 Hz, 4H). 13C NMR (151 
MHz, Chloroform-d) δ 137.95, 137.39, 135.72, 128.58, 128.15, 127.30, 126.99, 126.27, 
125.43, 121.67, 119.82, 119.03, 118.81, 109.34, 34.35, 32.79, 20.99.  IR (ν/cm-1): 2925 (m), 
2870 (s), 1472 (m), 1374 (w), 1328 (w), 1134 (s).  MS (ES+) [M+H]+ calcd for C19H20N+ 
262.16, found: 262.00. 
 
Synthesis of (E)-7-chloro-3-(4-phenylbut-3-en-2-yl)-1H-indole 3.11 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 7-chloroindole 
(16.7 mg, 0.110 mmol) and phenyl 1,3-butadiene (13.0 mg, 0.100  mmol) were added to a 
solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 0.0050 mmol) in diethyl ether 
Ph
5 mol % LiBF4
Et2O (0.67 M), 50 oC, 24 h
+ N
H
Me
N
H
Ph
5 mol %
N
N
N
N
PPh2
PPh2
Rh Ph
BAr4f-24
3.11
87% Conversion
71% Yield
96:4
Cl Cl
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(150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 50 °C for 24 h.  The resulting 
oil was purified by SiO2 column chromatography (15:1 Pentane/EtOAc) to afford 3.11 (19.9 
mg, 0.071 mmol, 71% yield, 96:4) as a colorless oil. 1H NMR (600 MHz, Chloroform-d) δ 
7.58 (d, J = 7.9 Hz, 1H), 7.40 – 7.34 (m, 2H), 7.29 (td, J = 7.8, 1.9 Hz, 2H), 7.20 (td, J = 7.4, 
1.1 Hz, 2H), 7.09 (dd, J = 2.4, 0.8 Hz, 1H), 7.03 (t, J = 7.8 Hz, 1H), 6.50 (d, J = 16.1 Hz, 
1H), 6.44 (dd, J = 15.8, 6.6 Hz, 1H), 3.92 (m, 1H), 1.57 (d, J = 7.0 Hz, 3H).  13C NMR (151 
MHz, Chloroform-d) δ 137.74, 135.10, 133.95, 128.62, 128.44, 127.15, 126.29, 121.74, 
121.48, 121.21, 120.20, 118.47, 116.74, 34.49, 20.81.  IR (ν/cm-1): 2964 (s), 2856 (m), 1566 
(w), 1491 (m), 1436 (m), 1335 (w), 1197 (s), 1144 (w), 1088 (w).  MS (ES+) [M+H]+ calcd 
for C18H17ClN+ 282.10, found: 282.18. 
 
Synthesis of (E)-5-nitro-3-(4-phenylbut-3-en-2-yl)-1H-indole 3.12 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 5-nitroindole (17.8 
mg, 0.110 mmol) and phenyl 1,3-butadiene (13.0 mg, 0.100  mmol) were added to a solution 
of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 0.0050 mmol) in diethyl ether (150 µL, [ ] 
= 0.67 M), and the reaction was allowed to stir at 60 °C for 24 h.  The resulting oil was 
purified by SiO2 column chromatography (100% Chloroform) to afford 3.12 (21.0 mg, 0.057 
mmol, 57% yield) as a yellow solid. 1H NMR (600 MHz, Chloroform-d) δ 8.65 (d, J = 2.1 
Ph
5 mol % LiBF4
Et2O (0.67 M), 60 oC, 24 h
+ N
H
Me
N
H
Ph
5 mol %
N
N
N
N
PPh2
PPh2
Rh Ph
BAr4f-24
3.12
72% Conversion
57% Yield
91:9
O2N O2N
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Hz, 1H), 8.38 (d, J = 15.6 Hz, 1H), 8.11 (dd, J = 9.0, 2.2 Hz, 1H), 7.39 (d, J = 9.0 Hz, 1H), 
7.38 – 7.34 (m, 2H), 7.29 (t, J = 7.7 Hz, 2H), 7.22 – 7.18 (m, 2H), 6.52 (d, J = 15.8 Hz, 1H), 
6.42 (dd, J = 15.8, 7.0 Hz, 1H), 3.98 (m, 1H), 1.59 (d, J = 7.1 Hz, 3H).  13C NMR (151 MHz, 
Chloroform-d) δ 141.64, 139.65, 137.48, 134.40, 129.12, 128.68, 127.34, 126.38, 126.33, 
123.64, 123.34, 117.94, 117.05, 111.23, 34.10, 20.91.  IR (ν/cm-1): 2967 (w), 1621 (m), 1517 
(m), 1470 (m), 1329 (s), 1094 (w).  MS (ES+) [M+H]+ calcd for C18H17N2O2+ 293.13, found: 
293.27. 
 
Synthesis of (E)-3,5-dimethyl-2-(4-phenylbut-3-en-2-yl)-1H-pyrrole 3.13 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 2,4-
dimethylpyrrole (10.5 mg, 0.11 mmol) and phenyl 1,3-butadiene (13.0 mg, 0.100  mmol) 
were added to a solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 0.0050 mmol) in 
diethyl ether (150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 22 °C for 24 h.  
The resulting oil was purified by SiO2 column chromatography (25:1 Pentane/EtOAc) to 
afford 3.13 (19.9 mg, 0.088 mmol, 88% yield) as a colorless oil. 1H NMR (600 MHz, 
Chloroform-d) δ 7.81 – 7.73 (m, 2H), 7.70 (dd, J = 8.5, 6.9 Hz, 2H), 7.62 (d, J = 7.3 Hz, 1H), 
6.86 – 6.71 (m, 2H), 6.09 (d, J = 2.8 Hz, 1H), 4.20 – 4.11 (m, 1H), 2.61 (d, J = 0.8 Hz, 3H), 
Me
Ph
NHPh
5 mol % LiBF4
Et2O (0.67 M), 50 oC, 24 h
+
5 mol %
N
N
N
N
PPh2
PPh2
Rh Ph
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2.44 (s, 3H), 1.83 (d, J = 7.1 Hz, 3H).  13C NMR (151 MHz, Chloroform-d) δ 137.53, 133.60, 
128.68, 128.55, 127.28, 126.30, 125.33, 113.96, 108.31, 33.67, 19.71, 13.09, 11.07. IR 
(ν/cm-1): 3275 (br, m), 2968 (w), 2925 (m), 2866 (w), 1698 (m), 1653 (m), 1541 (m), 1507 
(m), 1457 (m), 1268 (m), 968 (br, m).  MS (ES+) [M+H]+ calcd for C16H20N+ 226.16, found:. 
226.27. 
 
Synthesis of (E)-2-(4-phenylbut-3-en-2-yl)-1-(triisopropylsilyl)-1H-pyrrole 3.14 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, TIPS pyrrole (44.7 
mg, 0.200 mmol) and phenyl 1,3-butadiene (13.0 mg, 0.100  mmol) were added to a solution 
of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 0.0050 mmol) in diethyl ether (150 µL, [ ] 
= 0.67 M), and the reaction was allowed to stir at 70 °C for 24 h.  The resulting oil was 
purified by SiO2 column chromatography (100%  Pentane) to afford 3.14 as a colorless oil 
which could not be separated from starting material for a yield. NMR yield is based on 
addition of 5.0 µL of DMF as an internal standard. 1H NMR (600 MHz, Chloroform-d) δ 
7.36 (d, J = 7.6 Hz, 2H), 7.28 (t, J = 8.2 Hz, 2H), 7.18 (t, J = 7.4 Hz, 1H), 6.72 (d, J = 2.5 Hz, 
1H), 6.55 (s, 1H), 6.36 (m, 2H), 6.20 (t, J = 1.9 Hz, 1H), 3.58 (m, 1H), 1.42 (m, 6H), 1.09 (d, 
J = 7.6 Hz, 18H).   13C NMR (151 MHz, Chloroform-d) δ 138.25, 137.02, 130.06, 128.55, 
127.59, 126.81, 126.25, 124.23, 120.50, 109.88, 35.60, 21.49, 18.04, 11.86.  IR (ν/cm-1): 
Me
Ph
NTIPSPh
5 mol % LiBF4
Et2O (0.67 M), 70 oC, 24 h
+
5 mol %
N
N
N
N
PPh2
PPh2
Rh Ph
BAr4f-24
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38% Conversion
>98:2
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2946 (s), 2867 (s), 1464 (m), 1263 (w), 1099 (s)  MS (ES+).  [M+H]+ calcd for C23H36NSi+ 
354.26, found: 354.27. 
 
Synthesis of (E)-3-methyl-2-(4-phenylbut-3-en-2-yl)-1H-indole 3.15 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 3-methylindole 
(14.4 mg, 0.110 mmol) and phenyl 1,3-butadiene (13.0 mg, 0.100  mmol) were added to a 
solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 0.0050 mmol) in diethyl ether 
(150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 60 °C for 24 h.  The resulting 
oil was purified by SiO2 column chromatography (25:1 Pentane/EtOAc) to afford 3.15 (8.6 
mg, 0.033 mmol, 33% yield) as a colorless oil. 1H NMR (400 MHz, Chloroform-d) δ 7.77 (s, 
1H), 7.54 (d, 1H, J = 6.0 Hz), 7.40 – 7.33 (m, 2H), 7.34 – 7.27 (m, 3H), 7.25 – 7.19 (m, 1H), 
7.12 (m, J = 7.1, 1.4 Hz, 2H), 6.44 (m, 2H), 4.02 (m, 1H), 2.31 (s, 3H), 1.54 (d, J = 7.1 Hz, 
3H).  13C NMR (101 MHz, Chloroform-d) δ 137.24, 136.97, 135.28, 132.49, 129.58, 129.56, 
128.75, 127.53, 126.35, 121.37, 119.25, 118.38, 110.55, 106.86, 33.82, 19.59, 8.64.  IR 
(ν/cm-1): 2920 (s), 2851 (s), 1461 (s).  MS (ES+) [M+H]+ calcd for C19H20N+ 262.16, found: 
262.09. 
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Synthesis of (E)-3-(4-cyclohexylbut-3-en-2-yl)-1-methyl-1H-indole 3.16 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 1-methylindole 
(14.4 mg, 0.110 mmol) and (E/Z)-1-cyclohexylbuta-1,3-diene (13.6 mg, 0.100  mmol) were 
added to a solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 0.0050 mmol) in 
diethyl ether (150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 50 °C for 24 h.  
The resulting oil was purified by SiO2 column chromatography (40:1 Pentane/EtOAc) to 
afford 3.16 (17.6 mg, 0.066 mmol, 66% yield) as a colorless oil.  1H NMR (600 MHz, 
Chloroform-d): 7.66 (dt, J = 8.0, 0.9 Hz, 1H), 7.29 (dt, J = 8.2, 0.9 Hz, 1H), 7.22 (ddd, J = 
8.2, 6.9, 1.1 Hz, 1H), 7.09 (ddd, J = 7.9, 6.9, 1.0 Hz, 1H), 6.81 (d, J = 0.8 Hz, 1H), 5.61 (ddd, 
J = 15.4, 6.9, 1.0 Hz, 1H), 5.53 (ddd, J = 15.4, 6.6, 1.0 Hz, 1H), 3.75 (s, 3H), 3.70 (m, 1H), 
1.95 (dtt, J = 11.0, 6.8, 3.5 Hz, 1H), 1.69 (m, 4H), 1.59 (m, 1H), 1.44 (d, J = 7.0 Hz, 3H), 
1.21 (m, 2H), 1.07 (m, 3H).  13C NMR (150 MHz, Chloroform-d): δ 137.39, 134.83, 132.56, 
127.34, 125.10, 121.49, 119.91, 119.89, 118.51, 109.24, 40.77, 34.12, 33.41, 33.37, 32.73, 
26.39, 26.29, 21.32.  IR (ν/cm-1): 2923 (s), 2850 (m), 2359 (s), 1448 (m), 1373 (w), 1327 (w), 
1236 (w).  MS (ES+) [M+H]+ calcd for C19H26N+ 268.21, found: 268.36. 
Cy
5 mol % LiBF4
Et2O (0.67 M), 50 oC, 24 h
+ N
Me
N
Cy
Me Me
5 mol %
N
N
N
N
PPh2
PPh2
Rh Ph
BAr4f-24
3.16
85% Conversion
66% Yield
>98:2
2:1 (E:Z)
	 201	
 
Synthesis of (E)-3-(4-cyclohexylbut-3-en-2-yl)-5-methoxy-1H-indole 3.17 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 5-methoxyindole 
(16.2 mg, 0.110 mmol) and (E/Z)-1-cyclohexylbuta-1,3-diene (13.6 mg, 0.100  mmol) were 
added to a solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 0.0050 mmol) in 
diethyl ether (150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 50 °C for 24 h.  
The resulting oil was purified by SiO2 column chromatography (7:3 Pentane/Ether) to afford 
3.17 (25.8 mg, 0.091 mmol, 91% yield) as a colorless oil.  1H NMR (600 MHz, Chloroform-
d): δ 7.80 (s, 1H), 7.23 (d, J = 8.7 Hz, 1H), 7.09 (d, J = 2.5 Hz, 1H), 6.94 (dd, J = 2.4, 0.8 Hz, 
1H), 6.85 (dd, J = 8.8, 2.5 Hz, 1H), 5.49 (m, 2H), 3.85 (s, 3H), 3.64 (m, 1H), 1.94 (dtt, J = 
11.0, 6.6, 3.3 Hz, 1H), 1.67 (m, 3H), 1.63 (dtt, J = 12.2, 3.1, 1.5 Hz, 2H), 1.43 (d, J = 7.0 Hz, 
3H), 1.25 (dddt, J = 15.9, 12.5, 6.2, 3.2 Hz, 2H), 1.03 (m, 3H).  13C NMR (150 MHz, 
Chloroform-d): δ 153.54, 134.90, 132.25, 131.73, 127.25, 120.96, 120.90, 112.03, 111.67, 
101.65, 55.86, 40.66, 34.04, 33.35, 33.27, 26.21, 26.11, 26.09, 20.78. IR (ν/cm-1): 2923 (s), 
2849 (m), 1623 (w), 1581 (w), 1483 (s), 1451 (s), 1281 (w), 1212 (s), 1173 (m), 1031 (w).  
MS (ES+) [M+H]+ calcd for C19H26NO+ 284.20, found: 284.27. 
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Synthesis of (E)-3-(4-cyclohexylbut-3-en-2-yl)-2-methyl-1H-indole 3.18 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 2-methylindole 
(14.4 mg, 0.110 mmol) and (E/Z)-1-cyclohexylbuta-1,3-diene (13.6 mg, 0.100  mmol) were 
added to a solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 0.0050 mmol) in 
diethyl ether (150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 50 °C for 24 h.  
The resulting oil was purified by SiO2 column chromatography (20:1 Pentane/EtOAc, 3% 
Et3N) to afford 3.18 (17.5 mg, 0.066 mmol, 66% yield) as a yellow oil.  1H NMR (600 MHz, 
Chloroform-d): δ 7.64 (s, 1H), 7.61 (d, J = 7.7 Hz, 1H), 7.27 (s, 1H), 7.25 (s, 1H), 7.07 (dtd, 
J = 22.0, 7.1, 1.2 Hz, 3H), 5.77 (ddd, J = 15.5, 5.4, 1.2 Hz, 1H), 5.47 (ddd, J = 15.6, 6.8, 1.8 
Hz, 1H), 3.65 (m, 1H), 2.37 (d, J = 2.6 Hz, 3H), 1.68 (m, 3H), 1.60 (m, 2H), 1.45 (d, J = 7.3 
Hz, 3H), 1.02 (m, 5H).  13C NMR (150 MHz, Chloroform-d): δ 135.41, 134.43, 131.91, 
130.02, 127.80, 120.71, 119.52, 118.85, 115.78, 110.29, 40.88, 33.42, 33.37, 33.26, 26.40, 
26.31, 20.59, 12.34. IR (ν/cm-1): 2922 (mb), 1682 (w), 1619 (w), 1458 (w), 1141 (s).  MS 
(ES+) [M+H]+ calcd for C19H26N+ 268.21, found: 268.27. 
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Synthesis of (E)-3-(4-cyclohexylbut-3-en-2-yl)-1H-indole 3.19 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, indole (12.9 mg, 
0.110 mmol) and (E/Z)-1-cyclohexylbuta-1,3-diene (13.6 mg, 0.100  mmol) were added to a 
solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 0.0050 mmol) in diethyl ether 
(150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 50 °C for 24 h.  The resulting 
oil was purified by SiO2 column chromatography (15:1 Pentane/EtOAc) to afford 3.19 (21.0 
mg, 0.083 mmol, 85% yield) as a white solid.  1H NMR (600 MHz, Chloroform-d): δ 7.89 (s, 
1H), 7.64 (m, 1H), 7.35 (dd, J = 8.2, 0.9 Hz, 1H), 7.18 (ddd, J = 8.1, 7.0, 1.1 Hz, 1H), 7.09 
(ddd, J = 8.0, 7.0, 1.0 Hz, 1H), 6.93 (m, 1H), 5.57 (m, 1H), 5.49 (m, 1H), 3.70 (m, 1H), 1.94 
(tdt, J = 10.9, 6.8, 3.5 Hz, 1H), 1.71 (qd, J = 8.4, 6.9, 4.1 Hz, 4H), 1.63 (dtt, J = 12.4, 3.3, 1.6 
Hz, 2H), 1.44 (d, J = 7.0 Hz, 3H), 1.20 (m, 2H), 1.04 (m, 3H).  13C NMR (150 MHz, 
Chloroform-d): δ 136.73, 135.02, 132.40, 127.01, 121.94, 121.57, 120.20, 119.98, 119.11, 
111.17, 40.77, 34.16, 33.40, 33.36, 26.39, 26.28, 21.15. IR (ν/cm-1): 2922 (s), 2849 (m), 1455 
(m), 1417 (w), 1337 (w), 1222 (w), 1092 (w), 1008 (w).  MS (ES+) [M+H]+ calcd for 
C18H24N+ 254.39, found: 254.27. 
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Synthesis of (E)-1-benzyl-3-(4-cyclohexylbut-3-en-2-yl)-1H-indole 3.20 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 1-benzylindole 
(22.8 mg, 0.110 mmol) and (E/Z)-1-cyclohexylbuta-1,3-diene (13.6 mg, 0.100  mmol) were 
added to a solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 0.0050 mmol) in 
diethyl ether (150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 60 °C for 48 h.  
The resulting oil was purified by SiO2 column chromatography (40:1 Pentane/EtOAc) to 
afford 3.20 (29.2 mg, 0.085 mmol, 85% yield) as a pale orange oil.  1H NMR (600 MHz, 
Chloroform-d): δ 7.66 (d, J = 7.9 Hz, 1H), 7.33 (m, 2H), 7.23 (d, J = 8.4 Hz, 1H), 7.17 (m, 
1H), 7.12 (m, 2H), 7.07 (t, J = 7.4 Hz, 1H), 6.88 (s, 1H), 5.60 (dd, J = 15.5, 6.8 Hz, 1H), 5.52 
(dd, J = 15.5, 6.6 Hz, 1H), 5.28 (s, 2H), 3.70 (m, 1H), 1.94 (dtt, J = 11.6, 7.2, 3.8 Hz, 1H), 
1.75 (m, 5H), 1.65 (m, 1H), 1.43 (dd, J = 7.0, 1.2 Hz, 3H), 1.30 (m, 3H), 1.19 (m, 3H).  13C 
NMR (150 MHz, Chloroform-d): δ 138.00, 137.09, 134.95, 132.54, 128.83, 127.70, 127.58, 
126.87, 124.56, 121.67, 120.68, 120.15, 118.78, 109.73, 50.04, 40.76, 34.19, 33.41, 33.36, 
26.39, 26.28, 21.26.  IR (ν/cm-1): 2922 (s), 2849 (m), 1613 (w), 1466 (w), 1451 (s), 1354 (m), 
1177 (m).  MS (ES+) [M+H]+ calcd for C25H30N+ 344.24, found: 344.27. 
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Synthesis of (E)-2-(4-cyclohexylbut-3-en-2-yl)-3,5-dimethyl-1H-pyrrole 3.21 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 2,4-
dimethylpyrrole (10.5 mg, 0.110 mmol) and (E/Z)-1-cyclohexylbuta-1,3-diene (13.6 mg, 
0.100  mmol) were added to a solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 
0.0050 mmol) in diethyl ether (150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 
22 °C for 24 h.  The resulting oil was purified by SiO2 column chromatography (25:1 
Pentane/EtOAc) to afford 3.21 (12.2 mg, 0.053 mmol, 53% yield) as a colorless oil. 1H NMR 
(600 MHz, Chloroform-d): δ 5.66 (d, J = 2.8 Hz, 1H), 5.51 (ddd, J = 15.5, 5.9, 1.1 Hz, 1H), 
5.43 (ddd, J = 15.6, 6.6, 1.4 Hz, 1H), 3.53 – 3.47 (m, 1H), 2.21 (s, J = 0.9 Hz, 3H), 1.99 (s, 
3H), 1.75 – 1.68 (m, 6H), 1.65 (dtd, J = 11.9, 3.3, 1.7 Hz, 1H), 1.28 (d, J = 7.1 Hz, 3H), 1.22 
– 1.03 (m, 5H). 13C NMR (150 MHz, Chloroform-d): δ 135.49, 130.57, 108.22, 40.78, 33.41, 
33.40,  33.34, 26.35, 26.27, 26.26,  20.01, 13.09, 11.05.  IR (ν/cm-1): 3282 (br, s), 2925 (s), 
2852 (m), 1697 (s), 1652 (w), 1448 (m), 1374 (m), 1266 (br, m), 971 (m).  MS (ES+) [M+H]+ 
calcd for C16H25N+ 232.21, found: 232.36. 
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Synthesis of (E)-1-methyl-3-(1-phenylpent-1-en-3-yl)-1H-indole 3.22 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 1-methylindole 
(14.4 mg, 0.110 mmol) and (1E,3E)-penta-1,3-dien-1-ylbenzene (14.4 mg, 0.100  mmol) 
were added to a solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 0.0050 mmol) in 
diethyl ether (150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 50 °C for 24 h.  
The resulting oil was purified by SiO2 column chromatography (25:1 Pentane/EtOAc) to 
afford 3.22 (25.3 mg, 0.091 mmol, 91% yield) as a colorless oil.  1H NMR (600 MHz, 
Chloroform-d) δ 7.67 (dt, J = 8.0, 1.0 Hz, 1H), 7.38 – 7.34 (m, 2H), 7.33 – 7.25 (m, 7H), 
7.22 (ddd, J = 8.1, 6.9, 1.2 Hz, 1H), 7.20 – 7.15 (m, 1H), 7.11 – 7.04 (m, 1H), 6.89 (s, 1H), 
6.50 (d, J = 15.9 Hz, 1H), 6.40 (dd, J = 15.8, 7.8 Hz, 1H), 3.77 (s, 3H), 3.63 (m, 1H), 1.99 
(dt, J = 13.9, 7.0 Hz, 1H), 1.88 (dt, J = 13.3, 7.5 Hz, 1H), 1.00 (t, J = 7.3 Hz, 3H). 13C NMR 
(151 MHz, Chloroform-d) δ 137.35, 134.45, 129.21, 128.55, 127.47, 126.95, 126.26, 125.72, 
121.60, 119.83, 118.75, 117.75, 109.33, 42.37, 32.81, 28.40, 12.62. IR (ν/cm-1): 2958 (m), 
2871 (m), 1471 (m), 1374 (m), 1326 (s), 1333 (m).  MS (ES+) [M+H]+ calcd for C20H22N+ 
276.17, found: 276.09. 
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Synthesis of (E)-6-methyl-2-(2-(1-methyl-1H-indol-3-yl)pent-3-en-1-yl)-1,3,6,2-
dioxazaborocane-4,8-dione 3.23 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 1-methylindole 
(14.4 mg, 0.110 mmol) and 6-methyl-2-((1E,3E)-penta-1,3-dien-1-yl)-1,3,6,2-
dioxazaborocane-4,8-dione (22.3 mg, 0.100  mmol) were added to a solution of 3.8 (8.1 mg, 
0.0050 mmol) and LiBF4 (0.5 mg, 0.0050 mmol) in diethyl ether (150 µL, [ ] = 0.67 M), and 
the reaction was allowed to stir at 60 °C for 24 h.  The resulting oil was purified by SiO2 
column chromatography (20:1 DCM:MeOH) to afford 3.23 as a colorless oil which could not 
be separated from starting material for a yield. NMR yield is based on addition of 5.0 µL of 
DMF as an internal standard. 1H NMR (600 MHz, Chloroform-d) δ 7.55 (dt, J = 7.9, 1.0 Hz, 
1H), 7.28 (dt, J = 8.3, 0.9 Hz, 1H), 7.20 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.07 (ddd, J = 8.0, 
7.0, 1.0 Hz, 1H), 6.86 – 6.81 (m, 1H), 5.72 – 5.63 (m, 1H), 5.54 – 5.44 (m, 1H), 3.74 (s, 3H), 
3.73 – 3.69 (m, 1H), 3.52 – 3.39 (m, 2H), 3.23 (dd, J = 45.8, 16.3 Hz, 2H), 2.65 (s, 3H), 1.66 
(dd, J = 15.2, 7.2 Hz, 1H), 1.60 (dd, J = 15.2, 8.0 Hz, 1H), 1.43 (d, J = 7.0 Hz, 3H). 13C 
NMR (151 MHz, Chloroform-d) δ 166.85, 166.83, 137.69, 137.39, 126.88, 125.14, 124.46, 
121.81, 119.77, 119.35, 118.78, 109.61, 62.35, 62.26, 45.15, 34.07, 32.80, 20.70.  IR (ν/cm-
1): 3054 (w), 3011 (m), 2959 (m), 2926 (m), 2871 (w), 1770 (s), 1541 (m), 1457 (m), 1337 
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(m), 1300 (m), 1240 (w), 1074 (w), 1024 (m), 993 (m), 896 (m).  MS (ES+) [M+H]+ calcd for 
C19H24BN2O4+ 355.19, found: 355.36 
 
Synthesis of (E)-3-(1-(4-methoxyphenyl)pent-1-en-3-yl)-1-methyl-1H-indole 3.24 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 1-methylindole 
(14.4 mg, 0.110 mmol) and 1-methoxy-4-((1E,3E)-penta-1,3-dien-1-yl)benzene (17.4 mg, 
0.100  mmol) were added to a solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 
0.0050 mmol) in diethyl ether (150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 
50 °C for 24 h.  The resulting oil was purified by SiO2 column chromatography (15:1 
Pentane/EtOAc) to afford 3.24 (25.0 mg, 0.072 mmol, 72% yield) as a colorless oil. 1H NMR 
(600 MHz, Chloroform-d) δ 7.68 (dt, J = 8.0, 0.9 Hz, 1H), 7.30 (d, J = 3.2 Hz, 1H), 7.29 (d, J 
= 3.8 Hz, 1H), 7.22 (ddd, J = 8.2, 6.9, 1.1 Hz, 1H), 7.09 (ddd, J = 7.9, 7.0, 1.0 Hz, 1H), 6.88 
(s, 1H), 6.84-6.81 (m, 2H), 6.44 (d, J = 15.7 Hz, 1H), 6.26 (dd, J = 15.8, 8.0 Hz, 1H), 3.80 (s, 
3H), 3.76 (s, 3H), 3.70 (m, 1H), 2.06 (s, 1H), 1.95 (dddd, J = 13.1, 10.1, 6.5, 5.4 Hz, 1H), 
1.84 (dddd, J = 13.3, 9.9, 8.0, 5.2 Hz, 1H), 1.36 (m, 1H), 1.32 (ddt, J = 8.7, 3.7, 1.8 Hz, 3H), 
0.89 (t, J = 6.9 Hz, 3H). 13C NMR (151 MHz, Chloroform-d) δ 158.76, 137.34, 132.65, 
130.85, 129.34, 128.34, 127.32, 125.60, 121.56, 119.87, 118.70, 118.26, 113.97, 109.30, 
40.55, 35.64, 32.81, 32.11, 27.66, 22.80, 14.30. IR (ν/cm-1): 3059 (m), 3029 (m), 2918 (m), 
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2862 (m), 1612 (w), 1463 (m), 1356 (m), 1317 (m), 1255 (m), 1181 (m), 1139 (w), 1077 (w), 
1011 (w).  MS (ES+) [M+H]+ calcd for C24H30NO+ 348.23, found: 348.36 
 
Synthesis of (E)-3-(8-chloro-1-phenyloct-1-en-3-yl)-1-methyl-1H-indole 3.25 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 1-methylindole 
(14.4 mg, 0.110 mmol) and ((1E,3E)-8-chloroocta-1,3-dien-1-yl)benzene (22.0 mg, 0.100  
mmol) were added to a solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 0.0050 
mmol) in diethyl ether (150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 50 °C 
for 24 h.  The resulting oil was purified by SiO2 column chromatography (25:1 
Pentane/EtOAc) to afford 3.25 (27.7 mg, 0.079 mmol, 79% yield) as a colorless oil.  1H 
NMR (600 MHz, Chloroform-d) δ 7.66 (d, J = 8.0 Hz, 1H), 7.35 (d, J = 7.6 Hz, 2H), 7.29 
(dd, J = 11.9, 7.9 Hz, 3H), 7.22 (t, J = 7.6 Hz, 1H), 7.18 (t, J = 7.4 Hz, 1H), 7.08 (t, J = 7.4 
Hz, 1H), 6.89 (s, 1H), 6.49 (d, J = 15.8 Hz, 1H), 6.39 (dd, J = 15.7, 7.9 Hz, 1H), 3.77 (s, 3H), 
3.72 (m, 1H), 3.52 (t, J = 6.7 Hz, 2H), 1.97 (m, 1H), 1.91 – 1.83 (m, 1H), 1.77 (p, J = 6.9 Hz, 
2H), 1.53 – 1.35 (m, 4H). 13C NMR (151 MHz, Chloroform-d) δ 137.85, 137.32, 134.41, 
129.13, 128.57, 127.32, 127.03, 126.26, 125.68, 121.66, 119.76, 118.80, 117.63, 109.39, 
45.33, 40.50, 35.31, 32.84, 32.70, 27.20, 27.04.  IR (ν/cm-1): 3024 (w), 2932 (s), 2856 (m), 
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1598 (w), 1447 (s), 1327 (w).  MS (ES+) [M+H]+ calcd for C23H27ClN+ 352.18, found: 
352.09. 
 
Synthesis of (E)-3,5-dimethyl-2-(1-phenylpent-1-en-3-yl)-1H-pyrrole 3.26 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 2,4-
dimethylpyrrole (10.5  mg, 0.110 mmol) and (1E,3E)-penta-1,3-dien-1-ylbenzene (14.4 mg, 
0.100  mmol) were added to a solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 
0.0050 mmol) in diethyl ether (150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 
50 °C for 24 h.  The resulting oil was purified by SiO2 column chromatography (25:1 
Pentane/EtOAc) to afford 3.26 (19.9 mg, 0.11 mmol, 89% yield) as a colorless oil.  1H NMR 
(600 MHz, Chloroform-d)  δ 7.39 – 7.36 (m, 1H), 7.30 (t, J = 7.7 Hz, 1H), 7.23 – 7.19 (m, 
1H), 6.43 – 6.38 (m, 1H), 6.31 (dd, J = 15.9, 6.7 Hz, 1H), 5.69 (d, J = 2.8 Hz, 1H), 3.45 (q, J 
= 7.8, 7.3 Hz, 1H), 2.22 (s, 3H), 2.04 (s, 3H), 1.86 – 1.80 (m, 1H), 1.75 (m, 1H), 0.95 (t, J = 
7.3 Hz, 3H). 13C NMR (151 MHz, Chloroform-d) δ 137.64, 132.56, 129.32, 128.64, 127.38, 
127.21, 126.27, 125.40, 114.79, 108.12, 41.52, 27.66, 13.16, 12.43, 11.24. IR (ν/cm-1): 2921 
(s), 2854 (m), 1682 (m), 1652 (m), 1558 (m), 1540 (m), 1488 (m), 1455 (s), 966 (m). MS 
(ES+) [M+H]+ calcd for C17H22N+ 276.17, found: 276.09. 
 
Ph
5 mol % LiBF4
Et2O (0.67 M), 40 oC, 24 h
+ Me NH
Et
HN
Ph
5 mol %
N
N
N
N
PPh2
PPh2
Rh Ph
BAr4f-24
3.26
>98% Conversion
89% Yield
>98:2
85:15 C2:C3
Me
3:1 (E:Z)
Me
Me
Me
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Synthesis of (E)-3-(1-(4-chlorophenyl)pent-1-en-3-yl)-1-methyl-1H-indole 3.27 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 1-methylindole 
(14.4 mg, 0.110 mmol) and 1-chloro-4-((1E,3E)-penta-1,3-dien-1-yl)benzene (17.9 mg, 
0.100  mmol) were added to a solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 
0.0050 mmol) in diethyl ether (150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 
60 °C for 24 h.  The resulting oil was purified by SiO2 column chromatography (15:1 
Pentane/Et2O) to afford 3.27 (22.6 mg, 0.073 mmol, 73% yield) as a colorless oil. 1H NMR 
(600 MHz, Chloroform-d) δ 7.68 (dt, J = 8.0, 0.9 Hz, 1H), 7.30 (d, J = 3.2 Hz, 1H), 7.29 (d, J 
= 3.8 Hz, 1H), 7.22 (ddd, J = 8.2, 6.9, 1.1 Hz, 1H), 7.09 (ddd, J = 7.9, 7.0, 1.0 Hz, 1H), 6.88 
(s, 1H), 6.84 ? 6.81 (m, 2H), 6.44 (d, J = 15.7 Hz, 1H), 6.26 (dd, J = 15.8, 8.0 Hz, 1H), 3.80 
(s, 3H), 3.76 (s, 3H), 3.70 (m, 1H), 2.06 (s, 1H), 1.95 (dddd, J = 13.1, 10.1, 6.5, 5.4 Hz, 1H), 
1.84 (dddd, J = 13.3, 9.9, 8.0, 5.2 Hz, 1H), 1.36 (m, 1H), 1.32 (ddt, J = 8.7, 3.7, 1.8 Hz, 3H), 
0.89 (t, J = 6.9 Hz, 3H). 13C NMR (151 MHz, Chloroform-d) δ 158.76, 137.34, 132.65, 
130.85, 129.34, 128.34, 127.32, 125.60, 121.56, 119.87, 118.70, 118.26, 113.97, 109.30, 
40.55, 35.64, 32.81, 32.11, 27.66, 22.80, 14.30. IR (ν/cm-1): 3048 (w), 3029 (w), 2959 (m), 
2928 (m), 2871 (m), 1698 (m), 1653 (m), 1541 (m), 1507 (m), 1457 (m) 1418 (w), 1374 (w), 
5 mol % LiBF4
Et2O (0.67 M), 50 oC, 24 h
+
3.27
74% Conversion
73% yield
97:3
N
Me
Et
N
Me
5 mol %
N
N
N
N
PPh2
PPh2
Rh Ph
BAr4f-24
Me
Cl
Cl
1:1 (E:Z)
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1338 (w), 1234 (w), 1091 (m), 1011 (m), 966 (m).  MS (ES+) [M+H]+ calcd for C20H21ClN+ 
310.14, found: 310.27 
Synthesis of (E)-methyl 5-(1-methyl-1H-indol-3-yl)-7-phenylhept-6-enoate 3.28 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 1-methylindole 
(14.4 mg, 0.110 mmol) and (4E,6E)-methyl 7-phenylhepta-4,6-dienoate  (21.6 mg, 0.100  
mmol) were added to a solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 0.0050 
mmol) in diethyl ether (150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 50 °C 
for 24 h.  The resulting oil was purified by SiO2 column chromatography (25:1 
Pentane/EtOAc) to afford 3.28 (22.5 mg, 0.091 mmol, 91% yield) as a colorless oil.  1H 
NMR (600 MHz, Chloroform-d) δ 7.65 (dt, J = 8.0, 1.0 Hz, 1H), 7.36 – 7.32 (m, 2H), 7.31 – 
7.24 (m, 4H), 7.21 (ddd, J = 8.1, 7.0, 1.1 Hz, 1H), 7.19 – 7.16 (m, 1H), 7.08 (ddd, J = 8.0, 
7.0, 1.0 Hz, 1H), 6.90 (s, 1H), 6.50 (d, J = 15.8 Hz, 1H), 6.38 (dd, J = 15.8, 7.8 Hz, 1H), 3.75 
(m, 5H), 3.65 (d, J = 1.9 Hz, 3H), 2.36 (t, J = 7.5 Hz, 2H), 1.99 (m, 1H), 1.89 (m, 1H), 1.82 – 
1.68 (m, 2H).  13C NMR (151 MHz, Chloroform-d) δ 174.24, 134.01, 129.37, 128.57, 
128.43, 127.28, 127.07, 126.30, 125.78, 121.69, 119.72, 118.85, 117.24, 109.39, 51.63, 
40.38, 34.86, 34.21, 32.83, 23.37.  IR (ν/cm-1): 3024 (wb), 2919 (s), 2849 (m), 1736 (s), 1543 
(w), 1450 (m), 1372 (w), 1328 (w), 1154 (m), 1012 (w).  MS (ES+) [M+H]+ calcd for 
C23H26NO2+ 348.20, found: 348.09. 
Ph
5 mol % LiBF4
Et2O (0.67 M), 50 oC, 24 h
+
3.28
91% Conversion
91% Yield
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N
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Synthesis of (E)-3-(hex-4-en-3-yl)-1-methyl-1H-indole 3.29 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 1-methylindole 
(14.4 mg, 0.110 mmol) and (2E,4E)-hexa-2,4-diene (8.2 mg, 0.100  mmol) were added to a 
solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 0.0050 mmol) in diethyl ether 
(150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 22 °C for 24 h.  The resulting 
oil was purified by SiO2 column chromatography (40:1 Pentane/EtOAc) to afford 3.29 (13.7 
mg, 0.064 mmol, 64% yield) as a colorless oil. 1H NMR (600 MHz, Chloroform-d): δ 7.65 – 
7.63 (m, 1H), 7.28 (ddt, J = 8.1, 2.2, 0.9 Hz, 1H), 7.21 (tdd, J = 8.2, 3.2, 1.2 Hz, 1H), 7.08 
(dddd, J = 8.0, 6.9, 3.0, 1.0 Hz, 1H), 6.81 (d, J = 0.8 Hz, 1H), 5.65 – 5.60 (m, 2H), 3.75 (s, 
3H), 3.73 – 3.68 (m, 1H), 2.07 – 2.01 (m, 2H), 1.43 (d, J = 7.0 Hz, 3H), 0.99 (t, J = 7.4 Hz, 
3H). 13C NMR (150 MHz, Chloroform-d): δ 134.19, 130.40, 125.11, 121.53, 119.94, 119.93, 
118.57, 109.27, 34.02, 32.75, 25.66, 21.29, 14.10. IR (ν/cm-1): 2960 (b), 1540 (w), 1507 (w), 
1473 (m), 1374 (w), 1326 (w).  MS (ES+) [M+H]+ calcd for C15H20N+ 214.16, found: 214.18. 
Me
Me
5 mol % LiBF4
Et2O (0.67 M), 50 oC, 24 h
+
3.29
66% Conversion
64% Yield
67:33 α:β
N
Me
N
Me
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N
N
N
N
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α β
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Synthesis of (E)-2-(1-(4-chlorophenyl)pent-1-en-3-yl)-3,5-dimethyl-1H-pyrrole 3.30 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, 2,4-
dimethylpyrrole (10.5  mg, 0.110 mmol) and 1-chloro-4-((1E,3E)-penta-1,3-dien-1-
yl)benzene (17.9 mg, 0.100  mmol) were added to a solution of 3.8 (8.1 mg, 0.0050 mmol) 
and LiBF4 (0.5 mg, 0.0050 mmol) in diethyl ether (150 µL, [ ] = 0.67 M), and the reaction 
was allowed to stir at 50 °C for 18 h.  The resulting oil was purified by SiO2 column 
chromatography (25:1 Pentane/Et2O) to afford 3.30 (25.8 mg, 0.095 mmol, 95% yield) as a 
colorless oil. 1H NMR (600 MHz, Chloroform-d) δ 7.28 – 7.23 (m, 4H), 6.37 – 6.23 (m, 2H), 
5.67 (d, J = 2.7 Hz, 1H), 3.45 – 3.37 (m, 1H), 2.21 (d, J = 0.9 Hz, 3H), 2.02 (s, 3H), 1.86 – 
1.76 (m, 1H), 1.72 (dt, J = 13.4, 7.6 Hz, 1H), 0.93 (t, J = 7.4 Hz, 3H). 13C NMR (151 MHz, 
Chloroform-d) δ 136.17, 133.37, 132.73, 128.75, 128.11, 127.47, 127.08, 125.54, 114.96, 
108.17, 41.60, 27.59, 13.16, 12.42, 11.22. IR (ν/cm-1): 3452 (w), 2962 (s), 2928 (s), 3871 
(m), 1691 (m), 1597 (w), 1490 (s), 1451 (m), 1402 (m), 1100 (s), 1013 (s), 968 (s) MS (ES+) 
[M+H]+ calcd for C21H30NO+ 274.14, found: 274.36. 
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n  Procedure for styrene substitution  
In a dry box, an 8 mL vial was charged with 3.8 (10.0 mg, 6.18 µmol) and appropriate metal 
salt (6.18 µmol). THF-d8 (0.5 mL, [ ] = 0.012) was added and the reaction was allowed to stir 
for the specified time. Analysis of loss of styrene conducted on a 600 MHz NMR 
spectrometer. See scheme for conditions. 
 
 
n  Procedure for protonation of 3.33 to form 3.34  
 In a dry box, an 8 mL vial was charged with 3.33 (10.0 mg, 0.013 mmol) and CH2Cl2 
(0.5 mL, [ ] = 0.012). The vial was fitted with a Teflon lined septum cap and brought outside 
the glovebox. Tetrafluoroboric acid (50% solution in diethyl ether, 4.0 µL, 0.014 mmol) was 
added via syringe and immediately the solution turned from dark to light yellow. A solution 
phase IR was taken after 20 minutes using air free techniques. 1H NMR (600 MHz, 
Methylene Chloride-d2) δ 7.88 (q, J = 6.9 Hz, 4H), 7.76 – 7.58 (m, 16H), 4.51 (q, J = 11.0 
N
N
N
N PPh2
PPh2
Rh
BArf4
Ph
N
N
N
N PPh2
PPh2
Rh O
BArf4
metal salt 
(1 equiv)
thf-d8, 22 °C, 24 h
no metal salt: <2% styrene
AuCl: 81% styrene
LiBArF4: 6% styrene
d8 +
3.8 3.32
N
N
N
N PPh2
PPh2
Rh CO
2   BF4
H
vRh(CO) 2016 cm-1
>98% conversion
HBF4 • OEt2                                        
CD2Cl2, 
22 °C, 10 min
N
N
N
N PPh2
PPh2
Rh CO
BF4
vRh(CO) 1986 cm-1
3.33 3.34
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Hz, 2H), 4.39 (s, 1H), 4.23 (td, J = 11.4, 5.6 Hz, 2H), 3.96 (s, 4H), 3.79 (q, J = 10.7 Hz, 2H), 
3.50 (td, J = 10.9, 5.6 Hz, 2H).  13C NMR (151 MHz, Methylene Chloride-d2) δ 177.32 (t, J = 
18.8 Hz), 134.40 (t, J = 8.2 Hz), 133.73 , 133.08 , 132.49 (t, J = 8.3 Hz), 130.07 (dt, J = 14.5, 
5.5 Hz), 128.37 (dt, J = 116.5, 26.6 Hz), 59.00 , 46.01 , 42.53 , 29.03 (m).  IR (ν/cm-1): 2016 
(s), 2000 (m), 1614 (s), 1481 (m), 1437 (m), 1285 (w), 1012 (s). 
 
n  Procedure for deuterium incorporation experiments (Scheme 3d.) 
 
 
Synthesis of (E)-3-(4-phenylbut-3-en-2-yl)-d1-N-methyl-indole 
Following the general procedure for (CDC)-Rh-catalyzed hydroarylation, d1-N-
methyl indole (13.2 mg, 0.100 mmol, 98% C3-D), and phenyl 1,3-butadiene (13.0 mg, 
0.100  mmol) were added to a solution of 3.8 (8.1 mg, 0.0050 mmol) and LiBF4 (0.5 mg, 
0.0050 mmol) in diethyl ether (150 µL, [ ] = 0.67 M), and the reaction was allowed to stir at 
22 °C for 24 h.  The resulting oil was purified by SiO2 column chromatography (20:1 
Pentane/EtOAc) to afford d1-3.10 as a colorless oil (93% NMR yield, >95% D-
incorporation). 
 
 
 
5 mol % 3.8 
5 mol% LiBF4
Et2O, 22 °C, 24 h
Ph
+ N
Me
N
H
Ph
D
D
d1-3.9
93% conversion
>95% D incorporation
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n  Preparation of new dienes 
 
 
 
 
Procedure for the synthesis of 6-methyl-2-((1E,3E)-penta-1,3-dien-1-yl)-1,3,6,2-
dioxazaborocane-4,8-dione30–33 
At 0 oC under anhydrous, oxygen-free conditions, aTHF solution of LTMP (165 mg, 1.12 
mmol, [ ] = 0.31) was added via cannula to an 8 mL vial containing a THF solution of 
Me(Bpin)2 (300 mg, 1.12 mmol, [ ] = 0.52).  The reaction was allowed to stir at 0 oC for 10 
min. Trans-crotonaldehyde (60.2 mg, 0.0.86 mmol) was added via syringe and the reaction 
was allowed to warm to room temperature while stirring. After 1 h, the reaction was slowly 
quenched by the addition of 2 mL of ether and 2 mL of water. The reaction mixture was 
diluted with 10 mL more of ether and extracted 3 times (10 mL ether). The combined organic 
extracts were washed with brine (10 mL), dried over sodium sulfate, filtered through a plug 
of cotton, and concentrated. The diene was purified by column chromatography (20:1 
hexanes:EtOAc) to yield a clear oil (123 mg, 74% yield). In a 25 mL round bottoem flask, to 
this oil was added NaIO4 (488.2 mg, 2.28 mmol) and NH4OAc (175.7 mg, 2.28 mmol). 
Acetone and water (0.5 mL each, [ ] = 0.63 total) were added to the flask which was capped 
with a septum and allowed to stir for 24 h at 22 °C. This solution was filtered using acetone 
(5 mL) through a plug of Celite®. The acetone was removed in vacuo and the remaining 
solution was diluted with water (2 mL) and ether (10 mL). The organic layer was separated 
and the water layer was extracted an additional 2 times (10 mL ether). The combined organic 
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layers were washed with brine, dried over sodium sulfate, filtered through cotton, 
concentrated, and used immediately. The boronic acid and methyl amino diacetic acid (98 
mg, 067 mmol) were added to a 50 mL round bottom flask equipped with a stir bar. The flask 
was fitted with a Dean Stark trap and purged with N2. Anhydrous DMSO (3.2 mL) and 
toluene (32 mL) were added to the flask and the flask was purged. The reaction was allowed 
to heat to reflux with stirring for 18 h. After 18 h, the flask was cooled to room temperature 
and concentrated using a rotary evaporator with a water bath at 60 °C. The crude mixture was 
immediately purified by column chromatography (100% ether to 10:1 ether:MeCN) to yield a 
white solid (50.4 mg, 20% overall yield). 1H NMR (600 MHz, Chloroform-d) δ 6.63 (dd, J = 
17.3, 10.4 Hz, 1H), 6.13 (ddt, J = 14.1, 10.3, 2.0 Hz, 1H), 5.89 – 5.74 (m, 1H), 5.40 (d, J = 
17.4 Hz, 1H), 3.86 – 3.64 (m, 4H), 2.83 (s, 3H), 1.77 (dd, J = 6.7, 1.8 Hz, 3H). 13C NMR 
(151 MHz, Chloroform-d) δ 167.18, 145.20, 133.51, 132.68, 61.47, 46.70, 30.45, 18.28.  IR: 
3501 (br, m), 3012 (m), 2960 (m), 2854 (w), 1768 (s), 1650 (m), 1604 (m), 1456 (m), 1338 
(m), 1301 (s), 1249 (w), 1154 (m), 1126 (m), 1007 (s), 956 (m). MS (ES+) [M+H]+ calcd for 
C10H15BNO4+ 224.11, found: 224.18. 
 
n General procedure for substrates prepared through metathesis24 
Grubb’s 1st generation catalyst (5 mol%) was weighed into an oven dried 8 mL vial or 50 mL 
flask equipped with a stir bar, which was then capped using a Teflon® lined lid.  The vial 
was purged with N2 for 10 min then charged with dichloromethane ([ ] = 0.20).  Alkene 
followed by diene were added via syringe.  The reaction was allowed to warm to 40 oC and 
stir for 18 h. The reaction was plugged through a plug of silica gel using hexanes then 
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concentrated. The residue was purified by column chromatography using 100% hexanes to 
25:1 hexanes:ether.  
 
 
 
((1E,3E)-8-chloroocta-1,3-dien-1-yl)benzene  
Following the general procedure, Grubb’s 1st generation catalyst (168 mg, 0.205 mmol) was 
solvated with dichloromethane (20 mL, [ ] = 0.20). 6-Chloro-1-hexene (1.0 mL, 8.17 mmol) 
and phenylbutadiene (532 mg, 4.09 mmol) were added, the reaction was allowed to warm to 
40 oC and stir for 18 h. The colorless liquid was obtained in an 11% yield (122 mg, 0.50 
mmol).   1H NMR (600 MHz, Chloroform-d) δ 7.38 (d, J = 8.3 Hz, 2H), 7.31 (t, J = 7.7 Hz, 
2H), 7.21 (t, J = 7.3 Hz, 1H), 6.75 (dd, J = 15.7, 10.4 Hz, 1H), 6.46 (d, J = 15.7 Hz, 1H), 
6.26 – 6.18 (m, 1H), 5.81 (dt, J = 14.6, 7.0 Hz, 1H), 3.56 (t, J = 6.6 Hz, 2H), 2.19 (qd, J = 
7.2, 1.3 Hz, 2H), 1.82 (dt, J = 15.0, 6.8 Hz, 2H), 1.59 (m, 2H).  13C NMR (151 MHz, 
Chloroform-d) δ 137.66, 134.82, 131.27, 130.56, 129.28, 128.70, 127.32, 126.29, 45.08, 
32.19, 32.16, 26.63.  IR: 3059 (w), 3022 (s), 2936 (s), 2860 (m), 1643 (w), 1596 (m), 1494 
(m), 1447 (s), 1304 (m), 1071 (w).  
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(4E,6E)-methyl 7-phenylhepta-4,6-dienoate  
Following the general procedure, Grubb’s 1st generation catalyst (62.5 mg, 0.076 mmol) was 
solvated with dichloromethane (6 mL, [ ] = 0.25). Methyl pent-4-enoate (348 mg, 3.05 
mmol) and phenyl-1,3-butadiene (200 mg, 1.52 mmol) were added, the reaction was allowed 
to warm to 40 oC, and stir for 18 h. The colorless liquid was obtained in an 30% yield (100 
mg, 0.46 mmol).  1H NMR (400 MHz, Chloroform-d) δ 7.37 (d, J = 10.8 Hz, 2H), 7.31 (t, J = 
11.4 Hz, 2H), 7.21 (t, J = 10.8 Hz, 1H), 6.74 (dd, J = 15.7, 10.4 Hz, 1H), 6.47 (d, J = 15.7 
Hz, 1H), 6.25 (dd, J = 14.9, 10.4 Hz, 1H), 5.81 (ddd, J = 15.6, 7.8, 5.1 Hz, 1H), 3.69 (s, 3H), 
2.46 (td, J = 3.8, 3.3, 1.9 Hz, 4H). 13C NMR (151 MHz, Chloroform-d) δ 173.53, 137.54, 
132.95, 131.75, 131.14, 129.00, 128.70, 127.43, 126.35, 51.76, 33.87, 28.20. IR (ν/cm-1):  
3023 (m), 2951 (m), 2360 (w), 1734 (s), 1540 (b), 1196 (m).  MS (ES+) [M+H]+ calcd for 
C14H17O2+  217.1223, found: 217.27 
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Chapter 4 Development of Chiral CDC and CBA Catalysts for Enantioselective 
Hydrofunctionalization4 
4.1 Introduction 
 The development of new methods for the synthesis of non-racemic chiral molecules is 
an important goal for organic chemists. Over half of all pharmaceuticals contain at least one 
stereocenter.1 Most of these drugs are sold as racemates, even if only one enantiomer is 
active, which is highly inefficient. Therefore, innovative approaches for the enantioselective 
synthesis of small molecule building blocks are necessary. One way to achieve this goal is 
through enantioselective hydrofunctionalization of dienes.  
 Our group set out to develop chiral carbodicarbene (CDC) catalysts for the 
enantioselective hydrofunctionalization of dienes. We envisioned that by using readily-
available amino acid building blocks, we could design a chiral CDC Rh(I) pincer complex 
that would be highly modular and site- and enantioselective. 
4.2 Background 
4.2.1 Transition metal-catalyzed enantioselective hydroarylation 
 There exists a limited number of examples of transition metal-catalyzed 
enantioselective hydroarylation of olefins.2–4 To the best of my knowledge, no examples of 
																																																								
4 All results in this chapter are unpublished. All ligands and complexes were designed by S.J. 
Meek and C.C. Roberts. All syntheses were developed by CCR with the exception of the 
phosphorylation conditions for the valine-derived ligand, which were developed by M. J. 
Goldfogel. 
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the enantioselective hydroarylation of 1,3-dienes exist. For examples of nonenantioselective 
hydrofunctionalization of olefins see Chapters 2-3. 
 Widenhoefer reported a Au(I)-catalyzed intramolecular hydroarylation of allenes 
using tethered indoles.2 This reaction is proposed to proceed through the (S)-MeO-BIPHEP 
gold(I) catalyst binding to the allene followed by nucleophilic addition of the indole moiety. 
Enantioselectivities of up to 92% are reported.  
 The Widehoefer group also reported an intramolecular enantioselective 
hydroarylation of alkenes using a Pt(II) complex ligated by bidentate BIPHEP derived 
ligands.4 N-Meindole substrates generate the cyclized product in up to 90% ee but when the 
Me group on the nitrogen of indole is removed, the selectivity plummets to 47% ee. 
 Sevov and Hartwig disclosed the hydroarylation of bicycloalkenes using a DTMB-
SEGPHOS Ir(I) catalyst. Indole, pyrrole, benzofuran, furan, benzothiophene, and thiophene 
derivatives were tolerated under the reaction conditions. Yields of 21-98% are reported and 
enantioselectivities of up to 99% are reported. The mechanism of this reaction was probed 
and found to proceed through an insertion of the Ir(I) catalyst into the C-H bond of the 
heteroarene to form an Ir(III)-hydride.  
4.2.2 Transition metal-catalyzed enantioselective hydroamination 
 A number of groups have disclosed reports of late transition metal-catalyzed 
enantioselective hydroamination of olefins.5–7 There have only been two reports of the 
enantioselective hydroamination of 1,3-dienes (Scheme 4-1). 
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Scheme 4-1 Previous examples of enantioselective hydroamination of 1,3-dienes 
	
 In 2001, Hartwig and coworkers reported an intermolecular enantioselective 
hydroamination of cyclohexa-1,3-diene using aniline derivatives (Scheme 4-1a).8 Using 5 
mol% [Pd(π-allyl)Cl]2 and 11 mol% of a more hindered variant of the Trost ligand at room 
temperature, the allylic amine was generated in 63% yield and 92% ee after 120 hours. The 
substrate scope includes five aryl amines, but does not include any other dienes.  
 Toste and coworkers disclosed a gold(I)-catalyzed intramolecular hydroamination of 
dienes using electron-poor amines (Scheme 4-1b).9 The combination of the chiral DTBM-
Segphos ligated Au(I) complex and (-)-menthol additive produced the pyrrolidine product in 
95% conversion and 95% ee. This reaction proceeds through an electrophilic Au(I) catalyst 
activating the alkene for nucleophilic attack. 
 
 
 	
Me Me
NHMBs
Mbs
N
Me Me
Me
5 mol% (R)-DTBM-SEGPHOS(AuCl)2
6 mol% AgBF4
200 mol% (-)-menthol
CH2Cl2, 23 °C, 24 h 95% conversion
95% ee
b. Toste 2011
a. Hartwig 2001
PhNH2   +
HPhN5 mol% [Pd(π-allyl)Cl]2
11 mol% Trost's ligand
22 °C, 120 h 63% yield
92% ee
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4.3 Results and Discussion 
4.3.1 Catalyst design 	 	
	
Figure 4-1 Chiral CDC and CBA catalyst design 
 Our group wanted to design a chiral CDC catalyst for the enantioselective 
hydrofunctionalization of dienes using readily available amino acids as building blocks 
(Figure 4-1). Because there are only a limited number of examples of the asymmetric 
synthesis of allylic amines via hydroamination and no examples of the heteroarene analog, 
we didn’t want to limit ourselves to one design. Therefore, we designed both a chiral CDC 
catalyst that incorporates our diazapine scaffold (4.1) as well as a chiral cyclic bent allene 
(CBA) complex (4.2) analogous to the achiral variant developed by Bertrand and 
coworkers.10,11  
 When considering the structure of our desired complexes, we wanted to incorporate 
modularity in the amino acid substituents. For CDC complex 4.1, valine is used as the amino 
acid, but one could envision using phenyl glycine, phenyl alanine, or tert-leucine instead, 
which would provide a different steric environment. For CBA-Rh complex 4.2, proline 
provides a rigid 5-membered structure but could be substituted for an acyclic amino acid. By 
incorporating phosphines as donors, both structures provide points of electronic and steric 
tunability. CBA complex 4.2 also provides one more point of modification on the backbone. 
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Ph Ph
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PhPh
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The pyrazole core is derived from 1,2-diphenylhydrazine and be can modified to incorporate 
other aryl groups in order to modulate the electronics of the ligand. Finally, we wanted to 
design ligands with two different environments around the Rh(I) center. Varying the 
geometry of the chiral pocket generated two unique chiral environments for the diene to bind 
in. 
4.3.2 Chiral carbodicarbene catalyst synthesis 
	
Figure 4-2 Synthesis of chiral CDC Rh pincer complex 4.1 
 With the desired design of the chiral complex in mind, I synthesized chiral CDC-Rh 
complex 4.1 in six steps from commercially available boc-L-valine hydroxysuccinimide 
ester, which can also be prepared in two steps from L-valine.12 Two equivalents of boc-L-
valine hydroxysuccinimide ester were coupled with ethylenediamine in thf at 60 °C to yield 
the diamide in 84% yield. This was immediately deprotected with either trifluoroacetic acid 
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(TFA) in CH2Cl2 or HCl in dioxane to yield diamide salt 4.3, which had been previously 
synthesized through a similar strategy using different protecting groups.13 A borane reduction 
was carried out on 4.3 to generate tetraamine 4.4 in 64% yield of the crude product. Due to 
the polar nature of 4.4, purification by silica gel chromatography was unsuccessful. DIBAL-
H and LiAlH4 were also tested for the reduction, but resulted in complex mixtures of partially 
reduced compounds. Sometimes small quantities of partially reduced products were observed 
in the reduction of 4.3 with borane, but the cyclization to form 4.5 was unaffected by the 
byproducts. Using ammonium tetrafluoroborate and malononitrile, tetraamine 4.4 was 
cyclized to generate diazapinium salt 4.5 in 58% yield after purification on silica gel. 
Analogous scaffolds to 4.5 using phenyl glycine and phenyl alanine as the amino acid source 
were synthesized by M. J. Goldfogel (please see MJG dissertation for details). I subjected 
unsubstituted diazapinium salt 4.5 to phosphorylation conditions developed by M. J. 
Goldfogel (please see MJG dissertation for details). The diphenylphosphine substituted 
diazapinium scaffold 4.6 was generated in 57% yield. Other attempts in the laboratory to 
metallate 4.6 using the same conditions ([Rh(cod)Cl]2 and NaOMe) that I developed for the 
achiral analogs were unsuccessful. Therefore, I hypothesized that the bidentate cod ligand 
was interfering with the metallation so I subjected 4.6 to [Rh(ethylene)Cl]2 in CDCl3. I 
monitored the reaction by 1H NMR spectroscopy until conversion of the starting material to a 
Rh(III)-H had occurred. After removing the CDCl3 in vacuo, exposure of the CDC-Rh(III)-H 
to NaOMe in thf afforded the product 4.1 cleanly in 42% yield. The characteristic doublet in 
the 31P NMR spectrum has a shift of δ = 74.93 ppm which is in agreement with the achiral 
congener, which has a shift of δ = 79.20 ppm. All steps in this synthesis are unoptimized.  
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4.3.3 Catalysis with chiral carbodicarbene Rh complexes 
Scheme 4-2 Enantioselective hydrofunctionalization with CDC-Rh complex 4.1 
	
 Chiral CDC-Rh complex 4.1 was assessed for use in the enantioselective 
hydroamination of phenylbuta-1,3-diene (Scheme 4-2, top). Using aniline as a nucleophile 
yielded racemic product possibly due to the reversibility of the addition.14,8,15 Morpholine, 
which has a greater nucleophilicity than aniline and is more likely to be an irreversible 
addition, was tested as well and led to no enantioselectivity.16,17 Switching to the more 
hindered dibenzylamine produced allylic amine 4.7 in 5% conversion and 23% ee using 5 
mol% 4.1 and AgBF4. Due to the low conversion at 80 °C and low levels of 
enantioselectivity, the CDC-Rh catalyst was no longer pursued for enantioselective 
hydroamination of dienes. 
 Using complex 4.1 in the enantioselective hydroarylation of dienes proved to be more 
efficient. The product was obtained in a 50% yield but only 29% ee (result obtained by M. J. 
Goldfogel using the catalyst that I developed). Further optimization did not improve the 
levels of enantioselectivity. 
5 mol % 4.1
5 mol % AgBF4
PhCl, 80 oC, 48 h
+ Me
NBn2
5% conversion
23% ee
HNBn2
5 mol % 4.1
5 mol % AgBF4
PhCl, 80 oC, 48 h
+ Me
50% yield
29% ee
N
Me
N
Me
4.8
4.7
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4.3.4 Cyclic bent allene catalyst synthesis 
Scheme 4-3 Synthesis of CBA-Rh complex 4.2 
	
 Because the carbodicarbene scaffold that our group had designed was not amenable to 
enantioselective catalysis, we turned to cyclic bent allene 4.2. The previously prepared 2,4-
dichloropyrazolium salt 4.9 was substituted twice by commercially available prolinol derived 
(S)-2-[(diphenylphosphino)methyl]pyrrolidine in the presence of triethylamine.10,11 
Pyrazolium salt 4.10 was generated in 49% yield after purification by column 
chromatography. A number of different Rh(I) sources (Rh(PPh3)3Cl, [Rh(cod)Cl]2, and 
[Rh(cod)OMe]2) were tested for the metallation of 4.10, but were unsuccessful. Upon 
exposure to the Rh(I) source, no Rh-hydride was ever observed, indicating that the metal had 
not undergone an oxidative insertion into the methine C-H bond. Therefore, I tried to 
deprotonate pyrazolium salt 4.10 in order to generate the free bent allene. Bertrand and 
coworkers had been able to generate the Li-CBA adduct of the pyrrole substituted CBA using 
lithium bases (Chapter 1). Upon exposure to LiHMDS, the free CBA was never observed but 
upon addition of [Rh(ethylene)2Cl]2 to the reaction, two complexes were observed by 31P 
NMR spectroscopy. The two signals (doublets) were observed at 48.4 ppm and 33.5 ppm, 
most likely indicating that both a cationic ethylene complex and a chloride complex (4.2) 
were present in the reaction. In order to shift the equilibrium to form the chloride complex, 
the reaction mixture was concentrated in vacuo, resolvated with thf, and allowed to stir for 4 
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Ph Ph
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Ph Ph
NN
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22 °C, 18 h PP Rh
Cl
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Ph Ph
Ph Ph
PhPhPPh2Ph2P
BF4 BF4 1. LiHMDS,thf, 0 to 22 °C; 4 h
HN
Ph2P
2. [Rh(H2C=CH2)2Cl]2
thf, 22 22 °C; 18 h
49% yield 85% yield
4.9
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hours. After 4 hours, only one signal was observed by the 31P NMR spectroscopy at 33.5 
ppm indicating that the ethylene complex had converted to the neutral chloride complex. 
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4.3.5 Catalysis with CBA complex 4.2 
Table 4-1 Enantioselective hydroarylation of 1,3-dienes using chiral CBA catalyst 4.2 
	
 With CBA complex 4.2 in hand, I tested the hydroarylation of phenylbuta-1,3-diene 
with N-Methylindole using previously developed conditions.18,19 It should be noted that the 
Ph +
5 mol%
5 mol% additive
solvent [0.67], X oC, 18 h
Entry
1
2
3
4
5
6
7
8
9a
10b
11c
12
13
14
15
16
Solvent
Et2O
PhCl
Et2O
Et2O
Et2O
Et2O
Et2O
Et2O
Et2O
Et2O
Et2O
thf
dioxane
CH2Cl2
CHCl3
MeCN
Temp (oC)
45
45
45
45
50
50
22
70
50
50
50
50
50
50
50
50
Conv. to product (%*)
14
10
<2
30
40
20
10
multiple products
20
50
multiple products
<2
<2
50
20
<2
Ph Me
Additive
AgSbF6
AgSbF6
NaBArf4
NaBArf4, LiBF4
NaBArf4, LiPF6
NaBArf4,  LiBArf4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
N
Me
N
Me
ee (%)
27
-11
-
-50
-12
54
6
-
11
33
-
-
-
85
12
-
a. 2 equiv. diene, b. 2 equiv. indole c. 15 mol% LiBArf4
* Conversions calculated by consumption of N-Methylindole, and rounded to the nearest 10%
Note: Entries 1-4 run with catalyst that was a mixture of Cl and ethylene-BF4 complexes
PP Rh
Cl
NN
NN
Ph Ph
Ph Ph
PhPh
4.2
4.8
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catalyst that was used in Entries 1-4 was a mixture of 4.2 and the cationic ethylene analog 
with a tetrafluoroborate counterion (see section 4.3.4 for more details). Using 5 mol% 
AgSbF6 to abstract the halide, the reaction proceeded to 14% and 10% conversion for Et2O 
and PhCl, respectively (Entries 1-2). A modest 27% ee was observed in Et2O but when using 
PhCl as a solvent, 11% ee of the other enantiomer was observed. NaBArF4 without an 
additional additive did not produce product (Entry 3), but when combined with 5 mol% 
LiBF4 4.8 was observed in 30% yield and 50% enantiomeric excess (Entry 4) of the opposite 
enantiomer to that which was obtained in Entry 1. This highlights the significant effect that 
the counterion has on selectivity. Entries 5-16 were run using catalyst that showed only a 
single product by 31P NMR. Using LiPF6 as a Lewis acid cocatalyst, 4.8 was obtained in a 
40% yield and 12% ee. Switching to the extremely dissociating counterion BArF4 yielded 
only 20% product but 54% ee of allylic indole 4.8 (Entry 5). Optimization (temperature, 
equivalents of substrate, etc) was attempted using LiBArF4 as a Lewis acid cocatalyst and 
Et2O as solvent since that combination provided the best result (Entries 7-11) but the reaction 
yield and enantiomeric excess did not increase. A solvent screen was conducted (Entries 12-
16). Other ethereal solvents such as thf and 1,4-dioxane did not produce product. When I 
switched to halogenated solvents, the yield and enantiomeric excess increased to 50% yield 
and 85% ee with CH2Cl2 but 50% of a byproduct was also observed and no starting material 
remained. CHCl3 was not an effective solvent. MeCN did not produce any product, probably 
due to inhibition of the catalyst with acetonitrile. 
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Table 4-2 Optimization of the hydroarylation of dienes  
	
 Using dichloromethane as a solvent, the reaction was optimized. When LiBF4 was 
used as a cocatalyst (Entry 2) only 11% ee of the other enantiomer was observed. Dropping 
the temperature to room temperature (Entry 3) lowered the yield and ee of the reaction and 
dropping the temperature to 35 °C generated 4.8 in 35% conversion and 75% ee but did not 
produce the byproduct observed in Entry 1. For this reason, 35 °C was used for the remainder 
of the screen. Using 1.3 equivalents of either N-Meindole or phenylbuta-1,3-diene did not 
increase the yield or selectivity (Entries 5–6). A concentration screen revealed the [0.4] was 
Ph +
5 mol%
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solvent [0.67], X oC, 18 h
Entry
1
2
3
4
5
6
7
8
9
10
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CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
dce
dce
Temp (oC)
50
50
22
35
35
35
35
35
35
35
35
35
Conv. to product (%)
50
27
22
35
23
18
21
21
35
20
30
35
Ph Me
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NaBArf4, LiBArf4
NaBArf4,  LiBF4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
NaBArf4, LiBArf4
N
Me
N
Me
ee (%)
85
-11
77
75
73
76
79
75
78
77
80
84
PP Rh
Cl
NN
NN
Ph Ph
Ph Ph
PhPh
4.2
Δ from standard
-
-
-
-
1.3 eq diene
1.3 eq indole
[2.0]
[1.0]
[0.4]
[0.2]
-
[0.2]
4.8
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optimal (Entries 7–10) for both yield (35%) and enantiomeric excess (78%). Switching the 
solvent to 1,2-dichloroethane (Entries 11–12) increased the selectivity up to 84% ee with no 
formation of the byproduct that was observed in Entry 1. Optimization of this reaction is 
ongoing.  
4.3.6 Expanding the scope of nucleophiles 
Scheme 4-4 N- and C-based nucleophiles tolerated for hydrofunctionalization of phenylbuta-
1,3-diene with CBA-Rh catalyst 4.2 
	
 I was interested in expanding the scope of nucleophiles for the hydrofunctionalization 
of dienes (Scheme 4-4). Using morpholine as the nucleophile, allyl amine 4.11 was 
generated in 30% conversion and 47% ee. Chlorobenzene was found to be the optimal 
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solvent as no conversion was observed in Et2O or CH2Cl2. Using aniline, the allylic amine 
product was generated but found to be racemic. Methylene cyclopentane required five 
equivalents for reaction to occur, but produced hydrocarbon 4.12 in >98% conversion of the 
starting material diene. The enantioselectivity of that reaction is pending due to problems 
with separation by HPLC and GC. A hydroallylation between allyl BF3K salts and 
phenylbuta-1,3-diene generated  4.13 in 51% conversion with methanol as a proton source. 
Using 2,4-pentanedione as a nucleophile, the hydroalkylation of phenylbuta-1,3-diene 
generate 4.14 in 80% yield and 60% ee (result obtained by M. J. Goldfogel using my 
catalyst). 
4.4 Conclusion 
 I have developed two classes of chiral carbon(0) Rh complexes for the 
enantioselective hydroarylation, hydroamination, hydroalkylation, and hydroallylation of 
dienes. Expansion of the substrate scope is ongoing and represents a new and exciting project 
for my group.  
Experimental 
General: All reactions were carried out in flame or oven (140 oC) dried glassware that had 
been cooled under vacuum.  Unless otherwise stated, all reactions were carried out under an 
inert N2 atmosphere. All reagents were purged or sparged with N2 for 20 min prior to 
distillation or use.  All solid reagents were dried by azeotropic distillation with benzene three 
times prior to use.  Infrared (IR) spectra were obtained using a Jasco 460 Plus Fourier 
transform infrared spectrometer or a ASI ReactIR 1000, Model: 001-1002 for air sensitive 
rhodium carbonyl complexes.  Mass spectra were obtained using a Micromass Quattro-II 
triple quadrupole mass spectrometer in combination with an Advion NanoMate chip-based 
	 295	
electrospray sample introduction system and nozzle for low-res or Waters Q-ToF Ultima 
Tandem Quadrupole/Time-of-Flight Instrument UE521 at University of Illinois at Urbana 
Champaign for high-res or Waters Q-ToF Xevo Tandem Quadrupole/Time-of-Flight 
Instrument.  The Q-Tof Ultima mass spectrometer was purchased in part with a grant from 
the National Science Foundation, Division of Biological Infrastructure (DBI-0100085).  All 
samples were prepared in MeOH or MeCN for metal complexes.  Proton and carbon 
magnetic resonance spectra (1H NMR and 13C NMR) were recorded on a Bruker model DRX 
400 or a Bruker AVANCE III 600 CryoProbe (1H NMR at 400 MHz or 600 MHz, 13C NMR 
at 100 or 150 MHz, 31P NMR at 160 or 243 MHz and 19F NMR at 376 or 564 MHz) 
spectrometer with solvent resonance as the internal standard (1H NMR: CDCl3 at 7.26 ppm, 
CD2Cl2 at 5.30 ppm, C6D6 at 7.16 ppm, CD3CN at 1.94 ppm; 13C NMR: CDCl3 at 77.16 ppm, 
C6D6 at 128.4 ppm, CD3CN at 1.31 ppm).  NMR data are reported as follows: chemical shift, 
integration, multiplicity (s = singlet, d = doublet, t = triplet, dd = doublet of doublets, td = 
triplet of doublets, dt = doublet of triplets, ddd = doublet of doublet of doublets, septetd = 
septet of doublets, m = multiplet, bs = broad singlet, bm = broad multiplet), and coupling 
constants (Hz).  X-ray diffraction studies were conducted on a Bruker-AXS SMART APEXII 
diffractometer.  Crystals were selected and mounted using Paratone oil on a MiteGen Mylar 
tip.  
 
Solvents:  Solvents were purged with argon and purified under a positive pressure of dry 
argon by a SG Waters purification system: dichloromethane (EMD Millipore) and THF 
(EMD Millipore) were passed through activated alumina columns.  Chlorobenzene (Alfa 
	 296	
Aesar) was dried over K2CO3, distilled under vacuum, and stored over activated 5 Å 
molecular sieves in a dry box. 
 
Reagents:   
Ammonium tetrafluoroborate was purchased from Alfa Asaer and used as received. 
Boc-L-valine hydroxysuccinimide ester can be purchased from Sigma Aldrich and used as 
received. 
Borane (1M in thf) was purchased from Alfa Aesar, stored in the freezer, and used as 
received. 
Aniline was purchased from Aldrich, dried on CaH2, distilled under vacuum, and stored in a 
dry box freezer at -30 oC. 
Chloroform – d1 was purchased from Cambridge Isotope Labs, dried over CaH2 and stored 
in a dry box over activated 4 Å molecular sieves. 
Chloro bis(ethylene)rhodium(I) dimer was purchased from Strem Chemicals, stored in a 
dry box, and used as received.  
Chlorodiphenylphosphine was purchased from Alfa Aesar and used as received. 
Dibenzyl amine was purchased from Alfa Aesar, passed through a plug of alumina onto 
activated 5 Å molecular sieves for 24 h, and transferred to a vial in a dry box. 
Dichloromethane – d2 was purchased from Cambridge Isotope Labs, dried over CaH2 and 
stored in a dry box over activated 4 Å molecular sieves. 
(S)-2-[(Diphenylphosphino)methyl]pyrrolidine was purchased from Strem and used as 
received. 
Ethylenediamine was purchased from Sigma Aldrich and used as received. 
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LiHMDS was purchased from Strem, stored in a dry box, and used as received. 
Malononitrile was purchased from Aldrich and recrystallized from ethanol prior to use. 
1-Methylindole was purchased from Alfa Aesar, dried by azeotropic distillation with 
benzene directly after purchase, and stored at – 20 oC in a dry box. 
2-Methoxyethanol was purchased from Sigma Aldrich, dried over potassium carbonate, and 
distilled prior to use. 
Morpholine was purchased from Alfa Aesar, dried over KOH, distilled under reduced 
pressure and stored in a dry box. 
Silver tetrafluoroborate was purchased from Strem, stored in a dry box, and used without 
further purification. 
Sodium methoxide was purchased from Strem, stored in a dry box, and used as received. 
Trifluoroacetic acid was purchased from Alfa Aesar and used as received. 
Triethylamine was purchased from Fisher, dried over CaH2, and distilled immediately prior 
to use. 
 
 
 
 
(2S,2'S)-1,1'-(ethane-1,2-diylbis(azanediyl))bis(3-methyl-1-oxobutan-2-aminium) 
dichloride or di(trifluoroacetate) 4.3 
OO
iPr NHBoc
N OO
NH HN
H3NNH3
iPriPr
O O
commercially 
available
1. Ethylene diamine
thf, 60 °C, 18 h
83% yield
2. TFA, CH2Cl2
or HCl •  dioxane
22 °C, 18 h
>98% conversion
2 X
4.3
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 Boc-L-valine hydroxysuccinimide ester (20.51 g, 65.25 mmol, 2.0 equiv) was 
weighed into a 500 mL round bottom flask that was equipped with a stir bar. The flask was 
capped with a septum and purged with N2 for 10 min. Anhydrous thf (100 mL, [0.240]) 
followed by ethylene diamine (2.18 mL, 32.62 mmol, 1.0 equiv) were added via syringe. The 
reaction was allowed to stir under N2 while heating at 60 °C for 24 hours. Due to the 
heterogeneity of the reaction, it was sonicated (2 x 1 min) throughout the reaction. After 24 
hours, the reaction was cooled to 0 °C, filtered, and washed with 30 mL of cold thf. A white 
solid (12.6 g, 83% yield) was collected from the filter and was used without further 
purification.  
 The white solid (12.5 g, 27.5 mmol, 1.0 equiv) was weighed into a 250 mL round 
bottom flask equipped with a stir bar. The flask was capped with a septum and purged with 
N2 for 10 min. Anhydrous CH2Cl2 (25 mL, [1.10]) was added to the flask via syringe. The 
septum was quickly removed and trifluoroacetic acid (TFA) (8.4 mL, 4.0 equiv) was added 
to the flask via pipette, which was immediately recapped and purged with N2 for 5 min to 
remove CO2. The N2 line was removed but a 22 gauge vent need was left in. Note: Vigorous 
evolution of CO2 can occur so it is important to vent the reaction. The reaction was allowed 
to stir for 5 hours at room temperature. The excess TFA was removed by evaporation under a 
stream of N2. After 4 hours, aliquots of anhydrous CH2Cl2 (3 x 20 mL) were added to the 
flask and the solvent was removed by evaporation under a stream of N2. A white solid (4.726 
g) was isolated and matched the reported literature values.13 Note: 4 equiv HCl (4 M in 1,4-
dioxane) can also be used for the deprotection.  
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(2S,2'S)-N1,N1'-(ethane-1,2-diyl)bis(3-methylbutane-1,2-diamine) 4.4 
 Compound 4.3 (1.30 g, 2.67 mmol, 1.0 equiv) was added to an oven-dried 250 mL 
round bottom flask that was cooled under vacuum and equipped with a stir bar. The flask was 
fitted with a water-cooled reflux condenser, which was capped with a septum, and purged 
with N2 for 15 min. Anhydrous thf (75 mL, [0.0356] ) was added via syringe. The reaction 
was cooled to 0 °C in an ice water bath. Borane (40.3 mL, 1 M in thf, 15.0 equiv) was added 
slowly via syringe. The reaction was heated to 70 °C and allowed to stir for 20 hours. After 
20 hours, the reaction was cooled to 0 °C in an ice water bath and quenched by adding H2O 
dropwise until evolution of H2 had disappeared. The excess thf was removed by venting the 
reaction under a stream of N2 for 4 hours. Aqueous HCl (20 mL, 6 M) was added to the flask, 
which was then fitted with a septum capped reflux condenser that was vented through a 22-
gauge needle. The reaction was heated to reflux for 4 hours then cooled to room temperature 
and basified with solid NaOH. The solution was extracted with CH2Cl2 (2 x 25 mL) and 
EtOAc (2 x 25 mL). The combined extracts were dried over Na2SO4 (do not use MgSO4) and 
concentrated to produce an impure yellow oil (921 mg) that is used without purification. 
Note: The cyclization is not affected by the impurities (starting material and not fully 
reduced product). 1H NMR (600 MHz, Chloroform-d) δ 2.78 – 2.74 (m, 2H), 2.67 (dt, J = 
11.4, 2.7 Hz, 4H), 2.59 (ddd, J = 9.0, 5.3, 3.3 Hz, 2H), 2.45 – 2.27 (m, 8H), 1.57 (dt, J = 
13.3, 6.5 Hz, 2H), 0.87 (td, J = 6.9, 1.9 Hz, 12H). 13C NMR (151 MHz, Chloroform-d) δ 
56.35, 53.51, 49.20, 32.24, 19.28, 17.90. 
NH HN
H2NNH2
iPriPr
NH HN
H3NNH3
iPriPr
O O
2 X
Borane • thf
thf, 70 °C, 20 h
4.3 4.4
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(2S,9S)-2,9-diisopropyl-1,2,3,5,6,8,9,10-octahydrodiimidazo[1,2-d:2',1'-g][1,4]diazepin-
4-ium tetrafluoroborate 4.5 
 Tetraamine 4.4 (961 mg,4.17 mmol, 1.0 equiv), malononitrile (331 mg, 5.01 mmol, 
1.2 equiv), and ammonium tetrafluoroborate (1.310 g, 12.51 mmol, 3.0 equiv) were added to 
an oven dried/vacuum cooled 100 mL round bottom flask. The flask was outfitted with a stir 
bar and septum capped reflux condenser, then purged with N2 for 10 min. Anhydrous 2-
methoxyethanol (20 mL, [0.25]) was added via syringe. The reaction was heated to 135 °C 
and allowed to stir for 18 hours. The brown reaction mixture was concentrated in vacuo. The 
reaction was dissolved in 10:1 CH2Cl2:MeOH and filtered through a short plug of Celite® to 
remove excess NH4BF4 then concentrated in vacuo. The product (Rf of 0.2 in 20:1 
CH2Cl2:MeOH and can been visualized under 254 nm UV light) was purified by SiO2 gel 
chromatography with a solvent gradient of 50:1 to 10:1 CHCl3:iPrOH. A light yellow-tan 
solid (842 mg) was isolated in a 58% yield.  
1H NMR (600 MHz, Chloroform-d) δ 6.28 – 6.07 (m, 2H), 4.64 (s, 1H), 3.73 (t, J = 9.2 Hz, 
2H), 3.67 – 3.61 (m, 2H), 3.52 (s, 4H), 3.39 – 3.33 (m, 2H), 1.76 (m, J = 6.8 Hz, 2H), 0.94 
(dd, J = 39.6, 6.7 Hz, 12H). 13C NMR (151 MHz, Chloroform-d) δ 162.22, 60.62, 58.66, 
55.76, 46.77, 32.65, 18.27 (d, J = 50.9 Hz). 
 
N N
N
H
N
H
iPriPr
BF4
NH HN
H2NNH2
iPriPr
NH4BF4
malononitrile
2-methoxyethanol
135°C, 18 h 58% yield
4.4
4.5
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(2S,9S)-1,10-bis(diphenylphosphaneyl)-2,9-diisopropyl-1,2,3,5,6,8,9,10-
octahydrodiimidazo[1,2-d:2',1'-g][1,4]diazepin-4-ium tetrafluoroborate 4.6 
 In a dry box, diazapinium salt 4.5 (dried over P2O5, 20.0 mg, 0.0571 mmol, 1.0 equiv) 
and benzyl potassium (14.9 mg, 0.1142, 2.0 equiv) were weighed into an 8 mL vial equipped 
with a stir bar. Anhydrous thf (0.3 mL, [0.19]) was added and the reaction was capped with a 
septum cap. The reaction was stirred and heated to 50 °C for 2 hours or until the orange color 
had faded to white. The reaction was brought outside the glovebox, and cooled to -78°C in a 
dry ice-acetone bath. Diphenylphosphine chloride (20.5 µL, 0.1142 mmol, 2 equiv) was 
added via syringe. After 2 minutes, the reaction was taken out of the dry ice bath and shaken 
for 3 minutes. Anhydrous diethyl ether was added via syringe to triturate out an off-white 
solid. Once the solid had settled, the mother liquor was syringed off and more diethyl ether 
was added (3 x 5 mL) to wash the solid. The remaining solvent was evaporated under a 
stream of N2. The white solid (23.5 mg, 57% yield) was taken into the glovebox and handled 
under N2. 1H NMR (400 MHz, Chloroform-d) δ 7.43 – 7.32 (m, 20H), 5.22 (t, J = 4.5 Hz, 
1H), 4.04 (d, J = 13.3 Hz, 2H), 3.91 (t, J = 10.2 Hz, 2H), 3.76 – 3.67 (m, 4H), 3.51 – 3.40 (m, 
2H), 1.20 (d, J = 7.6 Hz, 2H), 0.57 (d, J = 6.9 Hz, 12H). 31P NMR (162 MHz, Chloroform-d) 
δ 47.44. 
 
N N
N
H
N
H
iPriPr
BF4
NH HN
H2NNH2
iPriPr
NH4BF4
malononitrile
2-methoxyethanol
135°C, 18 h 58% yield
4.5
4.6
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Synthesis of valine derived CDC-Rh Cl 4.1 
 In the glovebox, diazapinium salt 4.6 (20.0 mg, 0.0278 mmol, 1.0 equiv) and 
[Rh(ethylene)2Cl]2 (5.4 mg, 0.0139 mmol, 0.5 equiv) were weighed into an 8 mL vial 
equipped with a stir bar. Chloroform (1.0 mL, [0.0278]) was added to the vial which was 
capped and allowed to stir for 22 °C for 3 h. The brown solution was concentrated in vacuo. 
Sodium methoxide (1.5 mg, 0.0278 mmol, 1.0 equiv) was added to the vial and the solids 
were solvated with thf (1.0 mL, [0.0278]). The reaction was allowed to stir at room 
temperature for 18 h. After 18 h, the solvent was removed in vacuo and the brown solid was 
dissolved in chloroform (1 mL), filtered through a pad of Celite ®, and washed with 
chloroform (3 mL). The solution was concentrated to yield a dark brown solid (8.9 mg, 42% 
yield). 1H NMR (400 MHz, Chloroform-d) δ 8.37 (q, J = 6.2 Hz, 4H), 7.65 – 7.48 (m, 2H), 
7.48 – 7.37 (m, 10H), 7.33 (q, J = 8.2, 7.5 Hz, 4H), 4.27 (t, J = 9.3 Hz, 2H), 4.00 (d, J = 8.7 
Hz, 2H), 3.80 – 3.74 (m, 2H), 3.68 – 3.54 (m, 4H), 1.27 (d, J = 11.3 Hz, 2H), 0.74 (d, J = 6.8 
Hz, 6H), 0.59 (d, J = 7.0 Hz, 6H). 31P NMR (162 MHz, Chloroform-d) δ 74.93 (d, J = 106.7 
Hz).  
 
N N
NN
PP
Ph
Ph
Ph
Rh
Cl
iPriPr
Ph
N N
NN
PP
Ph
Ph
Ph
iPriPr
Ph
BF4
1. [Rh(H2C=CH2)Cl]2
CHCl3, 22 °C, 2 h
2. NaOMe, thf
22 °C, 2 h
42% yield57% yield
4.6 4.1
NN
Ph Ph
ClCl
NN
Ph Ph
NNEt3N
CH2Cl2: MeCN 2:1
22 °C, 18 h PPh2Ph2P
BF4
BF4
HN
Ph2P
49% yield
4.9 4.10
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Synthesis of proline derived pyrazolium salt 4.10 
 Pyrazolium salt11 4.9 was weighed into an oven dried 50 mL round bottom flask 
outfitted with a stir bar. The flask was capped with a septum and purged with N2 for 10 min. 
MeCN (6 mL, [0.15]) and CH2Cl2 (6 mL, [0.15]) were added to the flask, which was then 
cooled to -78 °C in a dry ice-acetone bath. Triethylamine (627 µL, 4.50 mmol, 5.0 equiv) and 
(S-)-2-[(Diphenylphosphino)methyl]pyrrolidine (500 mg, 1.86 mmol, 2.1 equiv, dissolved in 
6 mL CH2Cl2) were added via syringe. The reaction was allowed to come to room 
temperature and stir for 18 hours. After 18 hours, the solvent was concentrated under a 
stream of N2. The product was purified by column chromatography (20:1 CHCl3:iPrOH) by 
gravity to ensure separation. The product streaks on the TLC plate, has an Rf of 0.4 in 20:1 
CHCl3:iPrOH, and can be visualized under 254 nm UV light. A white solid (373 mg) was 
isolated in 49% yield. 
1H NMR (600 MHz, Chloroform-d) δ 7.47 (ddt, J = 15.9, 14.2, 6.7 Hz, 10H), 7.42 – 7.30 (m, 
17H), 6.91 (s, 4H), 4.64 (s, 1H), 3.72 (s, 2H), 3.18 (dt, J = 10.5, 7.0 Hz, 2H), 2.72 (d, J = 
12.2 Hz, 2H), 2.53 (ddd, J = 13.9, 4.1, 2.3 Hz, 2H), 2.23 (dd, J = 13.8, 9.3 Hz, 2H), 2.15 – 
2.05 (m, 2H), 1.86 (dtt, J = 20.0, 13.2, 6.8 Hz, 4H), 1.76 (dtd, J = 12.9, 6.5, 4.4 Hz, 2H). 31P 
NMR (243 MHz, Chloroform-d) δ -23.78. 13C NMR (151 MHz, Chloroform-d) δ 160.44, 
137.93 (d, J = 13.1 Hz), 137.52, 137.45 (d, J = 11.1 Hz), 133.12 (d, J = 19.9 Hz), 132.76 (d, J 
= 19.8 Hz), 130.72, 129.99, 129.29, 129.10, 128.84, 128.79, 128.74, 59.85 (d, J = 22.2 Hz), 
51.13, 32.74 (d, J = 15.9 Hz), 31.41 (d, J = 6.7 Hz), 24.05. 
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Synthesis of pincer CBA-RhCl complex 4.2 
 In the glovebox, pyrazolium salt 4.10 (201 mg, 0.266 mmol, 1.0 equiv) and LiHMDS 
(44.5 mg, 0.266 mmol, 1.0 equiv) were added to an 8 mL vial equipped with a stir bar and 
placed into the glovebox freezer at -20 °C for 1 hour. A vial with thf (4 mL, [0.0665]) was 
cooled to -20 °C for 1 hour. The cooled vial of solids was solvated with the cold thf and 
placed back into the freezer for 30 min. After 30 min, the reaction was allowed to come to 
room temperature while stirring. After 1 hour, [Rh(ethylene)2Cl]2 was added to the vial. A 
small amount of orange solid precipitated out of the reaction. The reaction was allowed to stir 
for 12 hours then concentrated in vacuo to remove ethylene. The solids were solvated with 
another aliquot of thf (4 mL) and the reaction was allowed to stir for 4 hours. After 4 hours, 
the reaction was filtered through a plug of Celite® and washed with thf. The solvent was 
concentrated in vacuo to generate a reddish-brown solid (202 mg, 85% yield). 31P NMR (243 
MHz, THF-d8) δ 33.53 (d, J = 137.7 Hz). The 31P NMR shows one doublet in the spectrum. 
The 1H NMR is very broad therefore, the integrations of peak are not accurate, and have been 
deleted. Please see spectrum for more detail. 1H NMR (600 MHz, THF-d8) δ 7.88 – 7.72 (m), 
7.72 – 6.81 (m), 6.13 (s), 5.83 (s), 5.70 (d, J = 7.9 Hz), 3.45 – 3.29 (m), 2.95 (d, J = 6.3 Hz), 
2.90 – 2.68 (m), 2.68 – 2.53 (m), 2.28 – 2.23 (m), 1.96 (dddt, J = 27.8, 21.9, 14.6, 7.4 Hz), 
1.71 – 1.61 (m). Because of this broadness, a 13C NMR could not be obtained. 
 
NN
Ph Ph
NN
PP Rh
Cl
NN
NN
Ph Ph
Ph Ph
PhPh
PPh2Ph2P
BF4 1. LiHMDS,
thf, 0 to 22 °C; 4 h
2. [Rh(H2C=CH2)2Cl]2
thf, 22 22 °C; 18 h
85% yield4.10
4.2
	 305	
 
Synthesis of pincer CBA-PtI complex 4.15 
 In the glovebox, pyrazolium salt 4.10 (50 mg, 0.0661 mmol, 1.0 equiv) and PtI2 (29.7 
mg, 0.0661 mmol, 1.0 equiv) were weighed into an 8 mL vial equipped with a magnetic stir 
bar. The vial was capped with a septum cap and brought outside the glovebox. 
Diisopropylethylamine (35 µL, 0.198 mmol, 3.0 equiv) and dry, deoxygenated thf (3.0 mL, 
[0.022]) were added to the vial via syringe. The reaction was allowed to stir for 18 h at 60 °C 
for 18 h. The solvent was evaporated under a stream of N2. The vial was brought into the 
glovebox, resolvated with thf (3 mL), and filtered through a 1.5 inch pad of Celite®. The 
solid on top of the celite was washed with thf (8 mL) until the solution was clear. The 
product was dissolved off the top of the Celite® plug in CH2Cl2 (10 mL) and concentrated to 
yield 4.15 as an orange solid (57.8 mg, 75% yield). 
1H NMR (600 MHz, Chloroform-d) δ 7.95 (q, J = 6.1 Hz, 4H), 7.58 – 7.31 (m, 20H), 7.27 (d, 
J = 8.1 Hz, 2H), 7.25 – 7.07 (m, 4H), 5.64 (p, J = 5.3 Hz, 2H), 3.24 (dt, J = 14.7, 4.6 Hz, 
2H), 3.15 (ddt, J = 13.8, 10.1, 3.3 Hz, 2H), 3.00 (ddd, J = 11.0, 7.0, 5.0 Hz, 2H), 2.79 (dt, J = 
10.5, 6.9 Hz, 2H), 1.98 (dt, J = 12.4, 6.7 Hz, 2H), 1.95 – 1.88 (m, 2H), 1.81 – 1.68 (m, 4H). 
31P NMR (243 MHz, Chloroform-d) δ 3.42 (t, J = 1200.4 Hz) 
 
 
PP Pt
I
NN
NN
Ph Ph
Ph Ph
PhPh
BF4
4.15
NN
Ph Ph
NN
PPh2Ph2P
BF4
4.10
PtI2, DIPEA
thf, 60 °C, 18 h
75% yield
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Synthesis of pincer CBA-PdBr complex 4.16 
 In the glovebox, pyrazolium salt 4.10 (28.4 mg, 0.0376 mmol, 1.0 equiv) and PdBr2 
(10.0 mg, 0.0376 mmol, 1.0 equiv) were weighed into an 8 mL vial equipped with a 
magnetic stir bar. The vial was capped with a septum cap and brought outside the glovebox. 
Diisopropylethylamine (20 µL, 0.113 mmol, 3.0 equiv) and dry, deoxygenated thf (2.0 mL, 
[0.019]) were added to the vial via syringe. The reaction was allowed to stir for 18 h at 60 °C 
for 18 h. The solvent was evaporated under a stream of N2. The vial was brought into the 
glovebox, resolvated with thf (3 mL), and filtered through a 1.5 inch pad of Celite®. The 
solid on top of the celite was washed with thf (8 mL) until the solution was clear. The 
product was dissolved off the top of the Celite® plug in CH2Cl2 (10 mL) and concentrated to 
yield 4.16 as an orange solid (18.8 mg, 48% yield). 
1H NMR (600 MHz, Chloroform-d) δ 7.96 (s, 4H), 7.60 – 7.31 (m, 20H), 7.15 (d, J = 44.7 
Hz, 6H), 5.51 (s, 2H), 3.35 (d, J = 14.8 Hz, 2H), 3.00 – 2.80 (m, 4H), 2.75 (d, J = 9.3 Hz, 
2H), 1.91 – 1.79 (m, 3H), 1.72 (d, J = 17.5 Hz, 2H), 1.57 – 1.43 (m, 2H). 
31P NMR (243 MHz, Chloroform-d) δ 12.23. 
 
 
Representative procedure for hydrofunctionalization reactions with 4.1 and 4.2 
PP Pd
Br
NN
NN
Ph Ph
Ph Ph
PhPh
BF4
4.16
NN
Ph Ph
NN
PPh2Ph2P
BF4
4.10
PtI2, DIPEA
thf, 60 °C, 18 h
48% yield
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 In a N2 filled dry box, an 8-mL vial equipped with a stir bar was charged with the 
complex 4.1 or 4.2 (0.005 mmol, 5 mol%) and additive (0.005 mmol, 5 mol%). The diene 
(0.100 mmol, 1.0 equiv) was added to the vial followed by the nucleophile (0.100 mmol 1.0 
equiv), which were added either as a solid or via syringe. The appropriate solvent was added 
to the vial via syringe.  The vial was capped with a Teflon® lined lid or septum cap, taped 
with electrical tape and brought outside the dry box. The reaction was allowed to warm to the 
appropriate temperature and stir for 18 h.  Then the reaction was allowed to cool to room 
temperature and an aliquot was taken to determine the conversion by 1H NMR.  The 
remaining solvent was removed in vacuo.  The products were purified by SiO2 column 
chromatography and visualized with UV light or vanillin stain (indoles).  
 
Preliminary characterization of products from Tables 4-1 and 4-1, and Scheme 4-4 
(E)-1-methyl-3-(4-phenylbut-3-en-2-yl)-1H-indole 4.8 matched the literature spectrum.18 
Diacel CHIRALPAK IA Column; 100% hexanes 1.00 mL/min; 22 °C, 210 nm.  
 
 
 
 
 
 
 
 
Racemic trace: 
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Diacel CHIRALPAK IA Column; 100% hexanes 1.00 mL/min; 22 °C, 210 nm.  
Enantio enriched material:   
 
(E)-4-(4-phenylbut-3-en-2-yl)morpholine 4.11 matched the literature spectrum.19 
(E)-(4-cyclopentylidene-3-methylbut-1-en-1-yl)benzene 4.12 
1H NMR (600 MHz, Chloroform-d) δ 7.39 – 7.29 (m, 3H), 7.24 – 7.17 (m, 2H), 6.34 (dd, J = 
15.8, 1.5 Hz, 1H), 6.24 (dd, J = 15.8, 6.6 Hz, 1H), 5.45 – 5.38 (m, 1H), 3.46 – 3.40 (m, 1H), 
2.32 (dq, J = 9.7, 3.5 Hz, 3H), 1.82 – 1.74 (m, 2H), 1.19 (d, J = 7.0 Hz, 3H). 
(E)-(3-methylhexa-1,5-dien-1-yl)benzene 4.13 matched the literature spectrum.20 
(E)-3-(4-phenylbut-3-en-2-yl)pentane-2,4-dione 4.14 matched the literature spectrum.21 
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